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Electrochemical Analysis of Some Drug Substances in Complex Matrices
A t 2 M
This thesis describes the development of several analytical methods, based on 
electrochemical techniques, for the determination of various drug substances in 
formulations, biological fluids and environmental samples. The work included 
a study of the voltammetric behaviour of both sumatriptan succinate and 
salbutamol sulphate at a glassy carbon electrode. Based on these studies, 
simple, rapid and sensitive voltammetric methods were developed for the 
determination of these drugs in tablet dosage forms without any interferences 
from the excipients. Using differential pulse voltammetry, the dissolution 
profile of salbutamol tablets was also investigated. The principal criteria for 
designing electrochemical flow detectors, and the great advantages of carbon 
fibre electrodes, have been utilized in the development of a versatile 
electrochemical detector for HPLC that is based on a carbon fibre (14 pm 
diameter) placed in a polyethylene tube connected directly to the end of the 
chromatographic column. The analysis of salbutamol in human plasma was 
then developed based on extracting the drug from the plasma into an organic 
solvent and separation of the drug on a reversed-phase Cjg column, followed 
by detection using the carbon fibre flow electrode. Several advantages of the 
carbon-fiber flow electrodes over conventional electrodes have also been 
demonstrated. The cell was then used for monitoring of terbutaline 
concentrations in human plasma in the range of 1-35 ngml'l using column- 
switching LC. The method involved direct injection of the plasma sample into a 
C i 8 extraction column for sample clean-up. This method was also applied for 
the simultaneous determination of both salbutamol and terbutaline at overdose 
levels in human plasma. A method was then developed to determine the 
suspected carcinogen gentian violet in human urine and in poultry feed. Liquid 
chromatography with electrochemical detection was also applied in 
environmental studies for the analysis of malachite green in drinking water and 
river water.
Drug Development and Electrochemical Analysis
Chapter 1
1 .1 .  Introduction
1. 1. 1. D r u g  D e v e l o p m e n t
Analytical methods are required to assure the purity of starting materials and can be 
used to monitor a systematic process to determine if it has reached completion., and 
to, isolate and quantitate by-products of the reaction.
Analytical research on a drug substance starts after synthesis, with the 
characterisation of its physicochemical properties to ensure that all pharmacological 
testing is done with pure material and to establish specifications so that future 
production lots will yield a reproducible in vivo response. These specifications will 
include studies of the purity of the drug, identification and quantitation of other 
products of synthesis and degradation, the pKa values of the drug , and physical 
characterisation such as thermal stability, optical activity, surface properties, 
particle size, and crystalline form. These studies will also include investigations of 
the stability and solubility o f the drug in aqueous media as a function of pH. Most 
drugs are weak acids or bases and are present in solution as both the nonionized and 
ionized species. Dissolution constants of weak acids and bases are numerically 
small and a logarithmic notation is, therefore, convenient. The dissociation constant 
exponent, pK, is derived from the dissociation constant in a manner analogous to 
the derivation of pH from hydrogen ion concentration. Hence
pKa = -logioK a (1)
It follows from this expression that the higher the value of Ka the smaller the value 
of pKa, so that the stronger the acid the smaller the pKa value.
Upon completion of the analytical profile, the drug is released for preliminary 
pharmacological and toxicological testing in laboratory animals. At this stage of 
development, the drug is usually administered in a simple preliminary formulation 
by parentral and oral routes, to determine its pharmacological activity, its relative 
safety, and dose-response characteristics. During toxicological testing, blood, urine, 
and tissue samples are collected and analysed to correlate both pharmacological 
response and toxicity to the blood level. These data aid in the assessment of 
adequate absorption, dose-response behaviour, metabolic effects such as 
accumulation, enzyme induction or attainment of steady-state conditions, intra- and 
inter-species variations, and the relationship of drug levels to symptomatology. 1
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In addition to toxicological studies, various in vitro studies are then performed to 
determine if any physicochemical factors such as solubility, dissolution or release 
rate, permeability, gastrointestinal degradation, and rapid biotransformation will 
affect the drug s oral absorption characteristics after administration of a given dose 
in a pharmaceutical dosage form^. The absorption, distribution, biotransformation, 
and excretion of a drug all involve its passage across cell membranes. It is essential, 
therefore, to consider the mechanisms by which drugs cross membranes and the 
physicochemical properties of molecules and membranes that infleuence this 
transfer. Important characteristics of a drug are its molecular size and shape, 
solubility at the site of its absorption, degree of ionization, and relative lipid 
solubility of its ionized and nonionized forms. Since drugs generally are too large to 
pass through membrane channels, they must pass membrane barriers by diffusion 
through the lipid components of the membranes. The nonionized molecules are 
usually lipid soluble and can diffuse across the cell membrane. In contrast, the 
ionized fraction is usually unable to penetrate the lipid membrane because of its low  
lipid solubility.
When a drug permeates a cell, it must obviously traverse the cellular plasma 
membrane. Other barriers to drug movement may be a single layer of cells 
(intestinal epithelium) or several layers of cells (skin). Despite these structural 
differences, the diffusion and transport of drugs across these various bounderies 
have many common characteristics, since drugs in general pass through cells rather 
than between them. The plasma membrane thus represents the common barrier.
Assays must be devised to assess the solubility and dissolution rate of drugs as a 
function of pH within the physiological pH 1-8 at 37°C, and to evaluate the drug s 
permiability characteristics across the intestinal mucosa. The utility of these in vitro 
studies has been reported Kaplan^- Metabolic transformation is evaluated in vitro 
by incubating the drug in a liver microsomal enzyme fraction (900 x g supernatant) 
at 37°C, which was separated from the liver homogenates^. Analytical 
methodology is needed for these studies to quantitate the rate of biotransformation, 
and to isolate and quantitate the metabolites formed.
The design of a suitable dosage form at a clinically effective and safe dosage level 
is based on the data obtained from the pharmacological and toxicological studies, 
together with biopharmaceutical data gained from the in vitro studies. Such dosage 
forms are evaluated for bioavailability following oral adminstration to laboratory 
animals at a relatively high dose (typically body weight in the dog). The 
bioavailability, rate, and extent of absorption of this formulation are then assessed
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by comparing its blood level, urine, and faecal elimination profile to that obtained 
from an intravenous and oral solution of the drug at the same dosing leveP. The 
dosage form exhibiting optimal bioavailability is used for dosing animals in toxicity 
studies, in several animal species, in which blood, urine, and tissue levels of drug 
and/or metabolites are monitored. If the drug is shown to be safe, it is then ready for 
limited testing in humans. An Investigational New Drug application (IND) is filed 
with the Food and Drug Adminstration (FDA) which describes the drug formulation 
(list of components, quantitative composition), the analytical procedures employed 
to establish and maintain standards of identity, strength, and purity, and all the pre- 
clinical information pertaining to the administration of the drug to laboratory 
animals.
With approval from the FDA the drug proceeds into Phase 1 clinical testing, where 
it is adminstrated to humans to determine its safe dosage range, pharmacological 
activity, side effects, metabolism, and distribution, absorption, and elimination 
characteristics. From these studies, samples of blood, urine, and faeces are collected 
and analysed to assess the preliminary bioavailability and pharmacokinetic profile 
in humans. Pharmacokinetics is defined as the study of the kinetics o f absorption, 
distribution, metabolism, and excretion of drugs and other endogenous substances. 
During Phase 2 and Phase 3 testing of a drug for the safety and effectiveness in the 
diagnosis, treatment, or prophylaxis of a given disease or condition, biological 
fluids are collected to obtain comprehensive pharmacokinetic information and to 
correlate such data with activity of the drug. At the completion of the clinical trials, 
all the data are accumulated about the drug from its initial synthesis to its clinical 
testing and submited to the FDA as a New Drug Application (NDA) for approval of 
the drug as a marketable product. Subsequent to marketing, constant quality control 
monitoring of the product from lot to lot must be maintained to provide the patient 
with a reproducible product. To guarantee this reproducibilty in the dosage form, it 
is necessary to develop assays that will analyse reagents, bulk chemicals, and 
intermediates which go into the dosage form, and also to obtain and analyse 
representative samples of the dosage form.
Analytical chemistry plays a critical role in the development of a compound from 
its synthesis to its marketing as part of a drug formulation. The instrumental 
methods for quantitation which are most commonly used in a pharmaceutical 
laboratory fall into four basic categories: chromatographic, spectrophotometric, 
electrochemical, and radiometric analysis.
The choice of the appropriate technique to solve an analytical pharmaceutical 
problem is often controlled by the sample matrix, and the amount of preparation 
that is required before the analytical measurement can be made. If the material is an 
organic bulk substance or intermediate, it is usually possible to dissolve the 
compound in a suitable organic solvent and analyse the sample by thin liquid 
chromatography (TLC), gas chromatography (GC) or high-performance liquid 
chromatography (HPLC). A dosage form may be dissolved in an aqueous medium, 
filtered, and analysed directly using an electrochemical technique or extracted into 
an organic solvent and analysed chromatographically or spectrophotometrically. 
The final selection for the determination step is dependent on the intrinsic 
physicochemical properties of the pure compound or its derivatives. Thus, 
compounds or their derivatives should be processed through an analytical screening 
program to examine their spectrophotometric, chromatographic, and 
electrochemical properties which might be amenable to chemical analysis. Based on 
the signal response per unit mass of a compound, a projected limit of detection 
(LOD) per milliliter or gram of sample can be calculated. Many analytical 
procedures can be eliminated at this stage of method development.
1.1 .  2. T h e r a p e u t i c  d r u g  m o n i t o r i n g
Chemists and biochemists have been routinely analysing biological fluids since the 
early part of this century when they discovered that a relationship existed between 
the concentration of various endogenous substances, for example glucose, 
hormones, enzymes, etc., and the cause of a disease^. The analysis of drugs in 
biological media, however, has emerged relatively recently, and it is only in the last 
twenty years that it has recieved widespread attention^. With few exceptions, drugs 
are low molecular weight organic compounds of known structure and well defined 
physico-chemical properties, readily available in pure form^. The analysis of drugs 
in biological materials possess a serious challange to the analytical chemist due to 
difficulties imposed by the complexity of these media.
Growth in the field of biopharmaceutical analysis has paralleled the expansion in 
the number of new drug compounds introduced onto the market. Assays for 
proposed new drugs are essential with a view to establishing protocols for new drug 
registration. It is necessary for a drug company to develop methods capable of 
determining low concentrations of their products in blood, plasma, urine and other 
biological matrices in order to establish the pharmacokinetic profile of that product. 
Drug levels are also monitored in cases of drug abuse, overdose, and as a guide to
£
optimise individual drug-dose regimens, i.e. therapeutic drug level monitoring 
(TDM.).
TDM may be required in the following circumstances: (a) where there is a question 
of patient compliance, (b) where there is a lack of therapeutic effect, (c) where the 
drug has a narrow therapeutic range, (d) where there is danger of toxicity, and (e) 
where there is a need for medico-legal variation of treatment. In many cases 
quantitation of metabolites in addition to the parent drug will be required if these 
metabolites are pharmacologically active. TDM may involve quantitation in the 
microgram (ppm), nanogram (ppb) or picogram (ppt) concentration ranged
1 .2 . D r u g  A n a l y s i s
Modem analytical chemistry must satisfy very diverse demands. Among the most 
difficult tasks are the continuous monitoring of substances and analyses of very 
complicated organic and inorganic systems, often at trace concentration levels 
(mainly in clinical analysis, pharmaceutical research, industry etc). Although the 
chemical structure of the drug will largely dictate the most suitable assay procedure 
for its determination^, the magnitude and frequency of the doses administered and 
the pharmacokinetics of the compound, govern the ultimate sensitivity and 
selectivity required of the assay for its quantitation in biological fluids. The 
requirements of an assay are that it is selective, sensitive, reproducible, and 
applicable to a large range of compounds. It should also be relatively simple to 
develop and execute, and ideally should not involve lengthy and tedious sample 
preparation stages.
1. 2 .1 .  S p e c t r o p h o t o m e t r i c  A n a l y s i s
Spectrophotometric absorption (UV-Vis) and emission (fluorescence and 
phosphorescence) methods have been the classical methods used extensively in 
drug analysis. They possess reasonable sensitivity, but lack high selectivity since 
spectral characteristics cannot usually differentiate between the parent drug from 
any metabolites present, unless used in conjunction with differential solvent 
extraction techniques using liquid-liquid or solid extraction separations. Most drugs 
exhibit moderate to strong absorption bands in the 215 - 300 nm region. While UV 
spectrophotometric methods are not as selective as chromatographic methods, they 
are simple and rapid, making them useful for screening purposes.
The most recent development in spectrophotometric detection has been the 
introduction of instruments based on a photodiode array detector^. By using
6
"reverse optics", all the light from a deuterium lamp is passed through the sample 
cell onto the monochromator, which spreads out the beam into a spectrum. This 
falls across an array of 230-350 photodiodes mounted on a silicon chip. These can 
readily be monitored virtually simultaneously by a microcomputer to provide the 
full absorption spectrum from 200 to 700 nm every 0.1 s. This detector can thus 
provide a continuous measurement of the full spectral absorbances of the eluent 
with time. Because they are very versatile and are supported by sophisticated 
computer software for the interpretation of the results, diode array detectors are 
relatively expensive (3-6 times more costly than a variable-wavelength detector).
1. 2. 2. Immunoassay Techniques
The discovery of competitive binding assays by Yalow and Berson^O in 1959 has 
proved to be a significant development in the fields of both clinical and analytical 
chemistry. Drug immunoassays are simple to perform but complex to develop. In 
development of such an assay, the drug first has to be coupled as a hapten to a 
carrier protein, usually bovine serum albumin, in order to raise antibodies against 
them, since most drugs themselves are not immunogenic^. If the drug molecule 
does not have an appropriate group for direct conjugation reaction, a chemical 
derivative may have to be prepared prior to the conjugation step. After formation of 
the immunogenic species, an animal (usually a rabbit or a goat) is immunised and 
the appropriate antibodies isolated. The drug must then be labelled with the 
appropriate label. Typical labels include radiochemical, enzymatic, fluorescent and 
electrochemical labels. Finally when all the reagents are available, the assay 
procedure itself must be optimised in terms of variables such as antibody dilution, 
pH, temperature and time of in cu b ation ^  These assays are amongst the most 
specific methods of drug analysis, but complications can arise from factors such as 
cross-reactivity.
1. 2. 3. Chromatographic Techniques
The first person to use the term "chromatography" was the Russian botanist Tswett 
(1872-1919), who reported on the separation of coloured plant pigments into bands 
on a column of chalk13,14 Tswett (1906) stated that: " Chromatography is a 
method in which the components of a mixture are separated on an adsorbent column 
in a flowing system". Recently the International Union of Pure and Applied 
Chemistry has defined chromatography as:
"A method used primarily for the separation of the components of a sample, in 
which the components are distributed between two phases, one of which is
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stationary while the other moves". The stationary phase may be a solid, or a liquid 
supported on a solid, or a gel. The stationary phase may be packed in a column, 
spread as a layer, or distributed as a film, etc.; in these definitions "chromatographic 
bed" is used as a general term to denote any of the different forms in which the 
stationary phase may be used. The mobile phase may be gaseous or liquid^. There 
are three principal elution procedures; isocratic(from the Greek, isochros, meaning 
equal strength); stepwise (or fractional); and gradient. The isocratic procedure is the 
operation of the chromatographic column by allowing a solvent mixture of 
unvarying composition to run through the column until separation is complete. If 
only one solvent is used ready elution of only some of the components of the 
original mixture from the column may result. To remove those which are more 
firmly held, a stronger eluting agent is required. Sometimes it may be necessary to 
use several different solvents of gradually increasing strength for the successive 
desorption of different components. This is known as stepwise elution. The 
technique of gradient elution analysis was first described in detail by Aim et al.16. 
It involves the use of a continuously changing eluting medium. The effect of this 
gradient is to elute successively the more strongly adsorbed substances and at the 
same time to reduce tailing.
It was not until the 1930s that chromatography in the form of thin-layer and ion- 
exchange chromatography became a regularly used technique. The 1940s saw the 
development of partition chromatography and paper chromatography with gas 
chromatography following in 1950. The 1960s saw a rapid rise in the routine use of 
chromatography as universal technique, particularly in chemistry, biology and 
medicine. Two nobel prizes have been awarded to chromatographers, Tiselius 
(Sweden) in 1948 for this research on "Electrophoresis and Adsorption Analysis", 
and Martin and Synge (UK) for the "Invention of Partition Chromatography".
Recent developments and technologies, such as microelectronics and 
microcomputers have enabled manufacturers to produce instruments that are 
reliable, with parameters that can be precisely set and measured, to give 
reproducible chromatograms and a vast expansion of our knowledge and 
understanding of this powerful analytical separation method. High-performance 
liquid chromatography (HPLC) and gas chromatography (GC) are the most widely 
used chromatographic techniques for quantitative analysis o f therapeutic drugs in 
biological media.
2
1. 2. 3 1. Gas Chromatography
Gas chromatography coupled to a variety of detection modes, i.e. flame ionisation 
(FID), electrón-capture (ECD) and nitrogen-phosphorous (NPD) detection, is a 
widely applied technique. Although analysis of an intact drug moiety 
(underivatised) is preferred to assure selectivity, derivatisation is often necessary. 
Simple derivatisation reactions such as alkylation or silylation can be used when 
needed to yield very sensitive and selective methods. When making a derivative, 
one must take account of the detection system to be used, so that during sample 
preparation contaminants are not introduced into the extract which could be 
deterimental to the determination. NPD is particularly susceptible to interferences 
by residues o f silylating reagents and phosphate plasticizers contained in plastic 
syringes.
1. 2. 3. 2. High-performance Liquid Chromatography (HPLC)
In 1963, Giddingsl^ showed that if the framework developed for gas 
chromatography applied equally to liquid chromatography, it would require high 
mobile phase inlet pressures. When such systems were demonstrated, high column 
efficiencies were obtained and high-performance liquid chromatography was 
described first by Kirkland^, Huber 19 and Horvath et al.20. By operating at high 
pressure, these instruments overcame the effect of higher liquid viscosities relative 
to gas viscosities, and gave analysis times comparable with gas chromatography 
(GC). HPLC is an attractive approach in drug analysis for a number of reasons. 
Firstly, sample preparation is often minimal; a simple protein precipitation step 
followed by centrifugation and injection of the supernatant may be all that is 
required. Secondly, there is rarely a requirement for sample derivatisation prior to 
the chromatographic step, as there is in GC. Thirdly, it can be used for samples that 
are thermolabile and unsuitable for GC. Fourthly, most analyses can be performed 
successfully on reversed-phase systems. These systems are ideally suited to drug 
analysis. Most drugs possess sufficient hydrophobic structure to ensure retention by 
the stationary phase. However, many also contain hydrophobic groups which will 
limit this retention and allow the chromatographic process to occur in a reasonable 
time. Mobile phase "strength" can be readily controlled by adjusting the organic 
solvent to buffer ratio. Variations in pH, ionic strength and the use of ion-pairing 
agents provide additional versatility.
Detectors for drug analysis using HPLC include ultraviolet and visible absorbance, 
fluorescence and electrochemical detection, depending on the chemical properties
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of the drug to be analysed. HPLC is of major importance to the analyst in the 
pharmaceutical, food and fine chemical industries and has also played a significant 
role in forensic, environmental, chemical and biochemical studies. In the latter field 
it has been used by molecular biologists to isolate gene probes, i. e. short lengths of 
DNA (ca 30 bases), from synthetic mixtures^!. For the practising chromatographer, 
often a search of the relevant literature will identify a similar application which 
with some minor modification will prove suitable for the particular need.
1. 2. 4. Guidelines fo r  Bioanalysis using HPLC
A bioanalytical method consists of several steps: sampling, sample treatment (clean­
up and/or pre-concentration), derivatisation (if required), separation, (post-column) 
reaction/detection, quantitation, and data p r o c e s s i n g ^ , 23 Sample pre-treatment 
and chromatographic separation are normally the most time-consuming steps. When 
developing a bioanalytical procedure, the problems and objectives should be clearly 
defined. This allows selection of the appropriate sample treatment step (STS), and 
chromatographic and reaction/detection techniques. In bioanalysis, the use of a 
guard column between the injection device and the analytical column is essential in 
order to avoid clogging of the latter by macromolecules and/or particulate matter. 
The internal volume of the guard column should be small enough (volume ratio less 
than 40% of the analytical column) to avoid additional band broadening. The 
following modes are frequently applied in modem HPLC.
(i) Normal-phase (NP) adsorption chromatography, using polar stationary phases 
(e.g. silica, alumina) in combination with non-polar solvents.
(ii) NP partition chromatography using chemically modified silicas. A wide variety 
of hydrophilic or polar modified silicas (e.g. cyanopropyl, diol, aminopropyl 
phases) are available.
(iii) Reversed-phase (RP) partition c h r o m a t o g r a p h y 24,25 a  wide selection of 
modified silicas (e.g. octadecyl, octayl, butyl, phenyl phases) is available for polar 
as well as non-polar compounds. It is now estimated that 60 - 80% of all HPLC 
separations are accomplished using RP p a c k i n g s ^ , 27
(iv) Ion-pair (IP) chromatography is another technique for the separation of ionised 
compounds. This can be performed as a liquid-solid adsorption or a liquid-liquid 
partition technique, using either the RP or the NP mode.
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(v) Chiral chromatography. It is now well understood that different enantiomers of 
compounds can have significant differences in their biological activity. Examples of 
this are commonplace, for instance, the (+) form of estrone is an estrogenic 
hormone whereas the (-) form is inactive. D-Penicillamine is an antiarthritic drug, 
but the L-form has been found to be extremely toxic. Sucrose can only be 
metabolised if it is in its naturally occuring D-form. The synthetic L-form tastes 
identical, but can not be metabolised and therefore has potential as a dietary 
sweetener. Since biological systems are generally stereospecific and stereoselective 
it is likely that the chemical or biological activity of a compound will depend on its 
stereochemistry. The aim of the chemical industry is to develop the most effective 
compounds for the market place that are both highly active and safe in the 
environment. Stereospecific compounds are therefore being developed with the aim 
that they will be more active than the racemates and safer in the environment 
because they will contain less inactive material.
The chirality of novel compounds is therefore examined at all stages in their 
development. During the early stages of the development of a chemical, different 
synthetic routes for stereospecific compounds need to be examined analytically. 
Individual enantiomers require biological and toxicological screening. During later 
stages of development and when the compound is in the market place, analytical 
methods are necessary for registration submissions, to provide enforcement 
methods for regulatory authorities and to monitor the quality of the product in 
manufacturing. Enantiomers have indistiguishable physical and chemical properties, 
except when they are in a chiral environment or in response to polarized light. They 
cannot therefore be resolved directly by conventional chromatography. Chiral high- 
performance liquid chromatography (HPLC) provides the chiral environment to 
enable enantiomer separation for analytical methods and, on a preparative scale, to 
isolate sufficient quantities for screening programmes. This can be achieved in 
essentially three ways, namely using chiral derivatization, chiral additives and 
chiral stationary p h ases .2 8  - 31
Chiral derivatizing reagents are treated with the chiral compound of interest before 
being separated chromatographically. The resulting derivatives are diastereoisomers 
and can therefore be separated using non-chiral chromatographic techniques. The 
derivatization reaction may be incomplete at the time of separation or the 
derivatization reagents or their impurities could interfere with the chromatography 
of the enantiomers of interest. An alternative is to use chiral additives that are 
dissolved in the mobile phase. The chiral complexes formed have different capacity 
factor so that the separation can again be achieved using non-chiral
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chromatographic techniques. With chiral stationary phases, however, the 
enantiomers are separated by their interaction with a chiral entity that is bound to 
the stationary phase. This is proving to be a popular technique, since no pre-column 
derivatization is required and it is not necessary to optimize the concentration of 
any chiral additives during development.
Differences in stability between the diastereoisomers is reflected in differences in 
retention times, the enantiomer forming the less stable complex being eluted first. 
An interesting example of this stationary phase separation of the anti-inflammatory 
drug, ibuprofen after derivatisation to its amide is shown in Figure 1.1.
(vi). Size exclusion chromatography (SEC) is a widely used clean-up technique to 
remove high-molecular-mass components that could interfere with liquid or gas 
chromatographic determination of analytes, such as pesticides and other organic 
compounds, in environmental m atrices^ - 34 SEC, though an established 
technique for the separation of macromolecules using open-column systems, met 
with limited success when applied to modem LC, as many of the commercially 
available packings did not meet the constraints and instrumental demands of HPLC. 
Recently (from 1982), a variety of packings have been developed which have led to 
a spectacular growth in the HPLC analysis of macromolecular samples, such as 
polydisperse polymer samples and biological materials, such as proteins and 
carbohydrates. SEC differs from other LC modes in that separation takes place 
exclusively because of differences in molecular size; consequently solvent selection 
is simpler, as the requirements of the solvent are simply that of sample solubility 
and packing compatibility.
(vii). Internal surface reversed-phase (ISRP). ISRP supports represent a relatively 
new concept in liquid chrom atography^, which combines the fundamental 
principles of size exclusion and bonded phase partitioning separations to produce a 
type of surface discriminating chromatography. The ISRP material has the ability to 
exclude large molecules, such as proteins, from the pores with negligible adsorption 
of these molecules on the external surface. Low-molecular-mass compounds, such 
as drugs, are separated with good capacity, selectivity and efficiency. Several 
methods have been described for direct injection of biological matrices, such as 
serum and plasma, for the determination of drugs36 - 41 jn which proteins did not 
interfere with the chromatographic analysis.
The physicochemical properties of the analyte primarily determine which 
chromatographic system is most appropriate, but the physicochemical properties of
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Figure 1,1. Reaction between chiral stationary phase and amide derivative of 
(R) - ibuprofen. Reproduced from Braith waite, A. and Smith,
F. (Eds), Chromatographic Methods Chapman and Hall, New 
York, 1985, p. 267.
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the biological matrix are also important. A major problem in developing 
bioanalytical procedures is the presence of proteins, which can clog the 
chromatographic system, especially when analyte-containing solutions are subjected 
to one or more freeze-thaw cycles.
1. 2. 4. 1. Choice o f Samples fo r  Drug Analysis
In drug analysis, the most commonly sampled body fluid is plasma or serum, 
because a good correlation between drug concentration and therapeutic effect is 
usually found.
Whole blood can be broken down into its general components as follows: plasma 
(which contains the serum and fibrinogen) and the cellular elements (which contain 
the erythrocytes, leucocytes and platelets). Plasma is the liquid portion of 
circulatory blood. The cells are separated from the blood by centrifugation of whole 
blood. If blood is allowed to clot, the fibrinogen is removed from plasma leaving 
serum. The majority of clinical analyses are performed on whole blood, plasma or 
serum. Urine is also often analysed. In urine, the analyte concentrations are 
sometimes higher than plasma or serum. However, many different types of solutes, 
including metabolites, are present in strongly varying concentrations. Urine analysis 
for drugs is most often used in connection with urinary excretion and bioavailability 
studies. Because of the constant ratio between the drag concentration in plasma and 
in saliva obtained for a number of non-protein bound analytes, saliva can be used 
for the analysis of samples from neonates. Drag concentrations in saliva are 
sometimes assumed to represent free plasma levels, but this is found to be true only 
for a few drugs (e. g. carbamezepine and phenytoin). For others the correlations are 
less satisfactory or apparently non existant^2 - 44 Cerebrospinal fluid (CSF) is also 
analysed for drugs, but not frequently. It is not practical to analyse CSF samples 
routinely but occasionally CSF. levels may be required if damage to the blood brain 
barrier is suspected.
1. 2. 4. 2. Collection and Storage o f Samples
Collection of samples at the correct time in relation to dose is important in drug 
analysis. If insufficient care is taken in the collection and handling of biological 
samples, the data generated will be invalidated. If plasma or serum is analysed, the 
expressions "blood samples" or "blood levels" should not be used in description of 
the analytical procedures unless whole blood samples are to be analysed for some 
reason (for example, for drugs with a high affinity for red cells such as 
chlorthalidone or cyclosporin). Sample collection tubes containing anti-coagulants
(for blood) or preservatives (for urine) are available. The choice of anticoagulant 
may affect assay results as may some plasticizers released from blood collection 
tubes. The selection of glass or plastic tubes for blood collection and subsequent 
separation of plasma or serum, and its effect on the drug in an in vivo sample with 
respect to adsorption losses, contamination by plasticizers, displacement of protein- 
bound drug by plasticizers and their effects on the plasma to haematocrit ratio, 
warrant investigation. Drug concentration data can be adversely biased by these 
phenomena, giving rise to poor pharmacokinetic data. For example, a significant 
decrease in plasma tricyclic antidepressant concentrations has been attributed to 
sample contact with the plasticizer tris-(2-butoxyethyl) phosphate (TBEP) which 
may be present in the rubber stopper of collection tubes. TBEP-free stoppers are 
now available^.
On no account should a blood sample be frozen without pre-treatment, since this 
would result in haemolysis, preventing the subsequent separation of plasma or 
serum. After collection of blood (5 - 10 ml), a clot can be allowed to form and the 
supernatant liquid (serum) collected after centrifugation. Coagulation is complete in 
about 30 minutes at room temperature. Alternatively the blood can be collected in 
tubes containing an anticoagulant (e.g. heparin, EDTA) and the supernatant liquid 
(plasma) collected after centrifugation. Since the anticoagulant effect is temporary, 
collected specimens must be centrifuged quickly to prevent eventual clotting. 
Plasma is more frequently used than serum in drug analysis, since although similar 
results are obtained from both fluids, plasma is preferred since the anticoagulated 
blood can be centrifuged immediately, whereas serum cannot be sampled until 
coagulation is complete. Secondly it is relatively easy to centrifuge blood that has 
been treated with anticoagulant, since the plasma separates quickly and the maximal 
volume can be recovered if required. Drugs stored under conditions of heat, light, 
humidity and pH should be examined for possible decomposition. Fresh plasma or 
serum samples can usually kept for 6  hours at room temperature, 1-2  days in a 
refrigerator at 40c, or frozen at -20^C for long term storage. The Council of the 
British Pharmaceutical Society has issued guidelines for a pharmacy-based 
pharmacokinetic service which includes instructions on sampling and storage of 
b lo o d s
Urine drug analysis is carried out either on a single or a 24 h specimen. Both pH 
and volume are important factors in urine analysis. If urine is allowed to stand at 
room temperature, bacterial action causes the decomposition of urea into 
ammonium carbonate and then to ammonia, with a resulting change in pH. Urine 
may be preserved by freezing or by addition of preservative (toluene, boric acid or
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concentrated HC1). Freezing should be done relatively fast to avoid losses during 
subsequent thawing: during the last stage of the freezing process an oversaturated 
solution will exist and a non-soluble structure of the analyte may then be formed. 
Frozen samples of plasma/serum or urine should be brought to room temperature 
and subjected to vortex mixing for 10  seconds to ensure homogeneity before 
analysis.
1. 2. 4. 3. Direct Analysis
In a few cases, direct injection of the biological fluid into a HPLC system is 
possible. For example in the case of theophylline, which is therapeutically present 
in relatively high concentration (mg/1) and possesses good UV absorption 
characteristics, a small volume of diluted serum can be injected directly onto the 
chromatograph, thus minimising the amount of non-eluting contaminants placed on 
the column with each injection. Li this case the mobile phase and the column 
packing release the drug from protein binding sites as the sample enters the column. 
Direct injection has also been applied to analysis of salicylate and naproxin in 
serum47.
Urine can also be directly injected onto the chromatograph following centrifugation 
to remove particulate matter, and suitable dilution, preferably with the mobile 
phase. For example, antibiotics^ and other drugs'^* can be determined in urine by 
HPLC with on-column injection.
When using direct injection the analytical column should always be protected by a 
guard column to prevent irreversible adsorption and blockage. Biological samples 
contain materials such as lipids and proteins which deposit on the chromatographic 
column and lower its performance. Direct injection is limited in its application. 
Normally to improve both the sensitivity and selectivity of an assay, some form of 
sample clean-up prior to injection will be necessary.
1. 2. 4. 4. Sample Pretreatment in Bioanalysis
Sample pretreatment steps are one of the most important in any bioanalytical 
method. To ensure sensitivity and selectivity, interferences in the chromatographic 
separation should be eliminated. Moreover, the required reproducibility and 
repeatability can normally be achieved when relatively clean samples are 
ana ly sed ^ . Since sample pretreatment is an integral part of the bioanalytical 
method, the most suitable pretreatment for an analyte can be totally different when
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the matrix, the number of samples to be analysed, or the concentration, is changed. 
The objectives of a sample pretreatment step are:
(i) removal of macromolecules; (ii) stabilisation of the analyte(s); (iii) avoidance of 
irreversible adsorption; (iv) removal of interfering micromolecules, and (v) 
preconcentration (trace enrichment) of the sample.
However, these objectives can seldom be combined in a single step. Therefore, 
combining an initial or non-selective step, with a selective pretreatment step is a 
general strategy in the development of routine procedures.
A number of features of sample pretreatment which should be optimised are:
(i) stability of the analytes(s); (ii) interferences by impurities from vials, reagents, 
and/or solvents; (iii) compatibility of the solvent(s), used in the last steps, with the 
applied chromatographic mode; (iv) simplicity; (v) accuracy, reproducibility, 
repeatibility, and precision.
Non-selective pretreatment regimes, e.g. protein precipitation, dialysis, 
ultrafiltration, freezing, dilution, and microwave irradiation, can be used for 
sampling, stabilisation, storage, or pre-concentration of the sample. The selective 
pretreatment regimes e.g. liquid-liquid extraction (LLE) and solid-phase sorption 
(SPS) are used for isolation, trace enrichment, and/or cleanup of the sam ples^. In 
practice the distinction between selective and non-selective pretreatment regimes is 
not always obvious. For instance, LLE can be used to denaturate proteins and to 
pre-concentrate a sample as well as isolating the analyte from the matrix.
Before a method is developed, it should be considered whether the non-protein- 
bound (free) fraction, the protein-bound fraction or the total amount of the analyte 
has to be determined. Depending on the non-selective pretreatment regime chosen, 
analyte-protein bonds can be quantitatively, partially, or not broken at all. It should 
not be assumed that the applied non-selective pretreatment regime is able to destroy 
the analyte-protein bonds^2 . in addition the analyte stability (enzymatic, 
hydrolytic) should always be established, i. e. can the samples be stored without 
any precautions, or stabilisation steps (e.g. pH regulation, enzyme inhibition, 
addition of antioxidants), or should the sample be analysed within a certain period 
of time?
In many cases, it is advantageous to combine the pretreatment regime with the 
chromatographic separation. This can, for example, be acheived by using a
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precolumn to retain the analytes, while the proteins are flushed through, and then 
switched on-line with a chromatographic column53,54 These techniques are 
especially attractive for relatively large numbers of samples.
1. 2. 4. 5. Factors Affecting Column Performance
1. 2. 4. 5. 1. Choice of Columns
For general clinical and biochemical HPLC analysis, and particularly for TDM, 
reversed-phase columns are the ones of ch o ice^ . Advantages o f these columns 
are:(a) resistance to contamination and water-based mobile phases, (b) ease of 
equilibration, and (c) broad applicability. The most popular reversed- phase 
columns are Cjg and Cg. The differences in chromatographic properties between 
both these columns are subtle, but at higher flow rates chromatographic efficiency 
decreases less with Cg than with C^g. More polar bonded phases, such as cyano 
and phenyl, can also be used in the reverse- phase mode by incorporating adequate 
water in the mobile phase.
Other important factors influencing separation efficiency are column length and 
particle size of the packing. In order to obtain maximum efficiency, the column 
must be evenly packed, the column must be packed as uniformly as possible to 
minimize distortion of the chromatographic boundaries. If the particle size of the 
adsorbent is uniform, it is easier to get homogenous packing. On no account should 
any part of the column be allowed to run dry during packing or during separation. 
The most widely used columns are those 15 cm in length packed with particles 5 
um in diameter. Gaining in popularity is "high speed liquid chromatography", which 
uses short columns 3 to 8 cm long of internal diameter 4.6 mm and packed with 3 
um particles. These are operated at a high flow rate (2 to 5 ml/min), using a small 
volume flow cell (2.4 ml) and a detector system with a fast response time. Analysis 
time is significantly shortened and there is less solvent consumption, but since a 
higher than usual back-pressure is used, wear and tear on equipment can be greater.
Most analytical columns have an internal diameter ranging from 3 to 6  mm. These 
dimensions provide a good balance between (a) ease of packing, with minor 
contribution from wall e f f e c t s ^ , 57 (5 ) compatibility of the sample and peak 
volumes on these columns with detectors in routine use, (c) limited elution volume 
of costly mobile phase, (d) limited amount of costly packing and (e) moderate 
pressure drops. As increased loading of the column (i.e. a higher amount of injected 
sample) results in a decrease in the column efficiency, a shift in the retention values 
and also, in some cases, in a change of the sample peak shape.
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The stability of a column can be greatly improved by the use of a guard column 
before the analytical column providing protection from contamination and clogging. 
Modem columns can withstand more mechanical stress, but more work is required 
to investigate the possibility of regenerating columns contaminated by impure 
substances, such as the usefulness of a strong solvent injection between sam ples^. 
A major factor affecting the stability of columns is the pH of the mobile phase. The 
pH range within which bonded-phase silica-based packings can be used is typically 
2 to 7. At lower pH values, the bonded groups are hydrolysed, and at higher pH, the 
silica matrix itself dissolves, leading to the release of bonded groups from the 
surface. The stability at higher pH may be extended by the use of a silica-packed 
pre-column between the pump and the sample valve, thus presaturating the mobile 
phase with silica before it enters the analytical column59. Mobile phases with a 
high pH can be used in normal phase HPLC with silica particles, because the high 
organic content of the mobile phase minimizes the solubility of the silica.
1. 2. 4. 5. 2. Column to Column Reproducibility
It is important that the same chromatographic conditions for a drag analysis give 
similar results with each new column. This is not often the case, and modification 
to certain parameters is often required in order to achieve separation on a new 
column, particularly for drugs that are susceptible to active sites on the column. It is 
important to develop mobile phase conditions not only to achieve separation but 
also to minimize column differences. Probably the most severe test of column to 
column reproducibility is the relative retention of acidic and basic substances 
analysed simultaneously. Although many drugs are neutral, avoiding major 
problems in column to column reproducibility when analysed by HPLC, some of 
the potential interferences may be acidic or basic, and so their retention may vary 
from column to column giving rise to interferences in the chromatogram.
1. 2. 4. 5. 3. Choice of Mobile Phase
A major advantage of HPLC over GC is the opportunity to influence the separation 
of drugs by changing the composition of the mobile phase, giving extra flexibility 
and control.
Reverse-phase chromatographic systems are the most popular for drug analysis. The 
most two most commonly used organic solvents in the reversed- phase mode are 
methanol and acetonitrile, acetonitrile being the less polar of the two. Another 
solvent which may be considered is tetrahydrofuran, because it offers further 
solubility properties (less polar, weaker dipole moment than acetonitrile, non
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hydroxylic relative to methanol). The temperature of the mobile phase can also 
affect chromatographic behaviour. The primary effect of increasing the temperature 
is to increase the solubility of drugs in the mobile phase solvent, thus diminishing 
their chromatographic retention. A higher temperature also improves column 
efficiency, largely because the mobile phase is less viscous. A disadvantage of 
higher temperature is decreased column stability.
1.3.  El e c tr o c h e m ic a l  T echniques in drug  a n a l y sis
In 1922, Heyrovsky60 reported his results relating to electrochemical reactions at a 
dropping mercury electrode (DME). His discovery of the technique that he named 
"Polarography" was so notable that the discoverer was subsequently awarded a 
Nobel prize in Chemistry in 1959. Unfortunately, electrochemical techniques did 
not immediately become popular on a world-wide scale but, for many years, 
remained within the institution of the discoverer and those of nearby countries of 
Central Europe. Some years after World War n, there was a renewed interest in 
electrochemical techniques, with the concomitant appearance of more sophisticated 
commercial apparatus. The past twenty years have therefore seen a tremendous 
upsurge in the number and innovativeness of reports in all areas of polarographic 
and voltammetric procedures.
In 1983, the first International Symposium on Drug Analysis was held in Brussels. 
At that time, several reports were presented on the application of electrochemical 
techniques to the analysis of drugs and pharmaceuticals. Patriarche et al.61 
expounded on the use of some new, modified electrodes in the analysis of 
pharmacologically active substances. B ers ie r^ ^  dealt with the ways in which 
polarography and voltammetry could be used in industrial pharmaceutical 
laboratories. He pointed out that frequently these techniques were overlooked when, 
in actual fact, they can offer rapid and sensitive means for the measurement of 
drugs in pure solutions, dosage forms, bulk materials and biological fluids. At the 
same conference, based on some of his own work as well as the experience of 
others, Chatten^3 presented a report on applications of various electrochemical 
techniques to the analysis of pharmaceuticals.
1. 3. 1. V o l t a m m e t r y  a t  S t a t i o n a r y  P l a n a r  E l e c t r o d e s
Voltammetric techniques of analysis, i.e. those based on the measurement of current 
resulting from an oxidation or reduction at an electrode surface following the 
application of a potential difference to an electrochemical cell 64, have assumed an 
important place in the armoury of analytical techniques for the identification and
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determination of trace concentrations (i.e. 10  ^ to 10~4 ppm) of many organic, 
organometallic, and inorganic molecules of biological and environmental 
significance. Techniques such as differential pulse voltammetry (DPV), anodic and 
cathodic stripping voltammetry (ASV; CSV), adsorptive stripping voltammetry 
(AdSV) and electrochemical detection (ED) coupled with flow injection analysis 
(FIA-ED), ion chromatography (IC-ED) and high performance liquid 
chromatography (HPLC-ED) are particularly notable in this respect, and are used in 
the determination of compounds such as pollutants, drugs of abuse, food additives 
and contaminants, and agrochemicals.
Differential pulse voltammetry (DPV) at stationary electrodes has been increasingly 
used for electrochemical analysis of substances which are oxidised at such a 
positive potential that they can not be detected using a mercury electrode.
In 1962, starting from phenolic resins, Yamada and Sato 65 prepared a gas- 
impermeable carbon material which they called "glassy carbon". This glassy carbon 
has interesting physical properties in comparison with other carbon materials such 
as, for instance, impregnated carbon. An important feature of their method of 
formation was that artefacts of various shapes could be produced. Furthermore, 
glassy carbon exhibits a much lower oxidation rate at elevated temperatures, 
suggesting a greater inertness to chemical attack than other types o f carbon 
materials, such as various graphites. This property, together with its very small 
pore-size, makes glassy carbon an attractive material for the preparation of inert 
electrodes. Glassy carbon electrodes were applied for the first time in 
electroanalytical chemistry by Zittel and Miller 6 6  They showed that its usable 
potential range extends to more positive values compared to those obtained for 
platinum. The good resistance of glassy carbon against chemical attack makes it 
possible to apply the electrode in very corrosive media, such as concentrated 
hydrofluoric acid. The existence of reactive groups on its surface was confirmed by 
the work of Laser and Ariel 67, who studied the behaviour of glassy carbon 
following anodic polarisation and subsequent reduction in acidic media. From 
current-voltage and reflectance-voltage curves they concluded that the overall 
process of anodic polarisation was the result of three processes: formation of a 
redox couple caused by chemical adsorption of oxygen, irreversible redox reactions 
of existing surface groups, and, at sufficiently positive potentials, the evolution of 
oxygen.
Possible surface groups found on oxidation are, for instance, carbonyl groups, that 
subsequently can be reduced to hydroxyl groups at more negative electrode
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potentials. Also, the possibility of the formation of a quinone/hydroquinone couple, 
as found on oxidized/reduced pyrolytic graphite 6 8 , cannot be excluded. It is 
evident that glassy carbon electrodes need some kind of pretreatment to obtain 
reproducible results.
It is, however, virtually impossible to summarise all the pretreatment procedures 
described in the literature, because there seem to be many different procedures as 
there are investigators who have used glassy carbon electrodes (GCEs). However, 
some general aspects are considered later in the thesis (2 . 1. 2 ).
1. 3. 2. Cells, electrodes and potentiostats
Modem voltammetric analyses are usually performed in a vessel containing a three- 
electrode system of the type shown in Figure 1. 2. This type of cell is commercially 
available in a range of sizes that can accomodate between 2-50 cm3 of solution; 
however, smaller volumes can be investigated using specially constructed 
m ic ro c e lls6 9 . The important considerations in the design are that the electrodes 
should be as close as possible to one another and there should be a simple means of 
deareation before analysis.
In polarography, the working electrode is the dropping mercury electrode, which 
consists o f a glass capillary about 15 cm long and about 0.05 mm in internal 
diameter. The mercury electrode can also take the form of a hanging drop; this may 
be achieved by a micrometer arrangement where the mercury drop size is produced 
manually. However, most modem voltammetric instruments incorporate a special 
electrode assembly, which may be operated by gas pressure or by a solenoid; this 
allows the operation to select either the dropping mercury or stationary hanging 
drop mode. As the mercury (Hg) oxidises at +0.2 V, mercury electrode is not 
suitable for electrooxidises compounds. Oxygen (O2 ) is easily reduced and must be 
completely removed and precautions should be made to prevent oxygen from 
reentering the system. Even at relatively low working electrode potentials, very 
large back ground current are produced by the reduction of oxygen. Other electrode 
materials used to extend the anodic potential range include the noble metals (gold, 
silver and platinum), carbon paste, glassy (vitreous) carbon, and pyrolytic graphite.
The three-electrode configuration is standard in the modem potentiostats and 
galvanostats that are used for control of potentials and current, respectively. The 
electrodes consist of the ( 1) working electrode at which the redox process of 
interest occurs, (2 ) the auxiliary electrode, which is the second current carrying 
electrode in the cell, and (3) the reference electrode, which carries no cell current,
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Figure 1.2. Voltammetric cell containing: (a) working electrode; (b) reference 
electode; (c) auxiliary electrode; (d) a two way nitrogen line for 
deareation. Reproduced from Hart, J„ Investigative Microtechniques in 
Medicine and Biology, Bitensky, I and Chayen, J. (Eds), Marcel 
Dekker Inc., 1981, p. 199.
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to accurately monitor the potential applied at the working electrode so that, if 
necessary, adjustments may be made. The most commonly used reference 
electrodes are the saturated calomel electrode (SCE) and the silver/silver chloride 
(Ag/AgCl) electrode. The auxiliary electrode is normally made from platinum wire 
and serves as a means of applying the input potential to the working electrode.
The potentiostat is a device which can compensate for the voltage drop across a 
high resistance solution; if this was not done, the actual potential at the working 
electrode would be different to the applied potential. The potentiostat contains an 
operational amplifier which is connected to the reference and auxiliary electrodes, 
as shown in Figure 1. 3; the reference electrode has a constant potential and is 
placed as close as possible to the working electrode in the cell. The input potential 
waveform is applied through the auxiliary electrode to the working electrode; 
therefore, any voltage drop is experienced by both the reference and working 
electrode. In this case, the operational amplifier will apply sufficient compensating 
potential to the auxiliary electrode to ensure that the potential at the reference 
electrode tip (and therefore the working electrode) is the desired one^O.
1. 3. 3. Solvents and Supporting Electrolytes
All electrochemical phenomena occur in a medium which generally consists of a 
solvent containing a supporting electrolyte. There is no universal solvent. 
Generally, a solvent system is used whose merits outweigh its disadvantages for a 
particular application. A good solvent system for one type of experiment or 
compound may be totally unacceptable for other applications. In order to permit the 
widest latitude in application, the solvent system should not undergo any 
electrochemical reaction over a range of potentials from very positive (strongly 
oxidizing) to very negative (strongly reducing) ones.
The potential at which the electrochemical reaction relating to the solvent system 
commences is known variously as the background limit, decay of supporting 
electrolyte, or decomposition potential. In order to support passage of an electrical 
current, the solvent system should have low electrical resistance, and hence a 
moderately high dielectric constant (>10), since the prevalence of ion pairing, and 
even multiple ionic association in less polar solvents, can result in low ionic 
mobility and conductance in such solutions. An electrochemical solvent must be 
able to dissolve a wide range of substances at acceptable concentrations. This 
generally means that electrolytes must be soluble at least to the extent of 0.1 M, 
while the electroactive material must dissolve to form approximately millimolar
Figure 1. 3. Three electrode operation with potentiostatic control: (w) working 
electrode (r) reference electrode; (a) auxiliaiy electrode;
(o) operational amplifier; (i) current-to-voltage converter;
(c) chart recorder. Reproduced from Flato, J.f Anal. Chem., 44, 
1972, 75A.
2 5
\
solutions (for application of the various electroanalytical techniques) or greater (for 
preparative electrolyses). The solvent should not react with the electroactive 
material, nor with intermediates or products of the electrode reaction under 
investigation. The solvent should be reasonably stable, so that purification, 
preparation, and storage of standard solutions will present no major problems.
1. 3. 4. Voltammetric Techniques in Pharmaceutical Analysis
Over twenty years dedicated to the application and adaptation of voltammetric 
techniques to given problems, and to the development of quantitative voltammetric 
procedures for inorganic and organic compounds (as "main" and "secondary" 
methods), have shown that numerous realistic problems in pharmaceutical industry 
can be solved by these techniques. "Main" methods refer to procedures preferably 
used for routine work; "secondary" methods refer to procedures used as an 
alternative to an established one.
In pharmaceutical analysis, it is becoming increasingly desirable, or even advisable, 
to have two different methods of analysis for a particular compound. This 
procedure often represents the only way to ascertain the correctness of analytical 
data provided by a new analytical method. "Secondary" procedures are also used for 
checking established analytical procedures, such as chromatographic, 
spectrophotometric, or microbiological procedures in the field of organic analysis, 
and X-ray fluorescence and atomic absorption spectrometry in inorganic analysis. 
Another type of application of voltammetry is in the determination of 
physicochemical, thermodynamic, and kinetic parameters required for the 
elucidation of electrode reactions.
In terms of pharmaceutical analysis, voltammetry (i.e. direct current, alternating 
current, fast scan, and pulse polarography, along with voltammetry at solid 
electrodes), coulometry (constant current and potential), and potentiometry 
(including the use of ion selective electrodes), are the most commonly employed 
techniques. Voltammetric techniques are quite useful for the direct measurement of 
the stability of some pharmaceuticals in aqueous solution. Depending on the 
compounds involved, voltammetry can be used to either monitor the decomposition 
of a drug and/ or the formation of a decomposition product. This type of study is 
typically performed by applying a potential to the working electrode which is on the 
voltammetric plateau for the starting material or end product to be monitored. The 
resulting current vs. time data then provides the desired kinetic information. The
application of voltammetric techniques to pharmaceutical analysis has been 
reviewed by Bersier and Bersier^ l.
l. 4. D e v e l o p m e n t of Liquid C h r o m a t o g r a p h y  
E l e c t r o c h e m i c a l D etection (LC-ED)
Electrochemical detection in liquid chromatography is not new. In 1940, 
Troistskii72 used a dielectric constant sensitive instrument to detect absorption 
boundaries in chromatography, and in 1952 Kemula et al. 73 attempted to use a 
DME for LC detection. In this case, the dead volumes were very large (many ml), 
and the polarograph was "low performance" by today s standards. As a result, only 
milligram quantities could be detected and chromatograms lasted for hours. Nothing 
of practical significance came of this early work, although it established the concept 
of using electrochemistry to follow chromatographic profiles. The development of 
electrochemical detectors only became really important with the wide application of 
HPLC techniques in the seventies. In 1974, several important clinical applications 
of LC-ED were reported^4. Figure 1. 4 illustrates the components of a typical LC- 
ED system .
At present, some applications of HPLC can not be imagined without the use of 
amperometric or coulometric detection. Electrochemistry also offers other methods 
for detection of substances in flowing liquids, mainly, equilibrium potentiometry, 
conductometry and high-frequency impedance measurements, but these methods 
have much more limited application. In fact, most authors use the term 
"electrochemical" as a synonym for "amperometric" or "coulometric" 
measurements. Since amperometric detection was employed in this thesis, the 
following section deals with this mode of operation.
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Figure 1. 4. Outline of a LC-ED system. Reproduced from ref. 64
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Unlike the commonly made potentiomteric pH measurement, electrochemical 
detection is usually based on amperometry at controlled potential. Electrochemical 
detection involves a chemical redox reaction, in contrast to ultraviolet or 
fluorescence detection where a passive, physical absorption of radiation occurs. The 
reaction occurs at an electrode surface, placed in or alongside the flow of eluent 
from the column. Either an oxidation or reduction may be forced to occur by 
judicious selection of a potential applied to the cell from the potentiostat. The 
potential is a source of electrochemical selectivity, in the same manner as the 
wavelength selected in spectrophotometric detection. In essence, the electrode acts 
as an oxidising or reducing agent of variable power. As with spectroscopic methods, 
molecular structure is the primary determinant for the electroactivity of an analyte. 
The accessability of various filled and unfilled molecular orbitals ultimately decides 
the thermodynamics and kinetics of the electrode process. As for spectroscopy, 
there is a great body of empirical information that can be drawn upon to predict the 
behaviour of individual compounds. In examining a candidate drug or metabolite 
for electrochemical analysis, several key questions must be answered. What 
functional groups are present? Does the parent structure permit delocalisation of the 
added positive or negative charge? Are there substituents present in the molecule 
that enhance or detract from electroactivity? Is the redox reaction pH-dependent? 
What is the solubility? All of these factors are important considerations in assessing 
electroactivity for LC-ED or any electrochemical technique. Electrochemical 
detection in liquid chromatography is in almost every case based on controlled 
potential amperometry. Coulometric detectors are defined as those where the 
conversion efficiency is 100%. For amperometric detectors, the efficiency is 
somewhat less (often 1-10%). Amperometric detectors presently have the advantage 
of giving better detection limits and being75 less complex than coulometric 
detectors. But how can the limit of detection be better if less material is converted? 
This is often true in practice because of the geometry required to achieve complete 
conversion in a flowing stream. As more electrode surface area is added 
downstream to improve efficiency, each increment of surface area contributes 
proportionately less to the total amount of material converted but approximately 
equally to solvent breakdown.
Perhaps more important is the fact that the advantage of the precision coulometry in 
titrimetry is not often realized in practice for chromatography detection where
1. 4. 1. Controlled Potential Amperometry
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sample preparation and injection are normally the primary sources of error and 
relative measurements (internal or external standards) predominate.
The active region of most amperometric detectors consists either of a wall-jet 
electrode or a thin-layer cell. If one considers Faraday s law:
Q = n FN (2)
for each chromatographic zone the number of coulombs (Q) passed will related to 
the number of moles (N) converted to product in the cell and the number of 
electrons (n) involved in the reaction. A schematic diagram of a thin-layer 
electrochemical detector cell is shown in Figure 1. 5. For clarity, only the 
immediate vicinity around the working electrode is shown. Eluent from the column 
passes into the thin-layer zone as a parabolic profile (represented by the arrows). A 
potential difference is then applied to the cell between the working electrode and 
the reference electrode (which is not shown) and external to the thin layer. This 
potential difference is adjusted to provide a sufficient driving force for the redox 
reaction to occur. Suppose an oxidisable species R is eluting from the column into 
the detector and that the potential is sufficient to drive the conversion of R to its 
oxidation product 0 , yielding a release of n electrons to the electrode surface for 
every molecule converted, according to:
R—*■ O + ne~ (3)
as the chromatographic band passes through the thin layer, those R molecules which 
are immediately adjacent to the electrode surface become oxidised due to the 
electric field imposed by the potential at the electrode solution interface Figure 1. 6 . 
It is crucial to recognise that electrochemical detection is a surface technique; those 
molecules more distant to the surface may or may not be oxidised at all. At typical 
flow rates of 1-2 ml/min, the residence time of any molecule over the electrode is 
only a few tens of milliseconds, a much shorter time than necessary for most to 
diffuse laterally to the surface. In actual practice, therefore, only 3-5% conversion 
efficiency is achieved. Frequently the amount reacts is less than 5 fEq. Near the 
detection limit of a molecule with a molecular weight of 2 0 0  undergoing a two- 
electron transfer, about 0.5 pg of sample is converted into product.
The current measured at the electrode surface in DC hydrodynamic amperometry is 
the summation of several factors: ( 1) the background (faradaic) current, due to the 
redox reactions of impurities, solvents, etc. contained in the mobile phase; the 
background current is relatively small over a wide range of potentials (-0.8 to +1.1V
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Schematic diagram of thin-layer electrochemical transducer.
Laminar flow developed in the channel (typically 50 um thick) passes 
over a planar electrode held at some dc potential with respect to a 
known reference electrode. Direct electrolysis current is measured. 
Reproduced from Shoup, R„ Liquid Chromatography/ 
Electrochemistry in High Performance Liquid Chromatography, 
Horvath, C. (Ed), Academic Press, Inc., New York, 1986, p. 94.
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Figure 1. 6. Electric field imposed by the applied potential at the interface between 
the electrode surface and the bulk solution. The field is localized over 
the electrical double layer, which is only 10 - 20 A thick.Reproduced 
from Shoup, R., Liquid Chromatography/Electrochemistry in High- 
Performance Liquid Chromatography, Horvath, C. (Ed), Academic 
Press, Inc., New York, 1986, p. 95.
3 2
i
versus Ag/AgCl), before abruptly rising exponentially outside this "window"; (2) 
the signal (faradaic) current, arising from the oxidation of the analyte(s) of interest; 
and (3 ) the charging (capacitance) current, which occurs whenever the cell is turned 
on or the potential is changed. The applied potential is very dependent on the 
restrictions imparted by the LC working conditions. Since reversed-phase LC 
conditions (aqueous, pH 2 to 8 ) are most widely used, a typical example is an 
applied potential between + 1.2 and + 1.3 V (using glassy carbon electrode material 
vs a Ag/AgCl reference electrode). The applied potential, however, is highly 
dependent on the redox behaviour of the compound to be detected and varies due to 
experimental conditions. The oxidising strength (increasingly positive potential for 
stronger oxidising capability) or reducing strength of the electrode surface 
(increasingly negative potential for stronger reducing capability) is determined by 
the applied potential. As the potential of the working electrode (see Figure 1. 7) 
relative to the reference becomes more positive, the surface becomes a better 
oxidant (electron sink).
Likewise, as the working electrode becomes more negative, the surface becomes a 
better reductant. The potential is applied between the reference and working 
electrodes, and the current is passed between the auxiliary and working electrodes. 
Positioning the auxiliary electrode opposite to the working electrode (i.e. across the 
flow stream) reduces the uncompensated resistance to a negligible value even when 
low ionic strength (<10 mM) mobile phases are used. With a low uncompensated 
resistance, the interfacial electrode potential is not significantly influenced by 
sample concentration, and a wide linear dynamic range is obtained 76.
An LC-ED detector should have an active volume (that volume of the cell where the 
detection is taking place) which is small relative to the volume occupied by the 
concentration zone passing from the column. The detector should respond rapidly in 
order to accurately represent the shape of the concentration profile. LC bands with 
volume well below 100 nl are becoming quite common. Often the peak width is 
measured in seconds. Obviously, not all LC-ED detector need to be used with such 
highly efficient columns. Nevertheless, the future clearly points to the need for 
development of ED flow cells with very small dead volumes.
1 . 4 . 2 .  H y d r o d y n a m i c  a n d  C y c l i c  V o l t a m m e t r y
The hydrodynamic voltammogram is used to help choose an optimum operating 
potential for detection. Hydrodynamic voltammograms (HDV) are generally 
developed by making repeated injections of standard solutions and increasing the
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Figure 1.7. Action of applied potential as the driving force in an electrochemical 
reaction. Reproduced from Radzik, D. and Lunte, S., Critical Reviews 
Anal. Chem., 20(1989) 317.
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potential of the detector between these injections. A typical HDV is shown in 
Figure 1. 8 . Initially, at negative or very low positive potentials, the energy applied 
to the cell is insufficient to cause any reaction to occur. As the applied potential 
increases in the positive direction, the energy requirement for the reaction is now 
partially met, and a faradaic current arises. As the potential is further increased, the 
faradaic current rises until a potential is reached, past which no further 
improvement in the current response is noted. The curve now attains a plateau. All 
points in this zone yield essentially the same current response. The hydrodynamic 
voltammogram just constructed may be broken into these regions:
Region I: Zero current region. The potential is insufficient to drive the 
redox reaction to the right; no current results.
Region II: Potential-controlled region. For a reversible system, the 
response is dictated by the Nemst equation.
Region III: Diffusion-controlled region. Further increases in the potential 
are irrelevant, since the material is oxidised at the 
surface as fast as diffusion rates permit. The current is 
constant since the constant flow of mobile phase 
through the cell provides a steady-state flux of new 
electroactive material at the surface.
HDVs may be used in tandem with a stationary CV experiment to determine the 
optimum detector operating potential, in the same way as the UV absorbance 
spectrum is used to help choose an optimum wavelength for detection. In addition 
to retention times, these current-potential curves can be compared. In this way, 
identities of peaks can be confirmed based on the chromatographic and 
electrochemical properties of a compound. Figure 1. 9. illustrates the individual 
hydrodynamic voltammograms for several hypothetical molecules which can be 
oxidised (A, B, C) and one which can be reduced (E).
The selectivity of electrochemical detection is inversely related to the 
experimentally observed oxidation (or reduction) potentials. Measured half-wave 
potentials are often significantly greater than the corresponding thermodynamic E 
values (particularly for organic molecules). Although it is often desirable to operate 
an electrochemical detector on the limiting current plateau E2 for compound A, in 
some cases it is advantageous to operate on the rising part of curve (Ej for 
compound A).
The lower the potential chosen, the better the selectivity. If, for example, A and B 
are not well resolved chromatographically, it may be difficult to detect A at E2 in
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Figure 1. 8. Hydrodynamic voltammogram for background current (solid line) and 
injected solute (dashed line). Per electrochemical convention, positive 
potential, positive potential versus the reference electrode is to the left 
and negative potential to the right. Current response for reduction is in 
the +y direction; current response for oxidation is in the "y direction. 
Reproduced from Shoup, R., Liquid Chromatography/ 
Electrochemistry in High-Performance Liquid Chromatography, 
Horvath, C. (Ed), Academic Press, Inc., New York, p. 96.
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Hydrodynamic voftammetry
Figure 1. 9. E(+): positive potentials vs. reference electrode; E(-): negative
potentials vs. reference electrode; ic: cathodic (reduction) current; ia: 
anodic (oxidation) current. Reproduced from Kissinger, P.,
Anal. Chem., 49 (1977) 445A.
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the presence of a thousand-fold excess of B. Lowering the potential to E i will 
decrease the sensitivity to A severalfold, but sensitivity to B may decrease by many 
orders of magnitude. This principle has been used to detect^  trace amounts of p- 
aminophenol in the presence of the analgesic drug N-acetyl-p-aminophenol 
(acetaminophen). At E3 , A and B will be detected with comparable sensitivity, 
while at E4  it would also be possible to detect C. Clearly, the selectivity for C will 
not be good, and a greater reliance has to be placed on the chromatographic 
separation. The sensitivity for C can also be expected to be somewhat diminished 
when compared to more easily oxidised substances due to the greater background 
current (greater "baseline" in the chromatogram). At E5 and beyond it is likely that 
the electrochemical detector will not be useful for trace analysis as the background 
oxidation (D) becomes very high. Hydrodynamic voltammograms can also be the 
result of bad flow-cell design, due to hydrodynamic or electrical factors^. Cyclic 
voltammetry (CV) rapidly provides useful preliminary information needed for the 
study of an electroactive compound^. This stationary solution experiment easily 
duplicates those conditions (electrode material, electrolyte, etc.) found in the LC- 
ED detector cell. CV may also used to evaluate the mechanism of redox reactions 
and subsequent chemical reactions^. Figure 1. 10 illustrates a cyclic
voltammogram for todralazine, a benzodiazine drug of the phthalazine group 
frequently used in pharmaceutical preparations as an antihypertensive agent. The 
cyclic voltammograms show one oxidation peak (A) and one reduction peak (B). 
The cyclic voltammetric peaks which appear at distinctly separate potentials, Epa =
0.58 V and Ep^ = -0.17 V, are characteristics of an irreversible process^!.
1 .4 .3 .  C u r r e n t  a n d  S i g n a l / N o i s e  R a t i o  a n d  O p t i m i s a t i o n  i n  L C - E D
All determinations are accomplished with some degree of imprecision. The 
understanding of the causes of imprecision, or noise, is an important part of the 
optimisation of an analytical system. To be able to use any theoretical expression 
for signal intensity in the calculation of detection limits or optimum conditions, 
some knowledge of the noise in the system is needed. The noise is that part of the 
quantity measured that does not contain information. In an ideal detector, the 
quantity measured would be zero in the absence of the test substance; in a real 
detector, the quantity measured consists of the signal (i.e. the response to the test 
substance) and of several other components that make up the background (baseline). 
The background involves a constant component originating for example from 
reactions of the flowing liquid and the impurities in it, or from bias currents of the 
signal amplifiers, noise with a relatively high frequency (up to hundreds of Hz); 
which is mainly caused by the line frequency noise; low-frequency noise (with a
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Figure 1.10.Cyclic voltammogram of todralazine (5 x 10"4M, pH 6.0, citric acid-
phosphate buffer). The scan rate was 200 mvs'l. Reproduced from 
Barrio, R., et al., Electroanalysis, 3 (1991) 429.
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frequency similar to the variations in the signal, which is usually due to unsuitable 
design of the detector, and a systematic shift in one direction, called the drift. In 
additional, occasional spikes appear, which are rapid random pulses of the quantity 
measured, usually caused by fluctuations in the line voltage, bubbles in the liquid, 
and other disturbances. A drifting baseline does not affect the quality of the 
measurement much, but complicates the operation of measurement, as frequent zero 
adjustments must be made. The constant component can be compensated for and 
the high-frequency noise with spikes can be suppressed by suitable electronic 
filtering (RC filter). To calculate detection limits, quantitative information about the 
noise is necessary. To determine optimum conditions, qualitative information will 
suffice, i.e. knowledge of the major source (or sources) of noise. The electrode s 
size, shape, and material undoubtedly influence the signal and the noise obtained^. 
Noise in highly sensitive electroanalytical systems is not nearly as well 
characterized as noise in optical systems, so that some hypothesizing must be done. 
While it is relatively straightforward to model the faradaic current response as a 
function of cell parameters, the ultimate issue is the signal/noise (S/N) ratio, which 
determines detection limits. The relationship of cell design to these variables has 
not been defined rigorously; estimates have been made based on the assumption that 
noise is proportional to electrode area. Weber and Purdy83 found that a properly 
optimised (i.e. maximum S/N ratio) cell would have the following characteristics: 
( 1) the width of the electrode should equal the width of the flow channel; (2 ) the 
length of the electrode along the direction of flow should be as small as possible, 
and (3) the flow cell should be as thin as practible.
Initially, it would seem worthwhile to increase the electrode surface area and 
thereby increase the conversion efficiency of the detector. However, conversion 
efficiency per se is rather irrelevant^4, since S/N ratios determine detection limits, 
not conversion efficiencies. Figure 1 .11  graphically summarises this fact. As the 
electrode area is increased incrementally, more solute R will be oxidised and the 
overall conversion effeciency will increase. By the same rationale, the conversion 
efficiencies for mobile phase components which contribute to the detector's steady- 
state background current will also increase. Since the supply of mobile phase 
components is essentially unlimited, each corresponding area increment adds an 
equal contribution to the background current. In other words, this current is directly 
proportional to the electrode area. For the solute R, however, the supply of 
molecules to be reacted is not unlimited. Each area segment adds a smaller 
contribution to the peak current, since diffusion must supply new material to the 
surface from points more distant than before. Therefore, the net peak current does
Figure 1. ll.Relatìonship of signal, noise, and signal/noise ratio versus electrode
area.Signal (S) is dependent on two-thirds power from a to b and zero 
power thereafter, depending on conversion effeciency. Noise (N) is 
dependent of area below c due to electronic noise and increases with 
area thereafter. Maximum signal/noise ratio is somewhere in the thin- 
layer region (a to b) at point d.Reproduced from Morgan and Weber, 
Anal. Chem. 56 (1984) 2560.
not increase linearly with area (Figure 1. 11). Since noise is roughly proportional to 
the background current, the S/N ratio is actually maximal at an electrode of 
vanishingly small area. Of course, limitations outside the cell also play a part in 
these arguments. For example, secondary noise, such as electronic noise of the 
potentiostat/current amplifier, may become important with very small electrodes^. 
It is a natural tendency to think of residual current as the unwanted element in an 
analysis. In fact, if the residual current for a given system is large, but more 
reproducible and noise-free than another system with a low residual current, then 
the detection limit will necessarily be lower in the former case^G. Other factors, 
however, play a decisive role in assessing conditions for maximum S/N ratios. 
Variations in temperature and flow rate may prove to be important^. As dual­
electrode experiments have demonstrated, much of the long-term drift and short­
term noise is not due to the vagaries of the working electrode per se, but rather to 
microscopic flow variations and irregular mobile-phase impurity lev e ls^ . Using 
appropriate pumps/pulse dampeners can avoid "flow noise". However, this may not 
be sufficient. For ordinary HPLC work the pump fluctuations can easily be filtered 
out electronically using a high-order filter^ ,
1. 4. 4. Detector Cell Design
Over the last 5 years, increased activity has been directed to detector cell design. 
Well over 100 publications have illustrated changes to existing commercial 
transducers or developed entirely new concepts of design. Electrochemical 
detection is now sufficiently commonplace alongside ultraviolet absorption and 
fluorescence methods which have become accepted in LC. From a manufacturer or 
even inventors point of view, transducers for sensitive LC-ED are not easily 
developed. In addition, the implementation of a working prototype into a 
reproducible, serviceable component is often fraught with difficulties. The design 
constraints may be summarized as follows:
(i). incoporation of a minimum of one working electrode, one reference 
electrode, and one auxiliary electrode within a cell volume 
sufficiently small to prevent chromatographic band spreading;
(ii). the electrodes must be electrically isolated from each other and 
from earth ground;
(iii). the mobile phase must not contact external connections to the 
working electrode, else these in turn become part of the active 
working electrode;
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(iv). expansion for multiple working electrodes measuring 
simultaneously, either in series or parallel orientations with respect 
to the flow;
(v). the active surface of the sensor must be sufficiently 
mechanically strong to withstand liquid flow;
(vi). interchangeability of electrode materials for specialised applications;
(vii). ultimate compatibility with microbore LC formats which are ideal for 
electrochemical methods.
These overlapping requirements can be troublesome to satisfy simultaneously. A 
majority of the developed prototypes satisfy requirements (i) to (iii) above, but 
major omissions of flexibility occur thereafter. The followings are the most 
common used cell designs:
1. 4. 4. 1. Thin-layer Amperometric Flowcells
The majority of applications have been worked out using this detector^,91 and it 
was the first commercially available design. The cell design and operation have 
been discussed in page 28.
1. 4. 4. 2. Wall-jet Transducers
An alternative geometry to the "thin layer" design is to use a "wall jet," as 
developed by Fleet and Little which subsequently modified by other workers. A 
schematic representation is shown in Figure. 1. 12, which shows the direction of 
flow perpendicular to the working electrode surface. The mobile phase escapes 
radially, past the outside reference and working electrodes. Patthy et al.93 
compared thin-layer and wall-jet transducer designs under actual analytical 
conditions for the determination of rat brain catecholamines and concluded that the 
thin-layer design was more sensitive.
1. 4. 5. Scope and Limitation o f Electrochemical Detection
The suitability of electrochemical detection to a given problem ultimately depends 
on the voltammetric characteristics of the molecule(s) of interest in a suitable 
mobile phase and at a suitable electrode surface. All detectors limit mobile phase 
composition to some degree; however, in electrochemical detection one must be 
conscious of the fact that a complex surface reaction is involved which depends on 
the medium. Therefore, some effort is required to simultaneously optimize both the 
column and detector performance. Fortunately, it is possible to make a few
Figure 1 .12. Wall-jet design proposed by Fleet and Little (Ref. 92). 
perpendicular to the working electrode surface.
H-H-
Fluid impinges
generalisations. For all practical purposes, direct electrochemical detection is not 
likely to be useful in normal phase adsorption separations since non-polar organic 
solvents are not well suited to many electrochemical reactions. The HPLC 
stationary phases of choice clearly include all ion-exchange and reversed-phase 
materials since these are compatible with polar solvents containing some dissolved 
ions. The limitations of amperometric and coulometric detection can be overcome 
in some cases. Pre- and post-column derivatization are now being utilized to make 
some compounds better candidates for LC-ED. Chemical, enzymatic, and photolytic 
derivatizations in conjunction with both oxidative and reductive detection schemes 
are being used to determine species with normally unfavourable redox properties.
1. 4. 5. 1 .Mobile Phase Restrictions
Electrochemical detection is different to ultraviolet absorption or, fluorescence 
measurements, in that it relies on a chemical reaction. As with any chemical 
reaction, conditions such as solvents, pH, and temperature play an essential role in 
successful LC-ED experiments. The requirements for the mobile are as follows: (1) 
it must be electrochemically inert (i.e. low background currents in the range of 
interest), and (2 ) it must be capable of supporting a dissociated electrolyte, usually
0.01 to 0.1 M in ionic strength, to minimize resistance and convey charge. These 
limitations are not generally restrictive, since most reversed-phase, ion-exchange, 
and some polar bonded-phase separations employ similar conditions. The most 
successful LC-ED determinations have typically utilised aqueous buffers (pH 2-7) 
with varying amounts of solvent (0-90% by volume). Ion-pairing agents have also 
been used very successfuly. When designing a mobile phase for LC-ED it is 
important to remember that the electrolyte must not only dissolve, but also 
dissociate, in order to guarantee conductivity. For a buffer salt such as KH2PO4 , 
the essential processes are
k h 2p o 4- >  [k+  -h 2 p o 4-]s - >  k +(S) + H2P 0 4-(S) (4)
where (S) signifies the solvated species. The user should always ascertain the 
approximate ionic strength of the mobile phase using appropriate factors such as 
pKa of the buffer salts, desired pH, buffer salt solubility products, etc. At least 5-10 
mM ionic strength, preferably buffered, is desirable. For the above reasons, non­
polar solvents such as hexane and chloroform are not compatible with LC-ED. 
Although a few papers have reported success with normal phase LC-ED^ 4  - 96 the 
detection limits do not approach those using reversed-phase separation, and in most
The choice of electrode material is a powerful variable in optimising selectivity in 
LC-ED. The choice of electrode material is more critical in LC-ED than for the 
usual electroanalytical experiment, primarily due to the ruggedness and long-term 
stability required. Mechanically awkward devices such as the dropping mercury 
electrode will try the patience of the most stalwart chromatographer, although these 
have been used in several reports. Electrodes subject to complicated surface 
renewal problems (platinum, glassy carbon, and mercury films) may work well in 
some cases and are disastrous in others. In spite of these difficulties, it is possible to 
routinely detect picomole amounts (or less in some cases) of electroactive 
components separated by HPLC.
Electrochemical reactivity can be altered considerably by changing the electrode 
material. In many cases this can be highly advantageous. For example, although 
mercury has been the most popular electrode material in the past due to its 
applications in polarography, solid electrodes such as glassy carbon and platinum 
have largely replaced mercury as the electrode material of choice, since the most 
important applications of LC-ED have been developed in regions of potential were 
the residual currents on mercury would be prohibitive. However, the hydrogen 
overvoltage on Hg/Au electrodes is more negative, an advantage in properly 
deoxygenated systems. Besides a material s applicable potential range, the extent of 
surface conditioning necessary before stabilisation must be considered. The 
background current derives from three sources: mobile-phase impurities, electrode 
charging currents, and surface redox reactions.
1.4.  5. 2. 1. Carbon Paste
Although the carbon paste electrode can be inherently sensitive, the main 
disadvantage of this material is that it is not very compatible with non-aqueous 
solvents. Solutions containing up to 25% (v/v) methanol or 5% (v/v) acetonitrile are 
tolerable, but these will decrease usable lifetimes. The semi-solid nature of carbon 
paste prevents its use in wall-jet flowcell configurations, a serious drawback to that 
design, since carbon paste has better S/N ratio than glassy carbon for several 
important applications.
1. 4. 5.2.  2. Mercury drops, Pools, and Films
Mercury provides excellent hydrogen over-potential, to about - 1.1 V versus 
Ag/AgCl for trace analysis work. For this reason it has proved popular for moderate 
and easily reducible species such as azo, nitro, nitroso, organometallic, and imine 
functional groups. Several cell configurations have been reported for mercury
1. 4. 5. L  Matching E le c t rode  P rope r t i e s  to the Analy t ical  P r o b l e m
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cases, the user would have been a better to employ simple ultraviolet detection. An 
electrolyte can be dissolved in the mobile phase normally without causing any 
deterious effects on the chromatographic separation. The use of non-aqueous 
reversed-phase chromatography97 is of particular interest for the exploitation of 
electrochemical detection since the solvents used in such separations often allow 
greater potential to be employed, thereby extending the range of application of the 
technique. Table 1. 1 lists the accessible potentials for some of the solvents 
commonly used in reversed-phase chromatography. The ionic strength, pH, 
electrochemical reactivity of the solvent and electrolyte, and the presence of 
electroactive impurities (dissolved oxygen, halides, trace elements) are all important 
considerations. Using cyclic voltammetric data, existing HPLC information and the 
tables below, a chromatographic system can often be developed which meets the 
requirements of both separation and detection.
T a b l e  1 . 1 .  A c c e s s i b l e  p o t e n t i a l  r a n g e  f o r  s o m e  s o l v e n t s
Solvent Cathodic limit 
V vs SCE
Anodic limit 
V vs SCE
Reference
Water -2.7 1.5 98
Methanol -2 .2 1.8 99
Acetonitrile -3.5 2.4 100
Dimethylformamide -3.5 1.5 101
Tetrahydrofuran -3.6 1.8 102
Methylene dichloride -1.7 1.8 103
Acetic acid -1.7 2 .0 104
The above figures can only be taken as a guide since the actual potential limit is 
dependent on solvent purity, electrode material and electrolyte.
electrodes 105. The early and some present designs incorporating the DME suffer 
from drop noise and baseline oscillation, high cell volumes, and cappilary clogging. 
Thin-film electrodes, such as mercury amalgamated onto gold or platinum, have 
been more extensively studied 106. While usually much less noisy, these surfaces 
have limited lifetimes due to intermetallic formation at the electrode surface.
1. 4. 5, 2. 3. Platinum/Gold
Electrocatalytic groups on Pt and Au, and precise electrochemical recycling of 
those groups, from the basis for detection of sugars, amino acids, and alcohols 
otherwise transparent to amperometry. The advantages and disadvantages of the 
different kind of electrodes used forLC-ED are given in Table 1. 2.
1. 4. 6. Selectivity in LC-ED
Selectivity is one of the principal requirements placed on any analytical procedure. 
In order to obtain meaningful information from the measurement of a particular 
analytical property, the signal must be unambiguously attributable to the substance 
to be determined; that is, the analyte and other components of the sample must not 
influence it. Such a measurement can then be considered specific for the given 
substance. Of course, this is the ideal objective for real analytical procedures, for 
they are only selective to varying degrees for any particular analyte.In general, such 
interferences arise to at least some degree from other sample components 
interferents. There is no general way of quantitatively describing the degree of 
selectivity (that is, extent of interferences) for an analytical procedure, as the effects 
of the interferents are often interrelated and depend strongly on the nature of the 
analyte matrix and the experimental conditions. The simplest and most common 
method specifies the concentrations (activities, absolute amounts) of individual 
interferents that produce a preset change in the magnitude of the measured signal 
under particular set of experimental conditions and a given significance level. Like 
any other analytical procedure, a flow determination always involves a separation 
of the analyte(s) from other sample components followed by measurement of a
suitable analytical property. The separation may be literal, e.g. in a column or 
reactor, or figurative as through the suppression of interferences 
(through masking of interferents, selective measurement at a particular 
wavelength or potential, etc.). Hence, any flow system can be considered as a kind 
of separation column followed by a more selective detector. The overall degree of 
selectivity attained depends on the relative strengths of physico-chemical 
interactions of the sample components ocuiring in the column, on the number of 
elementary equilibria or steady states attained along the column, and on the 
selectivity of the column. The most common approaches for attaining the required 
selectivity can be summarised as follows:
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Table 1. 2. Advantages and disadvantages o f  electrode materials used in LC-ED.
EJectrode Advantages Disadvantages Ref
Material
Mercury electrode
Solid electrodes
Carbon paste
used for electroreduction 
work
Used for electroox idzable 
and also for easily reduced 
compounds
Low residual current and 
noise.
Easy to prepare and replace
As the mercury (Hg) oxidises at 107
+ 0.2 V, it is not suitable for elect- 
reoxidisable compounds
the current oscillating over the 
lifetime of the necessitates some 
form of damping
oxygen (O2) is easily reduced and 
must be completely removed 
the dropping process causes high 
noise level.
Fouling of the electrode surface 108
Different formulations of carbon 109 
paste exhibit variations in sensitivity
Solubility of the binder in organic 110 
solvents restrict usage to mobile 
phases that contain typically less 
than 20% of organic modifier
(i) masking of interferents, by employing either thermodynamic or 
kinetic principles of a suitable physico-chemical process (usually 
complex formation);
(ii) separation, either in a high performance system, or in a cell or 
reactor preceding the detection unit;
(iii) use of selective detection methods, including selective sensors, 
rapid-scan techniques and multiple sensors;
(iv) treatment of the detector signal, leading to deconvolution
of overlapping signals and to differentiation of the signal from the 
background;
(v) combination of various detection methods
While the present-day LC column technology is at a when point one may quickly 
achieve excellent separation of closely related substances, this is often not 
sufficient. This is especially true when a determination involves a biological matrix, 
such as blood or urine. Often selectivity must be enhanced by a clean-up step prior 
to injecting material onto the column. This typically consists of one or more liquid- 
liquid extraction or liquid-solid extractions carried out in a batch mode.
The selectivity of amperometric detection has been shown to be useful in the 
determination of L-dopa in the presence of the decarboxylase inhibitor carbidopa. 
Levodopa and carbidodopa are used in combination to treat Parkinson s disease. 
Carbidopa is a dopa decarboxylase inhibitor which can significantly reduce the 
dosages of levodopa required for therapy. The selectivity of the column was also 
commonly augmented by the detector. This is a real strength of ED schemes. While 
a "universal detector" could be useful in solving some simple problems, a "selective 
detector" is much more applicable in difficult determinations. The ED detector is a
tunable device that permits enhancement of se lec tiv ity  by changing the applied 
potential.
SC>
1. 4. 7. Applications of LC-ED
The types of compounds that can be determined by LC-ED are compounds that 
undergo electron transfer reactions. Characteristics of a small oxidation (or 
reduction) potential and fast kinetics are most desirable for sensitive and selective 
detection. The classes of organic compounds with these characteristics are phenols 
(catechols and catecholamines), thiols, nitro compounds, and quinones. Compounds 
such as aldehydes and ketones require too high a reduction potential, while 
alkylamines and carboxylic acid functionalities require too high an oxidation 
potential, for direct determination by LC-ED. There are other classes of compounds 
that are electroactive, as well as some clinically important compounds, such as 
ascorbic acid and uric acid, and organo-metallics (such as cis- platinum).
LC-ED is also uniquely applicable to some heterocyclic compounds of 
pharmacological interest (e.g. phenothiazines, imipramine). Many biochemicals, 
pharmaceuticals, food additives, pesticide residues, industrial antioxidants, plant 
phenolics, and so forth are ideal candidates for LC-ED method development. 
Simple aromatic amines and their derivatives (hydroxylamines, amides, 
quinoneimines) represent another class of important molecules of natural and 
commercial interest. Most of these are not well suited to GC and can often be 
handled with ease by LC-ED.
1. 4. 7. 1. Applications in Bulk and Form ulated Drug Analysis
A great number of analytes of interest in all aspects of the pharmaceutical industry 
have been determined using LC-ED. The initial development of a pharmaceutical 
agent usually involves the development and characterisation of the bulk drag. 
Although this is not an area in which LC-ED is typically applied, recent 
applications have begun to demonstrate its utility, especially in the determination of 
the purity of reference standards. This issue is becoming more important as most 
current LC methods normally rely on single or perhaps dual UV wavelength 
detection to assign bulk drug purity. Auxiliary methods must be utilised to confirm 
the absence or the presence of non-UV-absorbing materials, which may elute during 
the normal course of a chromatographic method. LC followed by controlled 
potential coulometry has been utilized to determine the purity of electroactive 
drugs, such as acetaminophen H I . The utility of the ED detector to screen for 
electroactive impurities has also been dem onstrated^ When investigating the
SI
purity of a bulk drug that is not electroactive, the presence of electroactive 
impurities can provide important information about the causes of contamination or 
the route of degradation. The combination of UV and ED detection is becoming 
routine in many cases like this. Often the UV detection is used to quantitate major 
components, while ED selectivity detects the low-level impurities.
An important new area of pharmaceutical research is the development of 
biotechnology products. The lack of previous background information or 
therapeutic applications have led to stringent restrictions on trace levels of 
impurities in these bulk drug substances. Prior to their use for therapeutic 
applications, recombinant DNA products must be evaluated for trace levels of 
nucleic acids derived from recombinant bacterial chromosomes and plasmids. 
Previous techniques for such low-level determinations have been time consuming, 
laborious, and prone to experimental error. Kafile et al. have devloped a highly 
sensitive and precise method for quantitation of DNA/RNA fragments 113,114 The 
method is based on hydrolysis of nucleic acids followed by LC-ED.
Many smaller anionic species such as CN ", HS ”, Br ", I _, S2 O3 2 -, and SCN '  may 
be determined in bulk drugs using LC-ED. Simultaneous determination of cyanide, 
sulfide, iodide and bromide by ion chromatography followed by electrochemical 
detection at a silver electrode has been d e m o n s t r a t e d  115,116 Such rapid and 
sensitive determinations are especially applicable to bulk drug and formulated drug 
preparations, where meta-bisulfite is sometimes added as an antioxidant, and the 
other species are considered contaminants. In an evaluation of UV absorption vs. 
amperometric detection for LC, Musch et a l . H 7 , 1 1 8  reported minimum detection 
concentrations (ED vs. absorbance detection) for 94 different drugs. Classes of 
pharmacological compounds included local anaesthetics, antipyretics, sulfonamides, 
sex hormones, beta-adrenoceptor blocking agents, phenothiazines, alkaloids, 
diuretics, and penicillins.
1. 4. 7. 2. Applications in Biochemical Research
LC-ED is well known as an extremely powerful analytical tool and for its direct 
application to biomedical analysis. Amperometric detection is a significant 
technique in biomedical research, largely because of aromatic hydroxylation in 
small molecule metabolism. Most thiols have to be derivatised to be detected by 
HPLC with UV absorption detectionH9 Unlike UV detection methods, LC-ED can 
be used to detect thiols in biological samples directly. The most popular 
electrochemical detector for thiols is one which was introduced by Rabenstein and
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S a e t r e ^ O ,  This detector has the advantage that mercury oxidizes at a lower 
potential in the presence of thiols as follows:
2RSH + Hg * Hg(SR)2  + 2 r  + 2H+ (5)
In the original papers, a mercury pool set at a potential of + 0.1 V was used to 
detect thiols as they eluted from the column. At this potential only thiols and other 
compounds that form complexes with mercury are detected. Saetre and Rabenstein 
used this detector for the determination of cysteine, homocysteine, glutathione, and 
penicillamine in a variety of biological samples, including serum, urine, and 
plasmal^l - 123, Using the mercury pool electrode, less than 10 pmol of 
glutathione could be detected. This reaction can also take place at a gold electrode 
that has been amalgamated with mercury. Perret and Rudge reported the detection 
of D-penicillamine, thiomalate, and captopril using a gold electrode at + 0.8 V vs. 
Ag/AgCll24_ other endogenous analytes have been determined using LC-ED 
techniques, including p r o s t a g l a n d i n s  125 The important enzyme cofactor, NADH, is 
readily oxidised at carbon electrodes 126 an(j provides a unique opportunity for 
enzyme immunoassays coupled to LC-ED. The pterins are of particular interest 
because of their possible role in several d i s e a s e s  127; abnormal levels of various 
pterins have been observed in several diseases such as phenylketonuria, rheumatoid 
arthritis, Parkinson's disease and kidney dysfunction. The electrochemical 
behaviour has been exploited for the sensitive measurement of a variety of pterins, 
and their different oxidation states, in biological samples. In one of the first reports 
by Kissinger s g r o u p  128 on LC-ED methods for pterin analysis, an amperometric 
detector equipped with a single glassy carbon electrode, operated in the reductive 
mode, was used. The high sensitivity of the method may be seen from the detection 
limits shown in Table 1.3.
1. 4. 7. 3. Therapeutic Drug M onitoring and Determination o f Drugs in 
Biological Matrices
The routine use of LC-ED for the selective detection of pharmacologically active 
substances in biological samples has been particullarly highlighted in its use for the 
determination of biogenic amines. This includes blood, plasma, urine, organic 
tissues, and subcellular fractions (e.g. microsomes). The advantages of sensitivity 
and specificity have led to further applications, such as the study of metabolism of 
biologically active compounds. Lavrich and K i s s i n g e r l 2 9  have reviewed LC-ED as 
it relates specifically to therapeutic drug monitoring. In most cases, if a compound
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is electroactive, it will be detected selectively and generally with better detection 
limits than those found for UV spectrophotometric detection.
Table 1. 3. Detection limits fo r selected pterins.
Pterin LOD/pmol*
Biopterin 0.19
6-Hydroxymethylpterin 0.45
erythro -Neopterin 0.15
theo - Neopterin 0.14
Pterin 0.37
Pterin-6-aldehyde 0 .2 0
Pterin-6-carboxylic acid 0.33
Xanthopterin 0.28
Tetrahydrobiopterin 0.75
♦Limit of detection at a signal-to-noise ratio of 3.
Homogentisic acid (H6A; 2,5-dihydroxyphenylacetic acid) is an important 
compound in the primary catabolic pathway for tyrosine in man. In the LC-ED 
determination of HGA in serum it is clearly advantageous to operate the detector at 
a low potential where many possible interferences will not react (Figure 1. 13). This 
degree of selectivity is rarely possible with a UV spectrophotometric detector since 
the electronic spectra of aromatic compounds are broad and usually less sensitive to 
variation in substituents than oxidation potential. Since, in essence, the same 
detection principle has been applied for most pharmacologically active substances 
(buffered mobile phase followed by detection at a working electrode), the following 
are some examples of applications for some specific classes of compounds:
1. 4. 7. 3. 1. Analgesics
As a group, analgesics have been the drugs most widely studied by LC-ED 
techniques. The most widely studied of this group have been acetaminophen 130, 
salicylates!31, codeine^ , and m orphine^, LC-ED has been investigated in
5H-
Figure 1.13. Assay of homgentisic acid in serum at 100 ngml'l. Two samples of 
extract (7ng HGA) were injected using different electrode potentials 
(upper trace: E= +0.75 V, lower trace: E= +0.45 V). Mobile phase: 0.5
M pH 4 acetate buffer at 0.2 ml min-*.Reproduced from Kissinger, P., 
Anal. Chem. 49 (1977) 445A.
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more detail recently as a method for opiate alkaloids of abuse, including heroin, 
cocaine, and related c o m p o u n d s ^ 4  - 136 Detection limits were reported to be in 
the nanogram range for morphine, heroin and cocaine. Ciramadol and dezocine are 
synthetic opiod analgesics of the agonist-antagonist type and have a phenolic group 
that allows selective detection in plasma at the 10  jig/ml l e v e l  137 in a simillar 
manner, the narcotic analgesic ketobemidine (l-[4-(3-hyroxyphenyl)-l-methyl-4- 
piperidyl]-l-propane) is another new narcotic analgesic and phenolic that is 
amenable to EC detection at the 1 ng/ml level in p l a s m a *  38.
1.4. 7. 3. 2. Antibiotics
While many antibiotics are not electrochemically active, several elegant 
applications have been developed, including the derivatization of j3-lactamsl39 
Chloramphenicol is an antibiotic that can be assayed conveniently by LC-ED at 
negative potentials at mercury film electrodes, like other compounds containing an 
aromatic nitro group. Since there are very few reducible compounds found naturally 
in blood, this determination is highly selective^4®. Abou-Khalil et al.141 reported 
the determination of chloramphenicol and four other analgesics using both 
oxidation and reduction modes at a glassy carbon electrode, as well as by UV 
detection (Figure 1. 14). Both trimethoprim and sulfonamides can be detected 
utilizing LC-ED methodology at a greater sensitivity than is possible with UV 
detection, although the applied potential is high, generally about + 1.1 to + 1.2 V. 
Tetracyclines have several moieties that make them amenable to electrochemical 
detection (typically at about + 0.60 V)*42 Other antibiotics determined have 
included erythromycin and related macrolide antibiotics 143,144> enviroximel4  ^
and amoxicillin.
1. 4. 7. 3. 3. Chemotherapeutic Agents
Many of the diverse chemical agents used to treat various cancers have favourable 
redox properties for very selective LC-ED methods. Cis-platinum complexes have 
been widely studied by LC-ED with various degrees of success. These species have 
been detected following LC at dropping-mercury and hanging-mercury drop 
electrodes (using differential pulse amperometry), thin-layer Au/Hg electrodes, 
glassy carbon, and by a halide-catalyzed oxidation platinum e l e c t r o d e  146, 147 
Although detection limits tend to be very dependent upon the legends associated 
with the Pt (thus altering oxidation states and molcular geometry) and are also 
higher (typically in the micromolar range) than those usually expected with EC 
detection, most of the species lack significant UV activity, and LC-ED provides an
56
MIN
Figure 1. 14.HPLC separation and dual detection of a saturated mixture of (NPAP) 
Nitrophenylaminopropanedione: (CAP) Chloramphenicol; (NO-CAP) 
Nitrosochloramphenicol; (DH-CAP) Dehydrochloramphenicol. 
Reproduced from Abou-Khalil, S., et al. J. Chromatogr., 417 (1987) 
11.
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excellent method for their determination. Many anti-cancer drugs are based on a 
quinone or hydroquinone structure. This makes them very amenable to 
electrochemical detection. Table 1. 4 gives some of the quinone anticancer drugs 
and their metabolites that have been detected using LC-ED.
The anthracycline antibiotics, adriamycin and daunomycin, can be detected either 
by oxidative or reductive LC-ED due to the presence of both a quinone and 
hydroquinone moiety. Akpofure et al.1^8 have detected daunomycin and 
adriamycin and their metabolites in serum and plasma using oxidative LC-ED at a 
potential of + 0.65 V. The detection limits using electrochemical detection were 
comparable with those of fluorescence detection (2 ng on-column). Riley et al.149 
compared the use of coulometric and amperometric detection for doxorubicin. They 
found that amperometric detection was more selective than coulometric detection.
1. 4. 7. 3 . 4. Vitamins
There is a growing need for sensitive, selective and reliable methods for the 
analysis of vitamins in areas as nutrition and pharmaceutical chemistry, as well as 
in clinical chemistry and r e s e a r c h  156 However, these determinations may present 
difficult analytical problems for a variety of reasons; for example , in blood, 
interferences between structurally similar vitamers can occur; also, interference 
from the presence of other naturally ocurring compounds may exist. In addition, the 
low endogenous levels present put considerable constraints on both the sensitivity 
and selectivity of potential analytical p r o c e d u r e s  157
The electroreduction of vitamin A has been exploited for the determination of the 
vitamin in an oil-based pharmaceutical product containing a ten-fold excess of 
vitamin D2 ^ ° .  In a recent study, Hart and Jordan 159 investigated the possibility of 
using amperometric detection to monitor retinol in pharmaceutical compounds. 
Vitamin D has been found to undergo oxidation reactions at carbon electrodes. 
Atumal^O utilised this reaction and employed a glassy carbon electrode to monitor 
the vitamin D present in admixture with vitamin A. A number of vitamins have been 
determined using LC-ED. Vitamin E has been determined in plasma using LC-ED, 
the detection limit for being approximately 0.6 ng at a S/N of 10 at an applied 
potential of + 0.70 V.
Table 1. 4. Electrochemical Characteristics o f  Anticancer Drugs
Compound Electrode Potential Ref.
Doxorubicin (adriamycin) GC +0.80 154
Daunorubicin (daunomycin) GC +0.80 150
Teniposide (VM26) GC +0.75 151
Etoposide (VP 16) GC +0.75 151
4-Epidoxorubicin GC +0.80 152
Mitomycin C Hg -0.60 153
Daunorubinol GC +0.65 148
1-Napthol (napthoquinone) GC -0.40 154
Mitoxantrone (novantrone) GC 40.75 155
1. 4. 7. 3. 5. Tricyclic Antidepressants
The tricyclic antidepressants used in the treatment of endogenous depression have 
been widely prescribed in recent years. Since there is a strong correlation between 
the plasma levels of these compounds and their therapeutic efficacy, there is a great 
demand for routine laboratory procedures to assay plasma samples for these drugs 
and their metabolites. Laboratories performing therapeutic drug monitoring require 
techniques which are sensitive, selective, and simple. Present methodologies 
include GC-MS, LC-UV, and LC-ED. With GC-MS, assays are often long, 
requiring the synthesis of derivatives. LC-UV methodogies lack sensitivity; other 
methodologies cannot achieve the required detection limits and also have a problem 
with interfering endogenous compounds. LC-ED (Figure 1. 15) offers the advantage 
over GC procedures of measuring the compounds directly. Both the parent drug and 
the metabolites can be measured in a single chromatogram with LC-ED (Figure 1. 
15). This is a critical because some of these drugs produce active metabolites which 
should be monitored. The standard protocol for assay of these compounds utilises 
reversed-phase liquid chromatography with electrochemical detection at an applied 
potential of + 1.05 V.
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Figure 1. 15.Tncyclic antidepressants in plasma. Comparison of spiked
chromatograms obtained simultaneously by EC and UV detection. 
Legend:2-OH-D = 2-hydroxydesipramine, 32 ng injected; 2-OH-l = 2- 
hydroxyimipramine, 38 ng injected. As can be seen, EC detection has 
less baseline noise and a better signal response than UV detection. The 
potential is =0.05 V. Reproduced from ref. 133.
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The influence of a drug on a disease state or the metabolic functions of an organism 
is an important aspect in the determination of drug efficacy. Currently, 
developments in chromatographic technology have enhanced the manner in which 
biogenic amines are determined using EC detection. Lin et al.161 reported the 
separation of a series of 18 biogenic amines in 4 to 7 min following extraction from 
brain tissue. Detection limits for some biogenic amines have been reportedly in 
the range of 1 to 15 fmol. Future use of LC-ED in the neurochemistry area will be 
linked to development of improved sampling technology. By uniting microdialysis 
with LC-ED, the number of analytes that may be determined far exceeds that 
attainable using other in vivo techniques such as biosensors. Microdialysis is a new 
methodology that allows for the monitoring of chemical events in the extracellular 
space where chemical transmission takes place 163
1. 4. 7. 4. Methods Involving Chemically Modified Electrodes and Mediated 
Reactions in Pharmaceutical Analysis
Analytical, biological, and clinical chemists have for decades concerned themselves 
with the development of instruments and techniques capable of determining the 
identity and concentration of chemical substances that affect living things. 
Biosensors can be used to detect biologically important substances in vivo or in 
vitro. Tailoring electrode surfaces to exact the desired electroanalytical response is 
now being intensely investigated in electrochemical circles. All the important 
analytical properties of electrodes; namely sensitivity, selectivity, reproducibility 
and even applicability, have been shown to be capable of enhancement by the 
judicious use of chemical modification. Selective electrochemical sensors can be 
classified into:
(i) ISEs and related potentiometric sensors;
(ii) voltammetric electrodes whose selectivity can be regulated
within certain limits by adjustment of the experimental 
conditions;
(iii) physically or chemically modified electrodes; and
(iv) sensors whose selectivity depends on biochemical processes, 
such as enzyme catalysis or immunological interactions.
For LC-ED, modified electrodes must respond rapidly to the analyte of interest on
the time scale of the experiment and remain stable over a period of weeks for
reproducibility s sake. Physical adsorption of the mediator to the surface provides
1. 4. 7. 3. 6. Biogenic Amines
¿1
only limited stability, but the system is easily renewed; covalent attachment has not 
fared significantly better. Over the past few years there has been interest in the 
application of amperometric sensors for the determination of purine derivatives, 
which act as drug substances; such methods have generally been developed to 
enhance selectivity while maintaining simple experimental set-ups and procedures.
1. 4. 7. 5. Scope in Environm ental Analysis a n d  M onitoring
The biosphere contains a myriad of substances which can influence, inhibit, 
aggravate or simulate various aspects of the health and behaviour of whole living 
organisms or systems isolated from them. The endeavours of technologically 
advanced societies are increasingly reliant on the estimation, monitoring and control 
of chemical species. This requirement for analytical information applies to all 
sectors of activity, including health care and veterinary medicine, the food, 
pharmaceutical, bioprocessing and petrochemical industries, environmental 
monitoring and control, defence and agriculture.
Environmental pollution is an age-old trademark of man, and in recent years as 
technology has progressed, populations have increased and standards of living have 
improved, so the demands on the environment have increased, with all the attendant 
problems for the earth's ecosystems. Combustion of fossil fuels, disposal of waste 
materials and products, treatment of crops with pesticides and herbicides, have all 
contributed to the problem. Technological developments have enabled man to study 
these problems and realise that even trace quantities of polluants can have 
detrimental effects on health and on the stability of the environment. There is a vast 
amount of literature on the use of ED for studying a wide variety of these
problems 164 - 166
Chlorinated phenols and naphthals, alkyl phenols used as antioxidants, and hydroxy 
derivatives of biphenyls are present in the wastes from the manufacture of 
formaldehyde resins, lacquers and binders, pharmaceuticals and pesticides etc., and 
constitute a major part of environmental pollutants; they can be found in waste 
waters from cocking plants and brown coal distillation plants, in industrial 
effluents, and in the soil as degradation products of various pesticides.
Aromatic amines enter the environment either directly, as industerial wastes, or 
indirectly as degradation products of pesticides and through bacterial conversion of 
azo compounds into their precursors, amines. Many of these substances are highly 
toxic and/or mutagenic and occur in the atmosphere, in biological materials and in 
wastes. Because of the polar character of amines, their determination by gas
¿2.
chromatography requires derivative formation to be performed in order to prevent 
irreversible sorption of the analytes on the column packing and consequent peak 
tailing. A number of w o r k e r s  167 - 169 have demonstrated good results which can 
be obtained by HPLC with amperometric detection.
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2. 1. INTRODUCTION
Whereas potentiometric and coulometric titration methods are fairly universal and 
can be applied to a wide variety of problems, voltammetric methods are distinctly 
limited to easily reducible or oxidisable compounds. On the other hand, 
voltammetric methods are clearly the most useful for low-level quantitation and 
have a wide linear dynamic range. Solid electrode voltammetry, which is typically 
employed for anodic (oxidation) processes, can be carried outusing a rotating 
platinum electrode, a wax-impregnated graphite electrode, a carbon paste electrode, 
or a glassy carbon electrode.
Electroanalytical methods of measurement have a property that is usually 
considered as a serious drawback; namely, the sensor is in direct contact with the 
test medium and the measured signal is produced by a heterogeneous redox reaction 
occuring at the sensor surface. Consequently, it is very difficult to maintain the 
sensor surface in a reproducible, electroactive state because of contineuous 
interactions between the sensor and the test medium, for example, through 
adsorption, ion exchange, or redox processes. However, these interactions may also 
be very useful, as demonstrated by the broad field of chemically modified 
electrodes or techniques such as electrochemical stripping analysis.
2. 1. 1. Solid Electrode Surf aces
In most voltammetric measurements it is desirable that the electrode surface be as 
smooth as possible, for two reasons: the faradaic currents are proportional to the 
geometric surface area, whereas the background current, consisting mainly of the 
charging current, is proportional to the microscopic surface area; hence the signal- 
to-noise ratio deteriorates with increasing roughness of the electrode. Furthermore, 
the hydrodynamic pattern becomes poorly identified at rough surfaces and local 
turbulance often develops; the behaviour of the electrode then deviates from 
theoretical predictions and the precision becomes worse. Well-polished solid 
electrodes exhibit roughness factor values of a few units, while coarse surfaces, 
may attain values close to 10 0 0 .
Glassy carbon has a very low porosity but, depending on the quality of the glassy 
carbon, microscopic pitting can be observed at the polished surface. Presumably, 
these cavities are due to excessively fast heating during the carbonisation process so 
that the gases formed has too little time to diffuse to the surface. The more careful 
the heating procedure, the fewer the cavities and the better the electrode surface
73
will function.
An understanding of the deactivating processes at solid electrodes requires an 
insight into the surface reactions involved in the electrochemical conversion of the 
analyte as well as into other processes and reactions occuring at the electrode 
surface. However, little is known about general surface chemistry, and the field of 
electrochemistry at solid electrodes is no exception.
2. 1. 2. Pretreatm ent o f  Solid  E lectrodes
In physicochemical measurements, the test systems are made as simple as possible. 
Unfortunately, analytical systems are inevitably widely varied and often very 
complex and poorly defined. Therefore, the electrode pretreatment and surface 
modification procedures are empirical to a considerable extent, and specific 
conditions must usually be found for particular analytical tasks.
Techniques whose main purpose is to bring the electrode surface to a defined, 
active state are usually called the "electrode pretreatment." However, even these 
procedures are often carried out not only to attain a sufficiently sensitive and 
reproducible voltammetric signal, but also to improve the measuring selectivity 
through a suitable modification of the electrode surface. Many species dissolved in 
solution exhibit a tendency to adsorb on the electrode surface, a phenomenon that 
can markedly affect the results of electrochemical experiments. Adsorption is 
responsible for much "unusual" electrochemical behaviour and is frequently blamed 
for unexplained results. The efficiency of electrochemical methods for electrode 
activation depends mainly on; (i) electrode material, (ii) solution composition (pH, 
complexing agent), (iii) potential of the cleaning pulse, (iv) convection of the 
solution in the close vicinity of the electrode.
A wide variety of electrochemical pretreatment procedures have been recommended 
in the literature. Most of them have been developed through trial and error. This is 
understandable, since it has been shown that the optimum pretreatment is dependent 
on the electroactive species and on the type of supporting electrolyte used*. 
Besides, the reason for the increased activity of the electrodes after pretreatment is 
still not understood very well. The effects of these pretreatment procedures are not 
all beneficial. The background current becomes larger, as does the noise level. So 
far, application in trace analysis the pretreatment procedure must be chosen 
carefully. This has prompted us to investigate several electrochemical pretreatment 
procedures. Among the applicable methods of surface activation for laboratory 
measurement are mechanical and electrochemical methods.
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The first step in pretreatment of a solid electrode is mostly mechanical polishing to 
a mirrorlike finish. Certain solid electrode types—for example, wires, fibres, or 
classical carbon pastes— are difficult or impossible to polish, leading often to 
poorly defined geometry and uncertain roughness. Disk, ring and ring-disk 
electrodes are undoubtedly the most suitable geometric systems from this point of 
view^. Common metallographic procedures are employed in electrode polishing: 
emery wheels, papers, clothes, and polishing suspensions of alumina and diamond 
are used, with gradually decreasing grain size, down to values of around 50 nm.
Mechanical cleaning by polishing with abrasive material ranks among the oldest 
methods and have been used by many authors up to the present. It can be easily 
done manually, while an automatic mechanical cleaning is quite a complicated 
procedure. The reason is that the electrode and the cleaning tool must not be in 
constant contact but move independently against each other to prevent the 
deposition of the abraded electrode material on the tool. The accumulated abraded 
material adhering to the tool is in electrical contact with the electrode and increases 
its irreproducibility. The electrode is then degreased by washing with a suitable 
organic solvent and thoroughly washed with water. During use the electrodes must 
be repolished at certain intervals, depending on the electrode material, test solution 
composition, and measuring technique used; brief repolishing with a damp synthetic 
fabric is often sufficient. The efficiency and success of mechanical polishing with 
abrading paste or very fine emery paper depends on the skill of the operator: 
abrading must not either change the microstructure of the electrode surface nor its 
wetting angle by, for example, touch of fingers. The controversial results in the 
literature support the fact that commercially available electrodes are sometimes 
damaged after a certain time of use.
The results of mechanical polishing can usually results in: an even, smooth surface, 
which, however, contains a certain amount of loose microscopic particles of the 
electrode material and of the abrasive^ - 10 This is, of course, more pronounced 
with softer carbon materials. A thin layer of carbon macroparticles produced by 
polishing causes large variations in the double-layer capacityH. The loose particles 
may act as adsorption and catalytic sites. In fact, a catalytically active electrode has 
been prepared by deliberate mechanical pressing of o<-alumina particles into the 
polished surface of a glassy carbon electrode 12. Most contaminants are 
mechanically removed from the surface during polishing, but others may be 
introduced. Furthermore, polishing uncovers a fresh, highly reactive surface of the
2. 1 .2 . 1. Mechanical Grinding and Polishing
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electrode material which interacts with the ambient atmosphere; this interaction is 
affected by the heat of friction. It has been shown that polishing of glassy carbon in 
air causes an increase in the amount of chemisorbed oxygen^, whereas polishing 
in an inert atmosphere decreases this a m o u n t ^ , 14 Thus it can be seen that even 
the simplest procedure of mechanical polishing leads not only to mechanical 
changes, but also to chemical modification of the electrode surface. However, 
electrode polishing gives a surface that is in an unstable condition. This is 
manifested by often ill-defined and non-reproducible voltammograms obtained at 
freshly polished electrodes. Besides, electron-transfer rates are, in that case, 
relatively small 15 and thus a further activation step is usually employed.
2. 1.2. 2. Chemical and Electrochemical Pretreatm ent
Chemical, and especially electrochemical procedures are used by far most often to 
clean solid electrodes and bring them to an active state. In fact, virtually any 
electrochemical measurement with a solid electrode is preceded by polarization of 
the electrode under suitable conditions in a suitable solution. This approach is 
attractive because it is very simple, can be carried out without additional 
instrumentation and without dismantling the measuring cell, or often directly in the 
test solution and the pretreatment procedure can readily be incorporated in the 
measurement program, either at the beginning of the experiment, or periodically 
during the measurement. It is hoped that two principal goals are achieved during a 
chemical and/or electrochemical pretreatment of the electrode: The electrode 
surface is freed of passivating layers and brought to a state of the highest possible 
sensitivity (and often also an improved selectivity) for particular analyte(s). The 
electrode surface can attain three possible states: the reduced state in which it may 
be covered by adsorbed hydrogen; the oxidized state, chararacterised by the 
presence of various oxygen-containing species; and in between these two states, 
when the electrode is supposed to be "clean."
Repeated oxidation and reduction of the electrode surface in a suitable solution 
removes many passivating layers; however, some strongly adsorbed or chemically 
bound layers can only be removed by repolishing of the electrode or by a suitable 
heat (irradiation) treatment. Chemical pretreatment of solid electrodes strongly 
depends on the experimental conditions and sometimes it is useful to combine 
chemical and electrochemical pretreatment.
2. 1.3. Assay of dosage forms
Since voltammetric techniques demonstrate a large linear dynamic range ( 10 ‘3 - 10*
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8 M), any one method can readily be applied to the analysis of pharmaceuticals in 
bulk and in dosage forms. The appeal of the voltammetric methods of analysis for 
organic compounds is attributable to their simplicity and rapidity. The functional 
groups which show excellent voltammetric properties include the nitro, nitroso, 
quinone, azo, azoxy, activated double bonds 16. For the most part, the voltammetric 
activity of a compound can be deduced from an examination of its functional 
groups. However, to ensure that electrochemical activity of a compound is not 
missed, the analytical screen should include voltammetric scans of the compound in 
aqueous supporting electrolytes (it is convenient to use 0.1 M HC1, 0.1 M NaOH, 
and buffers with pH values of 3, 5, 7, 9, and 11) using either the DME or glassy 
carbon electrode.
If the compound is insoluble in aqueous media, then organic co-solvents such as 
alcohols, dioxane, acetonitrile, dimethyl sulfoxide, and dimethyl formamide must 
be employed. Occasionally, pure non-aqueous solvents of high dielectric constant, 
such as dimethyl formamide, acetonitrile , dimethyl sulfoxide, pyridine, or glacial 
acetic acid, containing tetraalkyl salts may be required to attain highly negative 
potentials (greater than -1.8 V vs. SCE) without supporting electrolyte 
decomposition. The voltammetric analysis of drugs in pharmaceutical products is by 
far the most common use of electrochemistry for analytical pharmaceutical 
problems. A better understanding of the electrode processes of compounds of 
pharmaceutical interest (active agents, excipients, additives, antioxidants, etc.); and 
application of oxidation waves are required. The USP (volume XX) quotes 16 drugs 
and formulations assayed by electrochemical techniques.
As a rule, many of the active constituents of formulations in contrast to excipients 
can be readily oxidised or r e d u c e d ^ ,  1 8  Thus sample preparation usually consists 
of dissolving out the active ingredient from the particular formulation with a 
suitable solvent (non-aqeous, if necessary) and performing direct analysis on an 
aliquot of this solution without prior separation of the active substance from the 
formulation m a t r i x ^ .  The selectivity of the method is usually excellent because the 
compound can be identified by its voltammetric half-wave potential. Examples of 
voltammetric determination of organic compounds in pharmaceutical preparations 
include many classes of drugs: tranqulizers, sedatives, hypnotics, antibiotics, 
steroids, antihistamines, diuretics, muscle relaxants, anticoagulants, and others. For 
instance, disulfiram [bis(diethylthiocarbomyl) disulfide] a drug used in the 
treatment of alcoholism, has been assayed directly by differential pulse 
polarography in an aliquot of a solution of a ground-tablet dissolved in ethanol- 
acetate buffer ( p H 4 . 5 ) 2 0 .  A mechanism for the electrode process was proposed
1involving the reaction of the disulfiram with the mercury drop to form an insoluble 
mercuric salt, which then underwent reduction at the electrode surface.
Carbon, in its particular pyrolytic and glassy carbon forms, has found common 
usage as a working electrode for determination of oxidisable drug substances 2 1 ,2 2  
Its popularity stems from the fact that it has compartively good electrolytic 
properties, and is, moreover, less suscepetible to surface poisoning (for example, as 
a result of surface oxidation) than other materials such as platinum and gold. 
Schwartz and B e n j a m i n 2 3  carried out differential pulse voltammetric (DPV) 
determinations of morphine in poppy straw concentrates at a staionary glassy 
carbon electrode and obtained results similar to those obtained by HPLC24 and gas
chromatography 25.
2 . 2 .  D if f e r e n t ia l  p u l se  v o l t a m m e t r ic  d e t e r m in a t io n  
o f  Su m a t r ip t a n  Su c c in a t e  (1:1) in  a t a b l e t  d o sa g e  f o r m
2. 2. 1. Introduction
Sumatriptan succinate(l:l) [I] is a 5-hydroxytryptamine agonist under development 
for use in human medicine for the treatment of acute vascular headaches26,27
(CH C O O H )
2 2
1. Structural formula of Sumatriptan succinate (1:1)
Oral administration of the drug is an effective and well tolerated treatment for acute 
migraine, with a dose of 10 0  mg appearing optimal in terms of efficacy: side effect 
ratio28. A review of the animal pharmacology, bioavailability, metabolisim and 
initial clinical studies using intravenous, sub-cutaneous and oral administration of 
the drug has been made by Oxford and L a n t 2 9 .  Existing liquid chromatographic and 
spectrophotometric procedures for this compound possess one or more 
disadvantages. These include a time consuming sample preparation, and long 
chromatographic elution times. Owing to the presence of several potentially 
oxidisable groups in its molecular structure, it was decided to investigate the 
voltammetric behaviour of this compound at a glassy carbon electrode, with a view 
to developing a simple and precise method for its determination in a tablet dosage 
form.
7 8
2. 2. 2. Experimental
2. 2. 2. 1. Reagents
Sumatriptan succinate (1:1) tablets ( containing 100 mg of active ingredient) were 
obtained from Glaxo Group Research Limited. A lxlO’^M solution of sumatriptan 
succinate ( 1 :1 ) was prepared in isotonic saline and stored in the dark under 
refrigeration. The graphite used in the construction of the carbon paste electrode 
was obtained from Aldrich Chemical Company. Deionised water was used to 
prepare all solutions. This water was obtained by passing distilled water through a 
Milli-Q water purification system. All other reagents were of analytical grade. A 
stock Britton-Robinson(BR) buffer solution was prepared which was 0.04M in each 
of glacial acetic acid, orthophosphoric acid and boric acid. Buffer solutions of 
varying pH were then prepared by the addition of 0.2M sodium hydroxide.
2. 2. 2. 2. Apparatus
For voltammetric studies, a three-electrode cell was used in which a calomel 
electrode served as the reference electrode, a platinum wire served as the auxiliary 
electrode, and a glassy carbon electrode was used as the working electrode. For 
coulometric studies, a carbon paste electrode was used as the working electrode. 
The potential of the working electrode was controlled using an EG&G Princeton 
Applied Research (PAR) Model 264A potentiostat connected to an Omnigraph 
2000 X-Y recorder . Rotating disc electrode experiments were carried out using a 
glassy carbon electrode connected to an analytical rotator and a PINE model ASRE 
416 speed controller. The pH values of the solution was measured using a Coming 
Model 240 digital pH meter. The pH electrode was standardised with the use of two 
buffers (phosphate buffer, pH 7.05 and phthalate buffer, pH 2.15). The accuracy of 
pH readings was equal to 0.02 unit.
2. 2. 2. 3. Methods
2. 2. 2. 3. 1. Electrode Activation Procedures
The glassy carbon electrode was first hand polished on silicon carbide paper (No. 
240), followed by polishing using an alumina slurry. Residual polishing material 
was removed from the surface by sonication of the electrode in a methanol bath for 
15 minutes, during which the methanol was changed every 5 minutes. As reported 
p r e v i o u s l y 3 0 ; activation of glassy carbon using a high anodic potential is highly 
effective. Activation of the glassy working electrode used in this study was 
achieved by holding the electrode at +1.5 V under stirring for 90 sec before
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recording each voltammogram. The appropriate initial potential was then selected 
and the electrode allowed to stabilise for 30 seconds; a scan was then initiated from 
+0-V+1.1 V using a scan rate of 10 mVs.‘ l
2. 2. 2. 3. 2. Assay o f Sumatriptan in Tablet Dosage Form
A single tablet was dissolved in 900 ml of isotonic saline solution. A series of serial 
dilutions was then performed to give a nominal final concentration of 6 xlO“4 M. An 
aliquot of this solution was then transferred to the voltammetric cell containing 20  
ml of BR buffer, pH 5.0, to yield a final concentration of 2x10'6m sumatriptan. 
The voltammogram was subsequently recorded by employing a scan rate of 10 
mVs'l. To quantify the unknown amount of sumatriptan in solution, a multiple 
standard addition procedure was employed.
2. 2. 2. 3. 3. Preparation of carbon paste electrode
The carbon paste electrode used for potentiostatic coulometry was made by pressing 
the active paste into the well of the body of plastic syringe (20 mm in diameter, 5 
mm deep). The paste surface was manually smoothed by polishing it on clean paper 
and a new surface was prepared for each experiment by removing the paste from 
the electrode body, which was washed with absolute methanol and water, then dried 
with tissue paper, and subsequently packed with a fresh portion of the required 
carbon paste. To simplify this procedure, the syringe plunger provided a screw 
system to slide the brass disk in and out which thus pushed the paste out of the 
electrode body for surface renewal.
Unmodified carbon paste was prepared by careful hand-mixing of 5 mg of UCP 
carbon graphite powder (Spectropure grade, Fluka Chemical Co.) and 3 mg of 
Nujol oil (McCarthy Scientific Co., Fullerton, CA) using a glass mortar and pestle, 
and blending the mixture into a paste. In its design the paste was in direct contact 
with a disk made of brass which was attached to a copper wire of about 3 mm o.d. 
providing electrical contact to the measuring circuit. The carbon paste electrode was 
stored in 0.05 M sodium dihydrogen phosphate, pH 5.0, at room temperature and at 
open circuit.
2. 2. 3. Results and D iscussion  
2. 2. 3. 1. Activation Procedure
The surface of the glassy carbon working electrode used in this investigation was 
fouled due to adsorbed products of the oxidation process. Different electrochemical
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pretreatment procedures were examined, and it was found that good reproducibility 
could only be achieved by holding the potential of the working electrode at a 
potential more positive than the oxidation potential of the drug. The optimum 
conditions were found to be at +1.5 V for 90 sec under stirring. The precision 
(expressed as the relative standard deviation) of the signal obtained for a 8x1 0 ' 6m 
solution of sumatriptan in Britton-Robinson buffer (pH5) under these conditions 
was 1 .1 % (n=1 0 ).
2. 2. 3. 2. E ffect o f  pH
Sumatriptan gave rise to a single oxidation process at the glassy carbon electrode in 
BR buffers of pH 2-11 using DPV. The effect of pH on the the peak potential (Ep) 
and peak current (ip) of the oxidation peak of sumatriptan is shown in Figures 2. 1 
and 2. 2 respectively. The graph of Ep versus pH clearly indicates that the peak 
shifts to more negative potentials with increasing pH. Between pH 2 and 5 the slope 
of the graph was 95 mV pH 'l. A break in the graph then occurred at pH 5.0, and 
the slope of the graph subsequently became 50 mV pH'l between pH 5-11. The 
position of this break is close to the pKai and pKa2 values of succininc acid at pH 
4.16 and 5.61 [Glaxo Group Research, personal communication]. Sumatriptan 
succinate(l:l) has pKa values (determined by UV spectroscopy) associated with the 
succinic acid ion pair at 4.21 and 5.67, with the tertiary amino group at 9.63 and the 
sulphonamide group at pH>12. The effect of pH on ip shows a maximum peak 
current at pH 5.0, which coincides exactly with the polarographic pKa value 
obtained from the plot of Ep vs pH. Below pH 4.0, the drug exists mainly in the 
monoprotonated form since the succinic acid will be mostly in the deprotonated 
state and the drug will be protonated at the tertiary amino group. On approaching 
the pKai value of succinic acid, the acid begins to dissociate into the hemisuccinate 
form which forms a neutral ion pair with the monoprotonated form of the drug. As 
the pH is increased beyond 5.0, and nears the pKa2 value of succininc acid, the ion 
pair becomes negatively charged as the concentration of succinate increases in 
solution. Only one polarographic pKa value was seen because of the relative 
closeness of the pKai and pKa2 values of succinic acid. The highest current value 
was obtained for the neutral species over either the positively or negatively charged 
moieties.
2. 2. 3. 3. Optimisation o f Operating Param eters
2. 2. 3. 3. 1. Variation o f Peak Current with Pulse Amplitude
The application of the differential pulse waveform (pulse amplitude = 50 mV)
81
PEAK POTENTIAL ( V]
   pH
Figure 2.1. Influence of pH on peak potential of sumatriptan succinate (1:1) (1x10  ^M). 
Scan rate = 20 mVs'l.
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Figure 2.2. Influence of pH on peak current of sumatriptan succinate (1:1) (lxl0'3 M). 
Scan rate = 20 mVs'*-
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yielded voltammograms in which the peak currents were on average twice as 
sensitive as those obtained by linear sweep voltammetry(LSV). The peak current 
intensity increased as the pulse amplitude was increased and a pulse amplitude of 
100 mV provided the most sensitive signal. However, the use of this pulse 
amplitude resulted in an increased capacitive current and the analytical process 
merged to a certain extent with the electrolyte discharge. A value of 50 mV was 
therefore used for further studies.
2. 2. 3. 3. 2. Variation o f Peak Current with Pulse Interval
Differential-pulse voltamograms recorded at various "pulse intervals" showed that 
the peak current increased as the pulse interval was increased. A pulse interval of 
0.25 sec gave rise to the most sharp and symmetrical peak shape.
2. 2. 3. 3. 3. Variation o f  Peak Current with Scan Rate
The oxidation process was studied at a different scan rates, 2 mVs'l ■+■ 100 mVs'l). 
The optimum scan rate was found to be 20 mVs'l. Higher scan rates gave rise to 
broader peaks and resulted in the oxidation process merging with the electrolyte 
discharge. The following operational conditions therefore gave rise to the best 
sensitivity and selectivity for the determination of sumatriptan : pulse height 50 
mV, scan rate 20 mVs'l and pulse interval 0.25 sec.
2. 2. 3. 4. M echanism o f  Oxidation Process
The cyclic voltammetric behaviour of sumatriptan succinate at a glassy carbon 
electrode in Britton-Robinson buffer, pH 5  is shown in Figure 2 .  3, indicating that 
the drug is irreversibly oxidised at the glassy carbon electrode. Studies were then 
undertaken to investigate the rate-controlling step of this process. Linear sweep 
voltammograms obtained for increasing values of the scan rate showed the 
existence of a linear dependence of the peak intensity upon the unit power of the 
scan rate between 5  and 1 0 0  mVs'l.The characteristics of this graph were slope 
4 . 0 0  pAmVs-!, current intercept 0 .2 5  juA, and correlation coefficient r= 0 .9 9 9 2 .  
When this data was plotted vs the 1 /2  power of the scan rate, a non-linear fit was 
obtained. These considerations pointed to an adsorption-controlled process, rather 
than a diffusion-controlled one. In order to further support this finding, 
hydrodynamic voltammograms were obtained for concentrations ranging from as 
low as 5 x 1 0 " 7  up to 1 .5 x 1 0 * 6  M sumatriptan at rotation speeds between 2 0 0  to 
1 0 0 0  r.p.m. The resulting voltammograms failed to show the typical plateaus 
expected. Instead peaks were obtained throughout, whose magnitude did not depend 
markedly on the rotation speed applied to the electrode. This evidence constituted
0 . 0  + 0 . 5  + 1 . 0  + 1 . 5
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Figure 2. 3. Cyclic voltammogram of sumatriptan succinate (1:1) (lxl0'3 M), at glassy 
carbon electrode in Britton-Robinson buffer, pH 5. Scan rate = 200 mVs'V
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further proof of a non diffusion-controlled oxidation process. Potentiostatic 
coulometry experiments were then carried out for a lxlO'^M solution of 
sumatriptan succinate in Britton-Robinson buffer, pH 5.0, using a carbon paste 
macroelectrode (diameter 2 cm) at a fixed potential of +0.90 V. The number of 
electrons involved in the oxidation process was found to be 0.80, indicating that one 
electron was transferred in the oxidation process. A comparison with the oxidation 
wave obtained for indole-3-acetic acid, which occured at a similar potential to that 
of sumatriptan indicated that the oxidation occurred at the N atom in the indole ring 
of the molecule.
2. 2. 3. 5. Assay o f  Sumatriptan Succinate (1:1) in a Tablet D osage Form  
2. 2. 3. 5. 1. Effect o f  Excipients
The effect of excipients on the DPV behaviour of sumatriptan succinate (1:1) was 
investigated by adding in the relative concentration of each excipient into a pure 
solution of the drug in BR buffer, pH 5.0. The magnitude of the peak current for 
sumatriptan succinate increased after the addition of each the additives. Interference 
was found to be caused by cellulose, lactose and magnesium stearate. A cumulative 
effect for these compounds was also noticed when the analysis was carried out 
using placebo tablets (Figure 2. 4). This effect could be nullified using the 
activation procedure described in the Experimental section.
2. 2. 3. 5. 2. Effect o f Concentration
Using the optimum conditions described, a linear calibration curve was obtained for 
sumatriptan in the range l-8xl0'^M. The characteristic of this graph were slope
1.75 pA mol'ldm^, current intercept 0.23 pA and correlation coefficient r=0.999. 
The limit of detection of the procedure was found to be 5 x 1 0 “^  M. Nine samples 
from different dissolved tablets were analysed using the proposed voltammetric 
method. Appropriate dilution to produce solutions within the linear range was used 
in the analysis. The values found ranged from 96 to 99 mg per tablet. The relative 
standard deviation for the analysis of nine tablets was 1 .86%.
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Figure 2.4. Effect of the excipients on the DPV determination of sumatriptan
succinate (1:1) (1.5xl0‘6 M); (a). 1.5x10'^ M sumatriptan succinate,(b). in 
presence of dissolved placebo tablet with no pretreatment, c. in presence of 
dissolved placebo tablet following electrode pretreatment.
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2. 3. VOLTAMMETRIC STUDY OF THE ELECTROCHEMICAL BEHAVIOUR 
OF SALBUTAMOL AND ITS DETERMINATION IN A TABLET DOSAGE 
FORM AND DISSOLUTION PROFILES FOR THE DOSAGE FORM.
2 . 3 . 1. Introduction
Salbutamol, 1 -(4-hydroxy-3-hydroxy methy lphenyl)-2-tertbutylamino-ethanol, also 
known as albuterol [II], is a sympathomimetic amine (or adrenergic drug) which
clinical application primarily as a bronchodilator and it is widely used in the
IL Structural formula of Sslbul&mol 
Methods for the assay of salbutamol in tablet dosage forms are usually based on
having the advantage of requiring minimal sample preparation, is relatively slow 
and expensive, requiring filtration, degassing and expensive grades of reagents, 
eluents and equipment. The objective of the work described in this section was to 
investigate the electrochemical behaviour of salbutamol and devise a suitable 
differential pulse voltammetric method for the analysis of salbutamol in a tablet 
dosage form without employing a preliminary separation step, and to study the 
dissolution profile for the drug.
Dissolution rate testing is an important aspect of the development of a drug. It can 
be serve as a guide to formulation development and may be correlated to the 
absorbability potential of some poorly soluble drugs. Voltammetric methods are 
ideal for these studies since they are selective and the electrode used to monitor the 
rate of dissolution may be placed directly in the dissolution apparatus obviating the
affects those cell chemicals that mediate sympathetic nerve transmissions^!. It has
prophylaxis of bronchospasms^, where it has more prolonged actions than other 
bronchodilators and has been reported to have a more selective a c t i o n 3 3 .  The drug 
is also used in obstetrics for the prevention of premature labour34 and as a nasal 
decongestant.
H0 - r u - r u  — WH — C(CH )
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spectrophotometric35 or colorimetric determinations^. Liquid chromatographic 
methods have also been developed for determination of this sympathomimetic drug 
in pharmaceutical preparations^. For such applications, however, HPLC, while
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need for respective sampling. The silicone-rubber-based graphite electrode has been 
employed as an appropriate voltammetric sensor to measure the rates of dissolution 
of several oxidisable pharmaceutical c o m p o u n d s ^ , 39 T ^ e  recirculating dissolution 
measuring arrangement with this sensing electrode and an Ag/AgCl reference are 
shown in Figure 2. 5. A peristaltic pump continuously samples the system in the 
thermostatically controlled dissolution vessel. A suitable constant potential is 
applied between the two electrodes and the current vs. time curve is recorded. An 
example of this system was demonstrated for the dissolution of aminopyrine 
tablets^O. A similar design experimental set-up using a dropping mercury electrode 
in a flow cell had been applied to the determination of drug dissolution of 
chlordiazepoxide, trimethoprim, omidazole, and isoniazide using polarography^l. 
The dissolution rate of L-dopa in 0.1M HC1 has been determined employing a 
tubular carbon electrode ( T C E ) 4 2 .  A liter sample was pumped through a filter unit 
to the TCE and returned to the beaker. After setting the electrode potential at +0.9V 
vs. SCE and establishing a baseline current, a tablet was added and the limiting 
current was recorded as a function of time.
2. 3. 2. Experim ental
2. 3. 2. 1. Reagents and Solutions
Salbutamol and the different excipients used in the interference studies were kindly 
supplied by Glaxo Group Research Limited (Park Road, Ware, Hertfordshire, UK). 
Analytical grade sodium dihydrogen phosphate was obtained from BDH Chemicals 
Ltd (Poole, England). The compound and the supporting electrolyte were used 
without further purification. Stock solutions (l.OxlO‘3 M) of salbutamol were 
prepared by dissolving the compound in deionised water obtained by passing 
distilled water through a Milli-Q water purification system (Millipore). The 
solutions were stored in the dark under refrigeration to minimise decomposition. 
More dilute solutions were prepared daily from the stock solution. The supporting 
electrolyte used for all the voltammetric studies was prepared from a 0.1 M stock 
solution of sodium dihydrogen orthophosphate. This was subsequently diluted with 
deionised water to give the required concentration and adjusted to the required pH 
with 0.2 M sodium hydroxide.
The standard polishing kit and the glassy carbon electrode were supplied by EG&G 
Princeton Applied Research (PAR). The saturated calomel electrode was obtained 
from Metrohm (Herisau, Switzerland). For chromatographic experiments, the 
mobile phase used was 0.067 M sodium phosphate, pH 5.0; methanol; 40 g/L
Figure 2. 5. Measuring setup for investigation of the dissolution of drugs from
pharmaceutical preparations. T, thermometer; K, stirrer; P, peristaltic 
pump; Ei, silicone-rubber-based electrode; E2, silver-silver chloride reference 
electrode. Reproduced from ref. 39.
sodium dodecyl sulphate (SDS) and diethylamine (DEA) in a ratio of 45: 55: 0.5: 
0.02 (v/v). The drug was separated on a LC column (2.5 cmx4.6 mm i.d.), packed 
with reversed-phase octadecylsilane, ( 10  ¿im spherical particles) obtained from 
HPLC Technology (Macclesfield, Cheshire, UK).
2. 3. 2. 2. Apparatus
For voltammetric studies, the experiments were carried out in an all-glass cell 
designed for a three-electrode potentiostatic circuit. A platinum wire and a saturated 
calomel electrode were used as auxilliary and reference electrode, respectively. The 
potential of the working electrode was controlled using an EG&G Princeton 
Applied Research (PAR) Model 264A potentiostat connected to a JJ Instruments 
Model PL4 X-Y recorder. Rotating disc electrode experiments were carried out 
using a glassy carbon electrode connected to an analytical rotator and a PINE 
Model ASRE 416 speed controller. For coulometric studies, a carbon paste 
electrode was used as the working electrode. Chromatographic experiments were 
carried out using a Waters Model 501 liquid chromatograph. The dissolution test 
was performed in a basket-stirrer recommended by the United States Pharmacopeia 
(USP)43 (Figure 2. 6).
2. 3. 2. 3. Procedures
2. 3. 2. 3. 1. Activation o f G lassy Carbon Electrode
The electrode surface was first polished successively with small-particle-size silicon 
carbide paper containing a light covering of distilled water to lubricate the glassy 
carbon-paper interface, wet and dry emery paper ( 12 0 0  grade) and finally with 
slurries prepared from 3, 1 and 0.03-jjm aluminium oxide on a felt polishing mat. 
Residual polishing material was removed from the surface after each polishing step 
by sonication of the electrode in a water bath for 15 min, during which the 
deionised water was changed every 5 min. Prior to use, the electrode surface was 
washed with a jet of deionised water and dried with tissue paper. This polishing 
procedure was followed by electrochemical pretreatment involving cyclic 
voltammetry where the electrode was cycled between -IV  and 0.6 V for 5 min at a 
scan rate of 100 mVs'l.
2. 3. 2. 3. 2. Differential pulse and cyclic voltammetry
The voltammetric conditions for a typical anodic differential-pulse scan were as 
follows: initial potential, 0.0 V; scan rate, 10 mVs'l, and final potential, 1.0 V.
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Figure 2. 6 . Adapted USP basket stirrer apparatus for determination of dissolution
profile of salbutamol tablet, Ew = working electrode (glassy carbon); Ej- =
reference electrode (SCE); Ec = counter electrode (platinum wire); M 
stirring motor; B = basket stirrer; T = thermometer; S = ampling orifice.
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From the voltammetric data, the optimum supporting electrolyte was found to 
consist of 0.05 M sodium dihydrogen phosphate. The following operational 
conditions gave rise to the best sensitivity and selectivity for the determination of 
salbutamol: pulse amplitude 25 mV, scan rate 10 mVs'l and pulse interval 0.25 s. A 
blank solution without addition of salbutamol was used to obtain the base current. 
Standard cyclic voltammetry experiments were performed on plain 0.05 M sodium 
dihydrogen phosphate pH 5.0 solutions and those containing 4 x1 0 '^  M salbutamol 
using a glassy carbon electrode and the instruments described above. The 
voltammetric conditions were as follows: initial potential 0 mV; final potential 1.0 
V, and sweep rate 20mVs'l.
2. 3. 2. 3. 3. Determination o f Salbutamol in Commercial Preparations
For bulk drug determination, 4 and 8 mg portions of drug were accurately weighed 
and transferred to two separate 100 ml volumetric flasks. The drug was dissolved 
and diluted to volume in deionised water. The prepared solutions were used within 
two days.
For tablets ten 8 mg tablets were selected at random, weighed, and the average 
value was determined. The tablets were then ground into a fine powder, an 
accurately weighed quantity of powder equivalent to the average mass was 
dissolved in deionised water, and transferred to a 100 ml volumetric flask. The 
resulting mixture was shaken for 15 minutes to ensure that salbutamol was 
completely dissolved. A 200 p i  aliquot of the dissolved sample was placed in an 
electrolytic cell containing 25 ml of 0.05 M sodium dihydrogen phosphate, pH 5.0 
and the voltammogram was recorded by employing a scan rate of 10 mVs'l. To 
quantify the unknown amount of salbutamol, successive 50 pi aliquots of a standard 
lxl0 '3 M salbutamol solution were added to the cell and the voltammograms were 
recorded.
2. 3. 2. 3. 4. Dissolution Profile Studies using Glassy Carbon Electrode
The dissolution test was carried out according to the USP XXII method^ with use 
of a USP basket stirrer type of apparatus Figure 2. 6 in 900ml of 0.05M sodium 
dihydrogen phosphate, pH 5.0 at a stirring rate of 50 rpm. The temperature of the 
cell was controlled at 37 ±0.05°C by use of a thermostatic bath (AGB Ltd, Ireland). 
The tablet was placed in the basket which was rotated at 50 rev min‘1. Using the 
voltammetric technique, the current values were recorded at an appropriate time 
interval and the amount of salbutamol released was determined from a calibration 
graph.
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2. 3. 3. Results and Discussion
The discharge current of the background electrolyte in the potential region close to 
salbutamol oxidation gave rise to inaccurate measurements of the currents using 
linear sweep voltammetry (LSV). DPV signals were preferred in order to determine 
salbutamol in real dosage forms. Of the four electrolytes investigated, i. e. 0.05 M 
boric acid, 0.9% sodium chloride, 0.05M sulphuric acid and 0.05M sodium 
dihydrogen phosphate, the last gave rise to the best response with regard to 
oxidation peak current sensitivity, morphology, etc. Thus for further investigations, 
a solution of sodium dihydrogen phosphate at constant ionic strength (J4= 0.05M) 
was used.
2. 3. 3. 2. Effect o f  pH
The DPV behaviour of the drug were investigated at various pH values. The glassy 
carbon working electrode was rinsed with deionised water prior to each analysis. 
The results obtained indicated that the peak potential (Ep) is strongly influenced by 
the pH. Figure 2. % shows the dependence of Ep on pH. The peak shifts towards 
negative potentials with an increase in pH, in such a way that two straight lines with 
different slopes can be observed. The two lines intersect at pH 9.0 , which coincides 
with the pKa value of salbutamol (Glaxo Group Research Data). The slopes above 
or below this pH were 0.004 and 0.002 V pH 'l, respectively. The peak obtained at 
pH 5.0 was found to be symmetrical in shape and easily measurable, and could be 
used to determine low concentrations of the drug. Hence, a pH of 5.0 was chosen 
for further study.
2. 3. 3. 3. Variation o f  Peak Current with Pulse Amplitude and Interval
The peak obtained for salbutamol at pH 5.0 was found to vary with pulse amplitude 
and interval. Differential pulse voltammograms recorded at various pulse intervals 
and with various pulse amplitudes showed that the peak current increased as the 
pulse interval and pulse amplitude increased. The application of the differential 
pulse wave form (pulse amplitude = 25mV) yielded voltammograms in which the 
peak currents were on average twice as sensitive as those obtained by LSV. A pulse 
amplitude of 100 mV provided the most sensitive signal. However, the use of this 
pulse amplitude resulted in an increased capacitive current and the analytical signal 
merged to a certain extent with the electrolyte discharge current. Optimum
2. 3 .3 . 1. Study of the Differential Pulse Behaviour ofSalbutamol
pH
Figure 2. 7. Dependence of peak potential on pH.
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conditions of pulse amplitude and pulse interval were found to be 25 mV and 0.2 s, 
respectively.
2. 3. 3. 4. Variation o f  Peak Current with Scan Rate
Figure 2. 8 examines the effect of the potential scan rate on the DPV heights of 
salbutamol at the glassy carbon electrode at different scan rates from 2  mVs‘ 1 to 
100 mVs'l. The response was increased markedly upon increasing the scan rate 
until it started to level off at 50 mVs'l. The increase in peak height was 
accompanied with broadening and distortion of the response (see inset). As a result, 
the optimum scan rate was found to be 10 mVs'l, and this was used subsequently 
throughout the study.
2. 3. 3. 5. Mechanism o f  Oxidation Process
The cyclic voltammetric behaviour of salbutamol at an activated glassy carbon 
electrode in 0.05 M sodium dihydrogen phosphate, pH 5.0, is shown in Figure 2. 9, 
illustrating a single voltammetric oxidation peak. On the reverse sweep, no distinct 
reduction wave was observed, indicating that the drug is irreversibly oxidised at the 
glassy carbon electrode. Studies were then undertaken to investigate the rate- 
controlling step of the process, in order to determine whether the oxidation process 
was adsorption or diffusion controlled. Linear sweep voltammograms were obtained 
at different scan rates, and plots of ip versus vl/2, where v is the scan rate (mVs_l), 
were constructed. The dependence of the peak current (ip) on the square root of the 
scan rate (vl/2) was found to be non-linear in the range 1 to 50 mVs'l- When the 
peak current was plotted versus the unit power of the scan rate (v) it was found to 
be linear in the range 1 to 50 mVs‘l, according to the equation
ip (pA) = 0.004 pA (mVs-1 ) + 0.046 (r= 0.9996 , n= 6 ) (6)
These considerations pointed to an adsorption-controlled process rather than a 
diffusion-controlled one. In order to further investigate this, studies were carried out 
under hydrodynamic conditions and hydrodynamic voltammograms were obtained 
for concentrations ranging from as low as 9 x 10_7 M up to 1 x 10'^ M at different 
rotation speeds between 200 to 1000 rpm. The resulting voltammograms failed to 
show the typical plateaus expected for diffusion controlled process and to increase 
linearly with the 1/2 power of the rotation speed (w*/2). Instead, peaks were 
obtained throughout whose magnitude did not depend markedly on the rotation 
speed applied to the electrode. This evidence constituted a further proof of a non- 
diffusion-controlled oxidation process. The effect of accumulation time is shown in
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Figure 2 .8 . Dependence of peak current on the scan rate of the differential pulse wave
form. Also shown (inset) typical voltammograms of salbutamol at 10 (a) and 
100 mV s' 1 (b).
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Figure 2. 9. Cyclic voltammogram of a 4 x 10 "^  M solution of salbutamol in 0.05 M
sodium dihydrogen phosphate, pH 5.0, obtained at a glassy carbon electrode 
and blank scan; initial potential, 0.0 V; final potential, + 1.0 V; reference
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Figure 2. 10. Greater sensitivity was achieved by using a 30 s accumulation time. 
This points to adsorption of the drug compound on the surface of the electrode. 
Longer times of accumulation time gave rise to the same response. A potentiostatic 
coulometry experiment^ was then carried out for a lx l0 ‘3 M solution of 
salbutamol in 0.05 M sodium dihydrogen phosphate, pH 5.0, using a carbon paste 
macroelectrode (diameter 2 cm) at a fixed potential of +0.85 V. The coulometric 
analysis of the drug showed that two electrons were involved in the oxidation 
process.
2. 3. 3. 6 . Electrode Activation
Glassy carbon electrodes used in electrochemical analysis are often pretreated in 
some way before measurements are performed. The voltammograms shown in 
Figure 2. 11 (b, c) and (d) represent the formation of an adsorbed film by the 
reaction product. Accordingly , a gradual loss in the electrode activity is observed 
on successive use. The reason for the low activity may result from the lack of 
functional groups on the surface or formation of passivating film45 ? gradually 
blocking the access of analyte to the surface and hindering the oxidation reaction. 
To provide a reproducibly active surface, and to improve the sensitivity and 
resolution, the glassy carbon electrode was polished to a mirror finish with a 1 pm 
diamond paste, carbide paper, and alumina and then rinsed with ethanol and 
deionised water. The electrode was then cleaned by ultrasonication.
The effect of electrochemical pretreatment was systematically evaluated with 
respect to the scan range, scan rate, and the duration of pretreatment. The 
pretreatment procedure found to give rise to the optimum response for salbutamol 
was cyclic voltammetry scanning between -1.0 to +0.6 V for 5 min at a scan rate of 
100 mVs'l. During this time, the electrode was kept in a quiescent solution. The 
current was then switched off, and the solution then stirred for 30 s. Before 
potential scanning the current was stabilised for 30 s at the required initial potential. 
Under this electrochemical pretreatment, no loss of electrode activity was observed 
(Figure 2. 11 "e") for similar analyses. Clearly, the "poisoning" effect appears to 
have been eliminated and the peak current was restored to its original height. 
(Figure 2. 11 "a").
The electrode pretreated in this way also exhibited a dramatic reduction in the 
background charging current. Some possible reasons for enhancement of the 
heterogenous electron transfer rates and the increase of the apparent rate of the 
electrode process are: (i) surface cleanliness or lack of impurities to adsorb on the
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Figure 2. ll.The effect of the pretreatment of glassy carbon electrode on the DPV
curves, (a) original response, (b) response after three scans (c) response after 
five scans, (d) response after six scans, (e) response after pretreatment.
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surface blocking active sites; (ii) surface roughness causing the effective area for 
electron transfer to be greater than the geometric area; (iii) formation of "oxide" 
layers on the surface. The voltammetric experiments, described below, were 
performed with no further polishing to avoid the likelihood of drastically changing 
the physicochemical charateristics of the carbon surface, and the electrochemical 
treatment was performed daily prior to use of the electrode, whereas the polishing 
procedure was performed weekly. Precautions were taken to keep potential limits at 
which the electrode was operating, to within the range -1.0 to +1.0 V versus SCE, 
which ensured that significant alteration of the carbon surface did not take place.
Background cyclic voltammograms were routinely run between experiments to 
check the state of the surface. From these voltammograms it appeared that the 
glassy carbon surface remained reasonably constant throughout the entire course of 
the experiments. The electrode was soaked overnight in distilled, deionised water. 
When the above-mentioned pretreatment procedures were followed, reproducible 
voltammetric signals were obtained. Figure 2. 12 demonstrates the reproducibility 
of seven succesive voltammograms of 8 x 10"  ^M salbutamol in NaF^PO^ pH 5.0, 
where a standard deviation of 2.4% was obtained. In view of the simplicity and 
speed of the pretreatment procedure step, it is recommended to carry out the 
pretreatment at the beginning of each analysis.
2. 3. 3. 7. Effect o f  Concentration
The peak current at +0.75 V was found to increase linearly over two orders of 
magnitude from 8 x 10‘7 M to 8 x 10 “^  M. The characteristics of the calibration 
graph of peak current versus concentration obtained by linear regression were: 
slope, 0.027 pA pM'l; current intercept, 0.002 pA; and correlation coefficient,
0.9998. The minimum detectable concentration for salbutamol at the pretreated 
glassy carbon electrode was found to be 2 x 10'7 M.
2. 3. 3. 8 . Interference Studies
In order to investigate the analytical application of this method, the effect of the 
excipients present in the dosage form was examined by carrying out the 
determination of 3 x 10~5 M salbutamol in the presence of each of the different 
excipients at conentrations that can be found in the tablet dosage form. Analysis of 
salbutamol was also carried out in presence of a placebo tablet. A deviation of more 
than 2 % from the peak current of the solution containing no interfering additives 
was taken as a sign of interference. These studies showed that none of the
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Figure 2 .12.Reproducibility of the DPV signals. Seven successive voltammograms were 
recorded following electorde pretreatment. [Salbutamol] = 8 x 10'^ M; scan 
rate lOmVs'l.
excipients at the concentration level existing in the dosage form caused a positive or 
a negative error indicating that there were no serious interferences to the method.
2. 3. 3. 9. Assay ofSalbutam ol in Bulk Drug and Tablet Dosage Form
Differential pulse voltammetry for the determination of pharmaceutical products is 
by far the most common electroanalytical technique employed in pharmaceutical 
analysis. The proposed procedure described under Experimental was used for 
salbutamol determination in 4 and 8 mg tablets and for the bulk drug. Such 
determinations yielded mean values of 3.87 and 7.80 mg of salbutamol for 4 and 
8mg tablets respectively. The accuracy of the assay is illustrated in Table 2. 1; 
Mean relative errors lower than 4 and 3%, and relative standard deviations lower 
than 2 and 3% ( n= 7) were observed, respectively. The results for the bulk drug 
samples showed mean values of 3.91 and 7.85 mg of salbutamol; the relative mean 
error was lower than 4%, and the relative standard deviation was lower than 3%  (n 
= 7), respectively. The recovery was in excess of 95% at the concentration levels 
studied. This is in a good agreement with official methods using high-performance 
liquid chromatography with UV d e t e c t i o n ^ , 47.
Table 2 .1 . Evaluation o f A ccu racy o f  the assay
Theoretical Mean absolute error Mean relative error RSD (% )
Concentration (mg) (%)
4 0.13 3.3 1.4
8 0 .2 0 2.7 2.5
2 . 3. 3. 10. Comparison Studies
Three different samples were analysed using a standard addition (Figure 2. 13) 
procedure and the proposed voltammetric method was checked by HPLC with 
carbon fibre electrochemical flow cell detection. This detection method is described 
in greater detail in chapter 3. The results obtained by both methods are summarised 
in Table 2. 2. As can be seen, the results obtained with the voltammetric method are 
in good agreement with those given by LC-EC. However, the voltammetric method
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Figure 2. 13. Application of the standard additions method to a tablet dosage form:
background current; sample and three additions of 50 pi of a 1 x 10'^ M 
standard solution of salbutamol.
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is simpler, faster and requires less expensive equipment than the chromatographic 
method.
Table. 2. 2. Comparative results for the determination o f salbutamol in tablet and 
bulk preparations with voltammetric assay and HPLC.
Sample Voltammetric assay* HPLC
Tablet, 
% found
Bulck,
%found
Tablet,
%found
Bulck,
%found
1 96 97 98 97
2 97 96 97 96
3 95 95 96 98
* Results are the means of three replicate determinations.
2. 3. 3. 11. Dissolution Studies Using G lassy Carbon Electrode
Figure 2. 14 shows the dissolution profiles of salbutamol tablets obtained using the 
differential pulse voltammetric method. The glassy carbon electrode used in the 
monitoring of the drug from the tablet dosage form was pretreated between analyses 
while it was immersed in the dissolution medium, this procedure showed the 
advantage of continuously monitoring the concentration of the active ingredient in 
the standard dissolution cell without the need of withdrawing aliquots for analysis 
purposes, as it is the case in UV detection.
2. 4. Conclusions
Using differential pulse voltammetry, methods for determination of sumatriptan 
succinate(l:l) and salbutamol in a tablet dosage forms and the dissolution rate of 
salbutamol tablets have been described. The activation procedures used in these 
studies permitted determination of these drugs without any interferences from the 
additives present in the dosage forms. The proposed methods are rapid, involves no 
sample preparation other than dissolving and transferring an aliquot to the 
supporting electrolyte, and do not require filtration, degassing and expensive grades 
of solutions that are needed for HPLC procedures. The methods also has the
Time(hr)
Figure 2 .14.Dissolution profile obtained with glassy carbon electrode for salbutamol 
tablets.
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advantage of good recovery and is able to continuously monitor the concentration of 
the active ingredient in the standard dissolution cell without the need of 
withdrawing aliquots for analysis purposes.
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Chapter 3
Analysis of Salbutamol in Human Plasma 
by High Performance Liquid Chromatography 
with Electrochemical Detection using a Micro­
electrochemical Flow Cell
3 .1 . I n t r o d u c t i o n
The analysis of salbutamol in plasma is important in pharmaceutical research and 
clinical chemistry, and because the drug is widely prescribed, it can sometimes be 
taken in over-dose. Until recently, the only methods sufficiently sensitive for the 
measurement of this sympathomimetic drug in plasma were based on gas 
chromatography-mass spectrometry 1 " 3 and were beyond the scope of the 
instrumentation available in most hospital laboratories. However, the development 
of detectors with improved selectivity and sensitivity has facilitated the 
measurement of salbutamol by HPLC using more conventional detection schemes^ 
■ 6 . Because of the difficulty of extracting this drug free from endogenous 
interfering compounds, coupled to the fact that it occurs in low concentrations in 
plasma, means that its determination usually requires a selective extraction scheme 
and sensitive detection using spectrofluorimetric^ or electrochemical methods^.
3. 1. 1. Solvent Extraction
The analytical chemist has a difficult task arising from increasing requirements for 
versatility and accuracy of analysis. Bioanalysis is normally performed on blood 
serum or plasma, urine. The matrix used depends on the analytical objectives, the 
type of testing (invasive or non-invasive) and the information required. For 
extraction of collected samples, a three-step procedure is usually employed, but as 
little as one step may be sufficient for some applications. Liquid-liquid extraction 
is by far the most popular method used for the clean up of biological fluids, 
mainly due to its versatility^ ~ It provides chromatographically clean extracts 
and allows for concentration of the sample by evaporation, thus enhancing 
sensitivity. It should be noted that a drug peak may often be accompanied by other 
peaks, because the likelihood of interfering peaks is probably about the same as 
with direct injection, because most if not all of the drugs and analogous 
physiological solutes will be included in the supernatant of these samples. 
Moreover, late eluting peaks from previous samples may co-elute with the drug 
peak, thereby distorting peak measurements and diversely affecting precision. The 
potential for late eluting peaks to degrade assay precision in therapeutic drug 
monitoring has been pointed ou t^ .
The size of the sample chosen will depend on the sensitivity required of the assay. 
Generally, however, 1 ml of plasma or serum is used and extracted into one 5 ml 
or more of organic solvent by vortex mixing followed by centrifugation. The 
addition of a large amount of extractant minimizes emulsion formation. Glassware
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used in extractions must be scrupulously clean and free from any residual 
detergents. Polarity is usually the most important factor in the choice of extracting 
solvent and generally as this increases the range of components extracted also 
increases. The solvent should be selected with minimum polarity consistant with 
high recovery of the drug. Drugs of high polarity are difficult to extract and 
require strongly polar and hence non-selective solvents. Polar solvents that are 
miscible with water (e. g. n-propanol) can be forced to form a separate layer by 
saturating the aqueous phase with an inorganic salt, a technique useful for very 
polar drugs. Salts can be important in other ways, as they help to form better 
phase bundaries (i. e. avoid emulsion) and can also reduce the water content of 
the organic phase. Furthermore, the addition of salts can be used to increase the 
selectivity of an extraction by aiding the transfer of a drug from the aqueous to the 
organic phase. A solvent used for extraction should be of the highest purity, non­
toxic, not highly flammable and have a suitable volatility. Modification of the 
aqueous phase is also most important in the development of an extraction scheme. 
Various solvents have been applied in this respect namely, diethyl ether, 
chloroform, n-hexane, n-heptane and ethyl acetate.
3. 1. 2. Electrochemical Detection using Microelectrophotometric
In the analysis of biological samples using HPLC, selective detection can be very 
welcome, especially when the analytical signal is to be differentiated from the 
sample m a t r i x  13,14 ¡n electrochemical detection micro-or ultra- 
microelectrodeslS - 18 can ^  used, either as single electroodes or as electrode 
arrays to improve selectivity. These electrodes have various advantages over 
conventional macroelectrodes 19,20: (j) their small dimensions render them 
especially suitable for detection in micropacked and capillary column sparations,
(ii) spherical or cylindrical symmetry of mass transport and electric field lead to 
fast establishement of steady state and extremely rapid electrode charging; 
consequently rapid scan techniques can readily be used, (iii) very low ohmic drop 
values permit measurements in poorly conductive media, often in the absence of 
base e l e c t r o l y t e 2 1 > 2 2 ; the accessible potential range and selection of solvents (e.g. 
in acetonitrile) are thus widened, (iv) the signal -to-noise ratio is improved .
All these properties have obvious effects on the measuring sensitivity and 
selectivity. The extremely low signals produced by microelectrodes place great 
demands on the measuring apparatus and its shielding against external noise. The 
properties of ultramicroelectrode detectors have been e x a m i n e d ^  and special 
attention paid to the signal to noise ratio with microelectrode detection^.
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Selectivity is achieved by the choice of appropriate operating potentials which 
allow the detection of compounds of interest whilst other electroactive species 
requiring a higher potential are not "seen". Even at the upper limit of the available 
potential range, the electroactive compounds in biological material are far less in 
number than those which absorb UV light. This means that samples such as 
blood, serum or urine require less pretreatment before injection into the 
chromatographic system. Although modem analytical instrumentation is a 
powerful tool for bioanalytical determination, the selective detection and/or 
separation of the target analytes from the host, inert and possibly interfering 
species, are important in order to avoid errors due to matrix effects.
In many laboratories, EDs are not used routinely. One reason for this is that, 
although several instruments are now commercially available, relatively little has 
been published on their application. The design, fabrication and application of 
novel ED ce lls^  - 33 have been well characterised experimentally and throughly 
reviewed and discussed. Such devices would complement (and sometimes 
replace) the use of costly machines. In addition, they offer the potential for 
continuous on-line analysis, for example, in critical care units and in non-medical 
applications such as industrial process monitoring and hydroponics.
Figure 3. 1 shows an electrochemical cell developed by Matysik et, al. for 
voltammetric measurements in flowing solutions. The cell body (d) consists of a 
glass tube (inner diameter 10 mm), which is closed by two PTFE plugs (c). They 
are pressed to the planar ends of the glass tube by PVC tightening devices (i). The 
inlet tube (a) with an inner diameter of 0.71 mm and the working electrode 
assembly (j) are fixed with the help of pierced brass screws (b). The home-made 
microelectrodes were produced using fine platinum with disk diameters between
0.7jim and 100 jim was directly sealed into glass. A silver-coated platinum coil (g) 
serves as a pseudo reference electrode and is contacted by a thicker platinum wire
(h) melted into the glass body. The cell was used in a vertical position, that is, the 
solution level was fixed by the position of the outlet (e). The platinum disk 
microelectrode (f) is located a few millimeters within the inlet tube.
The construction of an electrochemical detector requires a solution of three main 
problems: (i) the working electrode must be chosen and the working electrode 
constructed, so that the accessible potential range suffices for the given purpose, 
and the residual signal and noise are sufficiently low and reproducible for as long 
a time as possible, to achieve a high sensitivity and reproducibility of 
measurements; (ii) the active surface of the working electrode must be sufficiently
\Figure. 3 .1 . Flow cell construction: a) inlet tube, b) brass screw, c) FI FE plug, d) cell 
body, e) outlet, f) microdisk electrode, g) silver coated platinum coil, 
h) external contact oh the pseudo reference electrode, i) PVC 
tightening devices, j) external microelectrode contact. Reproduced from 
Matysik, F., et al., Electroanalysis, 4 (1992) 501.
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mechanically strong to withstand liquid flow and compatible with a wide range of 
aqueous and organic matrices; (iii) the measuring cell must have a very small 
working volume and favourable hydrodynamics to avoid post-column band 
broadening and distortion. Thus the tubes must be short, narrow, must not hold up 
the eluate, and the detector must have the smallest possible dead v o l u m e ^ .  
Common industrial analysers often have effective volumes of the order of lOOul, 
or even less. High-performance macrocolumns require effective cell volumes not 
exceeding a few ul, microbore packed columns a few hundred pi and open tubular 
capillary columns about 10 nl or even less; (iv) a suitable measuring technique 
must be selected, from the point of view of measuring sensitivity, reproducibility, 
selectivity and ease of signal handling; (v) a wide dynamic range (ideally linear) 
of response and a long term stability of the electrode's activity towards the 
analyte; (vi) simple and reliable fabrication that results in consistency of response 
from one electrode to another; (vii) fast response of the sensor, to attain a low  
time constant for the detector. This time is defined as the time necessary for the 
signal to reach 63.2% of the maximum v a lu e d  In addition to these criteria other 
factors can affect the detector applicability and performance. For example, it is 
advantageous if the detector exhibits the same sensitivity for all the solutes 
detected and if its signal depends as little as possible on the experimental 
conditions, mainly on the temperature and the mobile-phase flow rate and 
composition.
From the electrochemical point of view, an optimum arrangement of the 
electrodes should minimize the voltage drop between the working and reference 
electrodes by placing them as close as possible and enable homogeneous charge 
distribution on the working electrode (uniform polarisation), which is best 
achieved by placing the working electrode and counter electrodes against one 
another in the channel through which the mobile phase flows. However, it is 
simultaneously required that the geometric volume of the detector cell should as 
small as possible, i.e. the channel thickness must be very small (0 .02  - 0.1  mm). 
With such a small distance between the surfaces of the working and counter 
electrode, the products of the electrochemical reaction on the counter electrode 
might interfere in the reaction on the working electrode.
3. 1 .3 . Electrochemistry of Carbon Fibres
Carbon fibres are miniaturised chemical sensors, smaller in diameter than a 
human hair, and because of their very small size they exhibit very different 
voltammetric properties than do electrodes of conventional size. Carbon fibres are
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formed from the pyrolysis of pitch or polyacrylonitrile. The detailed picture of the 
chemical groups on the carbon fibre surface is confused, although some major 
points seem fairly clear^G. The surface of carbon fibers is populated with oxide 
functions, typically carbonyl, carboxyl, hydroxyl and ester groups predominate^.
Anodic oxidation increases the surface density of all these groups, but the degree 
and method of oxidation alter their relative proportions. Anodic oxidation in 
solution favours the formation of carbonyl and hydroxyl groups. Evidence from 
other carbon surfaces suggests that these functional groups may be assigned to 
aromatic structures such as quinone, hydroxyquinone and phenols. Aromatic and 
aliphatic carboxylates are also present. These functional groups may be formed in 
the bulk of the fibre as well as just on the surface; i.e. prolonged oxidation will 
increase not only the surface density of functional groups, but also the surface 
thickness.
3. 1 .4 . Fabrication o f Single Fibre Electrodes
Carbon fibers of high modulus have been produced by the pyrolysis of polymer 
textiles since 196438,39 Carbon fibres are manufactured from a range of 
precursors, but three predominate; polyacrylonitrile (PAN), cellulose (Rayon) and 
PVC pitch. Most fibers from the UK are made of PAN, whereas those from the 
USA are made from rayon. The PNA fibres, produced by wet spinning, are 
stretched and heated to 200^C. A ladder polymer is formed of linked 
hydrogenated naphthylpyridine rings. This process increases the thermal stability 
of the polymer by preventing easy formation of small volatile fragments, and by 
inhibiting melting. The fibres are heated to 220^0, when some of the CH2  groups 
are oxidised to ketones. After this final oxidation, an inert atmosphere is 
introduced into the heating chamber and the temperature is taken to 300 - 400^C. 
Further cross-linking takes place between adjacent polymer chains, as water, 
hydrogen cyanide and nitrogen are eliminated. At this point the fibre consists of 
ribbons of largely carbon atoms, arranged in aromatic ring structures. These 
ribbons begin to resemble the basal planes of true graphitic structures although the 
distance between them is much greater than in graphite, and the atoms in a plane 
are not ordered with respect to those in neighbouring planes. Once the evolution 
of gases has decreased, the fibres are heated to above 400^0. Further evolution 
takes place of inter-ladder hydrogen, hydrogen cyanide and nitrogen, until by 
lOOO^C the fibre has lost about 50% of its weight. This process, known as 
carbonisation, yields fibres that have a non-graphitic carbon structure, are of low 
modulus and high strength. Heating at 20(X)0C causes the degree of perfection to
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increase so that the fibre begins to look more like graphite. These fibres are most 
frequently encountered in structural materials and in analytical applications.
Clearly, for a material as fine and fragile as carbon fibre, a method of mounting 
the fibre must be used to produce reasonably rugged electrodes. There are several 
problems in handling carbon fibres, not the least being the safety aspect. The 
fibres are easily inhaled, and care should be taken to prevent this happening. The 
fibers also acquire a static charge, which can make placing or positioning them in 
capillaries particularly difficult. The fibers may well be coated in a sizing material 
that should be removed by washing in acetone. Finally, the fibres are very small 
and the use of a microscope and high-quality forceps for manipulations is 
recommended.
3 .  1 . 5 .  Practical Applications of Carbon Fibre Electrodes
During the past few years, significant progress in voltammetry has been achieved 
with the application of micro or ultra m i c r o e l e c t r o d e s 4 0 ,4 1  Due to the unique 
features of such working electrodes with at least one dimension in the micrometer 
or submicrometer range, new possibilities were opened in the fields of 
electrochemical kinetics, voltammetry in highly resistive media or in vivo 
electrochemistry. Recently, promising applications of microelectrodes in the field 
of analytical chemistry, particularly for HPLC or flow injection were r e p o r t e d ^  -
45. Carbon electrodes are particularly useful for studying anodic processes in 
cases where the use of platinum or gold electrode is complicated by the 
adsorption of organic m a te r i a ls ^ .
Neurotransmitters have a very important role in the brain since they are the key 
link in communication between neurons. A major challenge of the 
neuropharmacologist is to relate physiolgical functions to the numerous ligand 
binding sites identified in brain tissue. There are, for example, at least five 
postulated 5-hydroxytryptamine (5-HT) receptors and associated sub-types. 
However, carbon fiber electrodes figure 3. 2 have the most suitable charecteristics 
for neuropharmacological work. In particular, their tip small size (8  - 20 |im o.d.) 
make them ideal for use in small brain nuclei e. g. in the suprachiasmatic nucleus 
(SCN) and chemical and electrical pretreatment of these electrodes enables them 
to be used for measurement of amine neurotransmitter metabolites and , more 
recently, the neurotransmitter itself in the case of 5-HT47.
A part from the oxidation of neurotransmitters and related species, various other 
voltammetric determinations have been reported. Miniature, amperometric
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Figure 3 .2 . Diagram of a completed carbon fiber electrode in which electrically
conductive paitn has been used to form electrical contact between fibers 
and .silver wire. Reproduced from Martin, K., et al., Trends in Anal. 
Chem., 7. (1988) 334.
glucose sensors were constructed for implantation tissue of normal and insulin- 
dependent diabetic subjects'^. Implantable biosensors are being developed for use 
in clinical medicine because they allow continuous measurement of rapidly 
varying analytes, without the need for added reagents or withdrawal of body
fluids49.
3. 1 .6 . Development and Validation of a Chromatographic Assay
The most logical approach in the development stage of an assay involves opposite 
chronology to the final protocol. Although isolation precedes measurement, it can 
be more convenient to develop the analytical technique first. This is followed by 
selection of an internal standard and devlopment of the isolation procedure^. 
Samples of drug-free material (serum, urine) spiked with known drug 
concentrations should always be employed for calibration. Alternative "external" 
approaches on assaying or even just injecting (in the case of chromatography) 
pure standard solutions are unacceptable because they ignore the specific 
peculiarities of the biological matrix.
Most regulatory agencies, like the Food and Drug Adminstration, have mandated 
Good Laboratory Practice (GLP) regulations for clinical and non-clinical 
laboratory s t u d i e s ^  >52 Based on these regulations, the fundamental criteria 
required for validation of chromatographic methods to check their reliability and 
overall performance are the evaluation of drug stability, specificity, limit of 
detection, accuracy, precision, linearity and recovery. Each of these individual 
criteria will now be discussed.
3. 1 .6 . 1. Drug Stability
Drugs stored under different conditions of heat, light, humidity and pH (stock 
solutions and spiked biological samples) should be examined for possible 
decomposition. The stability under prolonged storage conditions for possible 
adsorption onto glass or other materials, such as plastics, must be determined. In 
certain instances, plasticisers from plastic syringes and containers and certain 
polymers from vacutainer stoppers have been known to interfere with drug 
measurement. The stability of the drag must also be checked under the conditions 
of analysis, since any losses or decomposition due to experimental manipulations 
can significantly affect the overall recovery, reproducibilty and precision of the 
assay. The method chosen should be sufficiently sensitive to detect low levels of 
decomposition products and sufficiently precise to observe small changes in the 
assay of the drug.
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3. 1 .6 . 2. Selectivity
The selectivity of a measurement is a rather vaguely defined criterion, expressing 
the ability of the sensor to respond to a particular substance without interference 
from other substances present in the test system. A sensor is said to be specific if  
no substance other than the particular analyte produces a response; this is an 
unattainable ideal, approached more or less closely by some sensors, such as the 
glass pH electrode. The selectivity requirements vary according to the purpose of 
the measurement. In industrial and environmental continuous monitors and in FLA 
instruments, the selectivity for a given analyte should be as high as possible, to 
decrease the number of operations that have to be performed on the sample prior 
to the detection; however; in some simple monitors (e.g. for the total content of 
salts in a solution, the overall acidity of a solution, etc.) the selectivity 
requirements are not very high. Chromatographic detection requires both selective 
and non-selective detectors. When a mixture of many substances is completely 
separated in the column, then a universal, non-selective detector suffices to detect 
all the components; on the other hand, when a complex mixture cannot be 
completely separated, a selective detector is advantageous as it provides a further 
means of differentiating and identifying the poorly resolved components, 
especially in trace analyses, when small amounts of the test substances must be 
determined in the presence of a great excess of other compounds.
The biological sample should be examined for the presence of endogenous 
components and/or other drugs which might interfere with the drug or its 
metabolites in the assay system. Should any peak interfere with the assay, a 
systematic search should be undertaken to find the origin of the interference. For 
example, an interfering peak eluting at the same retention time as phentermine 
was found during its GC analysis in plasma53. This was subsequently found to be 
due to the use of plastic pipette tips. However, selective extraction procedures, 
use of specific detectors or change in chromatographic parameters should 
normally eliminated interferences of this kind.
3. 1. 6 . 3. Lim it o f  detection
The limit of detection (LOD) is defined as the lowest concentration of an analyte 
that the analytical process can reliably detect. In mathematical terms, the most 
popular quantitative approach seems to be that which defines LOD as 3s (s = 
standard deviation of the peak to peak noise). The detection limit must be 
statistically defined, below which no data should be reported.
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The limit of detection, given in terms of the concentration or amount of the 
analyte, is directly related to the sensitivity and the noise. In the batch analysis, 
the concepts of the limit of detection and the limit of determination (limit of 
quantification, LOQ) are usually different, the former denoting the concentration 
(amount) of the test substance that can be qualitatively detected, whereas the latter 
is the lowest concentration (amount) that can be determined. However, in flow  
measurements the term limit of detection is usually used for quantitative analysis 
and will be employed in that sense in this study.
3. 1 .6 . 4. Accuracy and Precision
The reliability of the measurement is expressed in the same way as for any other 
measurement, i.e. in terms of the precision and accuracy, obtained by well-known 
statistical methods. In measurements in flowing liquids, long-term signal stability 
and reproducibility are especially important for obtaining reliable results. The 
term accuracy denotes the nearness of a measurement to its accepted v a lu e^  and 
is expressed in terms of error. The absolute error is the difference between the 
observed and the accepted value. The relative error is expressed as a percentage of 
the accepted value and is often used to express the accuracy of a chromatographic 
assay. In real terms, accuracy should be tested by comparison of results to another 
reliable method. Correlation of the two methods against each other by regression 
analysis (r > 0.98) is the most acceptable form of validation.
The term precision is used to describe the reproducibility of the m ethod^. The 
precision of a measurement is given by the percentage coefficient of variation of 
replicate experiments performed under identical conditions.
In chromatographic methods of drug analysis, the precision and reproducibility of 
the method usually described both in term of intra-assay (within-day) and inter- 
assay (between-day) results. In performing intra- and inter-assays, at least four 
replicate analyses over the entire concentration range of calibration should be 
performed. For intra-assay, the mean values of the peak height or peak area 
should be obtained and a linear regression analysis performed by plotting the 
mean values versus the accepted value (the accepted value is based on the amount 
of test drug to the drug-free biological fluid). Then the concentration based on 
each individual value, expressed either as a peak height or peak area is calculated 
from the generated regression curve and precision defined based on these results. 
For inter-assay, a linear regression analysis is performed for each day of 
calibration, and then three or more of these calibration curves are used for
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statistical calculations and for expressing reproducibility. Long-term signal 
stability and reproducibility are especially important for obtaining reliable results. 
Many of these calculations will be shown in following chapters.
3. 1. 6 . 5. Linearity
The linearity of the assay should be defined by the linear regression analysis of 
replicates of spiked biological standards in the expected concentration range of 
the "unknown". In practice the linear regression curve obtained in intra-assay may 
be used to demonstrate the measure of linearity of the curve.
3. 1. 6 . 6 . Recovery
The overall recovery of a given drug from spiked biological standards is 
calculated from the limit of detection to the upper end of the linear calibration 
curve by two different m ethods^. The first method compares the peak 
heights/area of a series of spiked biological samples which have taken through the 
entire analytical procedure with the peak heights/area of a series of authentic 
standards. The second method compares the slope (determined by linear 
regression analysis) of a processed standard curve to that of the reference 
standards.
3. 1 .6 . 7. Quality Control
The performance and reliability of routine drug assays should be checked with 
each batch of samples. Quality control standards are prepared by accurately 
spiking drug-free biological fluids with known amounts of the test drag by a 
person other than the analyst. At least 10% of these standards should be subjected 
to quality control and the results of these should be within - 10% of their accepted 
value, or the batch repeated^.
If a method is modified it should be statistically revalidated even if one assumes 
that it had been correctly validated in the first place. A method might have to be 
modified in the following cases.
If the initial method had been developed on a used column and then is repeated on 
a "new" column, the two columns may behave differently for any of the following 
reasons:
(i) The lack of readily available identical column, e. g. not all C js columns 
behave simillarly.
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(ii) If the chromatographer decides to use a column which may perform 
differently, he or she may be forced to change other chromatographic conditions.
(iii) The chromatographer may have different requirements from the method in 
terms of sensitivity, and may be forced, for example, to change the extraction 
technique.
All the above points necessitate revalidation.
The above strategy for the development and validation of chromatographic 
methods of analysis of drugs in biological fluids forms the foundation for the 
analytical work in the following sections. In this chapter, an LC-ED method 
analytical method using a microelectrochemical flow cell based on carbon fibre 
for the determination of salbutamol in human plasma is described, and validated. 
This approach permits the determination of salbutamol at levels down to 1 ng/ml 
in this biological fluid. A comparison was also made with a conventional macro- 
glassy carbon based flow cell for this particular application.
3. 2. EXPERIMENTAL
3. 2. 1 .M aterials
Salbutamol sulphate was kindly supplied by Dr. J. Bloomfield ( Trinity College 
Dublin). Plasma obtained from Beaumont Hospital (Dublin,Ireland) was frozen 
until required, and thawed at room temperature. Analar grade sodium dodecyl 
sulphate (SDS), sodium dihydrogen phosphate, and reagent grade diethylamine 
were obtained from BDH (BDH Ltd., Poole, Dorset,UK). HPLC grade methanol 
and ethyl acetate were supplied by Labscan Analytical Sciences, Dublin, Ireland. 
Water was distilled and then further purified using a Milli-Q water purification 
system (Milford, MA, U.S.A.). Carbon fibres, 13 pm in diameter, were obtained 
from Kureha Chemical Company, Tokyo, Japan. Graphite powder was obtained 
from Aldrich Chemical Co.Ltd, ( Gillingham-Dorset, England). Silver epoxy was 
purchased from RS Components, Corby , Northants, U.K. All glassware was 
cleaned in chromic acid and then thoroughly rinsed with triply distilled water. The 
glassware was stored in a drying oven at 150°C.
3. 2. 2. Construction o f Carbon fibre flow  cell
The carbon fibre working electrode was inserted through the centre of a 25-mm- 
length polyethylene tubing (2 mm x 0.5 mm I.D.) as demonstrated in figure 3. 3 
(a). The silver phosphate reference electrode was prepared by connecting a silver
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Figure 3. 3. (a) Method of fixing a carbon fiber into polyethylene tube, (b) The structure 
of the carbon fibre micro-flow cell consisting of: 1, silver wire coated 
with .Ag3P0 4  ; 2, reference electrode body; 3, internal reference solution; 
4, T .tube; 5, ceramic rod; 6 , stainless steel counter electrode; 7, fibre flow
electrode.
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wire (0.1  mm in diameter) to the anode and a platinum electrode to the cathode of 
a 1.5 V battery while immersing the assembly for 2 minutes in a solution of 1 M 
phosphoric acid. The wire was then inserted into a polyethylene tube, which was 
15 mm long, 1 mm in diameter and a porous rod 2 mm long, 1mm in diameter was 
fitted to one end of the polyethylene tube. The reference electrode tube was then 
filled with an internal reference solution containing 1 M phosphoric acid, and this 
end was closed by heating. A length (2 cm) of stainless steel tubing (1 mm x 0.2 
mm i.d.), served as the counter electrode. The working, reference and counter 
electrodes were mounted in a T-tube arrangement and the working electrode was 
connected to the outlet o f the HPLC column (downstream of the working 
electrode). Hence the mobile phase eluent passed first through the working 
electrode and then via the counter electrode to waste. A diagram of the flow cell is 
shown in figure 3. 3 (b).
3. 2. 3. High-performance L iquid Chromatography
The separation reported in this section was based on the work of Jarvie a l7  
following a slight modification in the methanol:water ratio to obtain a suitable 
retention time for salbutamol. The drug and plasma extracts were separated on a 
Spherisorb ODS (10 (im) column (25 cm x 4.6 mm i.d.) and were introduced onto 
the column via a Rheodyne Model 7125 (Cotati, CA, U.S.A.) 6 -port injection 
valve fitted with a 20 |il loop. The mobile phase consisted of 0.067 M phosphate 
buffer, pH6 : methanol: sodium dodecyl sulphate (40g/l): diethylamine 
(250:250:2.5:0.1), and was delivered by a Waters Model 501 HPLC pump at a 
flow rate of 0.9 ml/min. The eluted compounds were detected using the carbon 
fibre electrode connected to an EG&G Princeton Applied Research (PAR) Model 
400 EC detector and recorded using a Philips Model PM8261 X-T recorder. 
Before use, the column was conditioned by passing 100 ml mobile phase adjusted 
to contain 10 times the standard concentration of sodium dodecyl sulphate and 2.5  
times the standard concentration of diethylamine. Prior to the addition of SDS and 
diethylamine, the mobile phase was filtered through a 0.45 |im membrane and 
degassed by sonication. A conventional PAR Model 400 glassy carbon detector 
was used for comparison studies.
3. 2. 4. Sample Preparation
2  ml aliquots of plasma standards in a stoppered 10 ml glass tube were spiked 
with 2 ngml'l salbutamol. 0.1 ml of 0.1 M sodium dodecyl sulphate was then 
added to each sample and the pH adjusted to 2.0. The samples were then extracted
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with 4 ml 0.1 M ethyl acetate by vortex muting for 2 min. The phases were 
separated by centrifugation (1 0 0 0  g for 10 min) and the ethyl acetate phase was 
transferred to another tube, dryed under a stream of nitrogen and reconstituted in 
40 |xl mobile phase. A 20 nl aliquot was injected into the chromatograph. For 
calibration, drug-free plasma aliquots were spiked to give a series of salbutamol 
standards in the concentration range 0-55 ng drag per ml plasma.
3. 3. RESULTS AND DISCUSSION
3. 3. I. Conostruction o f M icroflow Cell
The major drawback with microelectrodes is that fabrication difficulties increase 
as one decrease the size of the m ic r o e le c t r o d e ^  and so far they have relatively 
limited commercial availability. Hence, most workers normally prepare their own 
microelectrodes by sealing thin wires of fibres in glass capillaries either by 
melting the glass or by using an epoxy res in^5  - 59  Sealing wires or fibres into 
glass is more technically demanding, and there is always a risk that the relatively 
high temperatures needed to melt the glass might change the characteristics of the 
electrode material. It has been reported that carbon fibres which had been in 
contact with a flame were more fragile and needed longer electrochemical 
conditioning^. The carbon fiber electrodes used in potentiometric stripping 
analysis (P S A )^ 7  - 5 9  js constructed by sealing a carbon fiber in a poly(vinyl 
chloride) tube. However, this kind of electrode is not suitable for LC because the 
epoxy glue used for sealing the needle holes on the electrode tube is not stable in 
organic solvents. The heat sealing of the needle holes on the microelectrode used 
in this work circumvented the use of epoxy glue, which is liable to attack by 
organic solvents. In addition, the method was easy and rapid to perform and did 
not change the characteristics of the electrode material.
3. 3. 2. Hydrodynamic Studies
The hydrodynamic voltammogram for salbutamol was obtained by injecting 16 ng 
of the drag into the chromatograph with the detector set at different working 
electrode potentials vs. Ag/Ag3 P0 4 . The hydrodynamic voltammograms shown in 
Figure.3. 4 indicates that a working potential of +1.45 V was required for 
maximum response. When the potential was greater than +1.3 V, however both 
background current and the noise level increased rapidly. Hence a potential of 
+1.3 V was choosen for detection purposes.
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Figure 3. 4. Hydrodynamic voltammogram of salbutamol obtained by injections of 16ng 
into the chromatograh with detection at carbon fibre working electrode at 
differentpotentials (vs.Ag/Ag3PC>4).
Several organic solvents, such as chloroform, dichloromethane, and ethylacetate, 
could be used for the extraction of salbutamol from plasma samples. Ethyl acetate 
was tried first because of its lower toxicity, and the extraction recovery was found 
to be more than 90%. Other solvents were therefore not investigated. The 
extraction of salbutamol was studied at different pH values; the optimum pH was 
found to be 2.0. A typical chromatogram of a plasma extract spiked with 
salbutamol at the 20 ng ml"* level is shown in Figure 3. 5. This figure shows that 
peaks due to endogenous plasma components did not interfere with the salbutamol 
peak.
3. 3. 4. Assay Performance
The linearity of the method was determined by constructing a calibration curve in 
the concentration range 0-55 ngml'l salbutamol in plasma . As shown from the 
data in Table 3. 1, the method is linear over this range with correlation 
coefficients of greater than 0.999 over three days during which this experiment 
was carried out.
3. 3. 3. Sample Preparation
Table 3 .1.  Calibration Plots Data For Salbutamol
Equation of the regression 
line
correlation
coefficient^
Day 1 y= 0.0020  + 0.00028x 0.9998
Day 2 y= 0.0019+ 0.00013x 0.9997
Day 3 y= 0.0019 + 0.00021x 0.9994
Analysis with good reproducibilities are often possible, without the use of internal 
standards^*. The reproduciblity of the overall method was determined by 
extracting and injecting quadruplicate plasma standards at each of six 
concentrations, i.e. 1, 5, 10, 20, 40 and 50 ngm l'l, and by calculating the amount 
of "drug found" by interpolation of the y-values (peak current) on the individual 
regression lines. The values of "amount found" were then used in the calculation 
of the mean, standard deviation SD and coefficient of variation CV, and as shown 
by the results in Table 3. 2, the method had an overall mean coefficient of 
variation of 5.40%. The recovery of the extraction method was then estimated by
1 27
Figure 3. 5. HPLC chromatogram obtained by analysis of a plasma extract spiked with 
20  ng ml-1 of salbutamol.
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comparing the peak current of extracted standards at the 3, 5, 10, 20, 40 and 50 
ngm l'l levels with the peak current of authentic standards, which were injected at 
the same concentration levels in reconstituted residues, assuming 100% recovery.
Table 3. 2. Reproducibility Studies 
Day I
Amount added 
(ng)
Mean amount found 
(ng)
Coefficient of variation(%)
1 0.85 12.00
5 4.40 8.20
10 9.00 8.00
20 18.50 5.84
25 23.87 3.58
40 38.88 2.20
50 48.75 2.14
Day n
Amount added 
(ng)
Mean amount found 
(ng) _
Coefficient of variation(%)
1 0.75 11.25
5 4.00 7.20
10 9.30 6.08
20 19.00 4.55
25 24.00 3.90
40 38.58 1.43
50 48.50 0.98
Day in
Amount added 
(ng)
Mean amount found 
(ng)
Coefficient of variation^
1 0.8 9.3
5 4.5 7.0
10 9.2 7.4
20 18.9 4.8
25 24.2 4.4
40 38.9 2.1
50 49.2 1.1
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The results in Table 3. 3 show that, at these concentration levels, drug recovery 
was always greater than 85%, and usually greater than 90%. The limit of 
detection was found to be 1 ng of drug per ml of plasma at which the signal-to- 
noise ratio was greater than 3. The limit of quantitation was approximately 3 ng 
ml- *, at which the signal-to-noise ratio was greater than 10. This limit of 
detection compares favourably with previous methods for the determination of 
salbutamol in biological fliuds and the method is capaple of monitoring the 
therapeutic range of the drug62.
Table 3 .3 .  Recovery Studies
Concentration(ng) Peak current (nA) Recovery(%)
Extract(E) Authentic(A)
3 0.005 0.007 85
5 0.0087 0.01 87
10 0.018 0 .0 2 90
20 0.036 0.039 92
40 0.077 0.08 97
50 0.0975 0 .1 0 98
3 .3 .5 .  Electrode pretreatment
A variety of methods have been devised for pretreating carbon fibre electrodes, 
including laser and electrochemical 63 - 67 an(j the methods need to be evaluated 
individually for the problem at hand. Electrochemically treated electrodes have 
been found advantageous, e.g. in flow detection of hydrazines^, ascorbic acid^9 
cathecholamines^O 0r tetracycline antibiotics^*. The requirements for 
pretreatment is that the surface of the electrode changes with time due either to 
the adsorption of species from solution or chemical changes on the electrode 
surface itself. These changes often result in variations in sensitivity , 
reproducibility and selectivity.
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The amperometric oxidation of salbutamol is particularly troubled by poisoning of 
the electrode surface, owing to a build-up of a polymeric film, which is an 
accumulation of electrode reaction products. Various attempts at overcoming the 
electrode poisoning associated with the detection of salbutamol and their 
suitability for continuous monitoring were investigated. One protocol which 
would improve the peak current and reduce the noise to its original level involved 
the anodisadon of the microelectrode at + 1 .4  V for 5 sec, then cathodisation at -
1.4  V for 5 sec vs. Ag/Ag3P0 4  followed by equilibration for 5 min. It has been 
proposed^ that the improved performance is as a result of the removal of surface 
contaminants or inhibitory layers which hinder electron transport. The 
electrochemically modified carbon fibre electrode was less susceptible to 
poisoning than a non modified one and prolonged lifetime of the electrode was 
obtained after electrochemical pretreatment.
The effect of electrochemical pretreatment is shown in Figure 3. 6 . The current 
response of the electrode was found to increase after the pretreatment regime. 
This is probably due to activation of the surface produced quinoidal 
functionalities^. It also seemed to stabilise the contribution due to the charging 
current. One of the sources of noise in the system might be the potentiostat, which 
was designed for a conventional glassy carbon working electrode, and tailored to 
analyses at higher currents. A lower noise level would be expected with a 
potentiostat more suitable for the lower current encountered with carbon fibre 
electrodes.
3. 3 . 6. Comparison with Conventional Glassy Carbon Based Detector
The performance of the microelectrochemical flow cell was compared to a 
conventional macro-glassy carbon electrode flow cell, the electrode of which was 
polished successively with small particle size silicon carbide, alumina, diamond 
paste and then subjected to ultrasonic c le a n in g 7 4 . As shown in Figure.3. 7 , the 
current scale for the fibre electrode is 2 0 0  times smaller than that for the glassy 
carbon electrode. This is consistent with the surface area ratio between them. The 
surface area of the glassy carbon electrode is about 170  times greater than that of 
the carbon fibre electrode.
The detection limit of the carbon fibre electrode was, however, shown to be about 
three times better than that obtained using glassy carbon electrode. Similar 
findings have been reported by Luscombe et al.^5 for the determination of copper 
in urine using platinum disc microelectrodes instead of a conventional carbon disc
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Figure 3. 6 . HPLC chromatograms of 20 ng salbutamol obtained by analysing the drug 
before (a) and after (b) electrochemical pretreatment of the working 
electrode .surface.
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Figure 3. 7. Chromatograms obtained by analysis of (a) 1 ng salbutamol using the 
carbon fibre microelectrode at +1.3V vs Ag/AgjPO# and (b) 3ng 
salbutamol using a .macro-glassy carbon electrode at +1.3V vs 
Ag/Ag3PQ4.
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macroelectrode. In addition, carbon fibre electrodes can overcome many problems 
associated with a conventional glassy carbon based detection system. For 
example, the glassy carbon electrode requires frequent polishing, which can be 
quite tedious; fluid can leak from the cell, air bubbles can form in the cell, and a 
high electrolyte concentration is needed in order to reduce the iR drop in the cell 
caused by the large surface area. A lower limit of detection could be obtained 
using a potentistat tailored for measurements using microelectrodes because the 
noise levels are undesirably high when small currents are meaured under the 
potentiostatic control provided by commercial instruments^.
3.4. C o n c l u s i o n
A reversed-phase HPLC method has been developed for the assay of salbutamol 
in human plasma, based on liquid-liquid extraction and detection using a carbon 
fibre flow cell. The cell is simple to prepare and easy to manage. Carbon fibre 
electrodes have the advantages that the rate of mass transport to and from the 
electrode increases as the electrode size decreases, iR drops are very small and the 
capacitive charging currents are reduced to insignificant proportions. The limit of 
detection of the method was found to be 1 ngml'l, the mean overall coefficient of 
variation was 5.4% even without using an internal standard, and drug recovery 
was in excess of 85% at all concentration levels studied. The limit o f detection 
reported in this paper is approximately 2-3 times lower than that reported for 
ferrocene by Bixler and Bond^7 using a microdisk electrochemical wall-jet flow  
cell, and could be further improved by lowering the electronic component of the 
noise.
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Analysis of Terbutaline in Human Plasma 
by on-line Solid-Phase Extraction with 
Amperometric Detection
Chapter 4
i t i
4 . l .  I n t r o d u c t io n
Terbutaline (l-(3,5-dihydroxyphenyl)-2-(t-butylamino) ethanol) is a 
sympathomimetic agent affecting those neurotransmitters which mediate 
sympathetic nerve transmissions*. Its clinical application is primarily that of a 
bronchodilator, and it is widely used in the prophyllaxis of bronchospasms. Plasma 
concentrations of unchanged drug associated with effective therapy^ are in the range 
10-30 pmol/ml. The analysis of terbutaline [HI] is important in pharmacuetical 
research and clinical chemistry, and because the drug is widely prescribed, it can 
sometimes be taken in over-dose. Because of the low concentrations encountered in 
biological fluids, the complexity of the sample matrix and the reactivity of the drug 
to trace impurities, sensitive and selective detection is necessary for its 
determination in plasma.
OH
111. Structural formula of Terbutaline
As has been mentioned in the previous chapter, HPLC has become a widely applied 
analytical technique, particularly in the determination of pharmaceutically active 
compounds. Coupled with this growth there has been a rapid development in the 
quality of chromatographic supports and equipment available^. However, 
particularly in the case of biological samples, extensive sample clean-up is often 
required prior to analysis and this has been a limiting factor in the past
The column switching t e c h n i q u e ^  offers the analyst a powerful technique allowing 
him to combine the separative powers of HPLC with simple sample clean-up 
procedures^ ' 8 . The term "column switching" is used in modem liquid 
chromatography for different operating modes without a strictly defined sense. 
Synonymous expressions such as "multiple column chromatography", isomodal, bi- 
or heteromodal chromatography", etc., are used for column switching, but with 
different objectives for chromatographic separations. The term "column switching"^ 
includes in the widest sense all techniques by which the direction of the mobile 
phase is changed by valves, so the effluent from a primary column is passed to a 
secondary column for a defined period of time. The use of valves means that the 
chromatographic system involves not one, but a number of columns forming a
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network. Switching within this network may be effected manually or by automated 
controllers.
In the following section, valve switching, and in particular column-switching, will 
be presented as on-line method for sample preparation which allows the analyte to 
attain the goals set out above. The following section includes a through review of 
important research in this area to date and highlights the versatility, and efficiency 
possibility of employing this technique in particular for sample clean-up and trace 
analysis in biological fluids.
4. 1. 1. Column Switching
A generalised set-up of multidimensional HPLC is shown in Figure 4. 1. Mobile 
phase compatibility of different modes of columns, and the additinal extracolumn 
effects introduced by the switching valves, tubings, size of transfer volumes, etc., 
will determine the optimum configuration for a particular application. In most cases, 
a much simpler setup than in Figure 4. 1 will be adequate to do the job. The set-up 
in Figure 4. 1 basically reveals two important modes of operation commonly used in 
column switching automated sample preparation and enhancement of system 
resolution. The small columns, LI, L2, etc., located in the switching valve loop are 
commonly used for automated sample preparation such as trace enrichment, peak 
compression, sample cleanup, etc.; since they are located on the valve loop, they are 
sometimes refer to as loop columns. Pre-concentration is usually carried out on 
relatively short (2-30 mm long) precolumns, with similar diameter to the analytical 
column, packed with a sorbent employed in HPLC, such as chemically bonded 
s i l ic a s * ® .  Depending on the applications, packings of these columns can be different 
from the analytical column. The analytical columns, A l, A2, etc., however, are 
connected in series to provide multidimentional separation.
4. 1. 2. Valve Switching
In general, valve switching is a method of rerouting chromatographic eluents by 
means of valves. When combined with the automatic switching of pumps, samplers, 
detectors and other apparatus, valve switching allows automation of those areas of 
chromatography that can be time consuming and require large numbers of man 
hours**.
The type of valve commonly used in valve switching is the Rheodyne 6 -port, 2 way 
valve (Model 7000) which operates at high pressure (figure 4. 2). This valve has two 
internal pathways connecting ports 1 and 2, 3 and 4 and 5 and 6  in the nonswitched
/  *¿3
0 3 ______
- OfTECTOR
Figure 4.1. Generalized setup of column switching. Reproduced from Chow, F., in HPLC 
in the Pharmaceutical Industry, Fong, G. and Lam, S. (Eds.), Marcel Dekker, 
Inc., New York, p. 47.
N O N S W I T C H E D  P O S I T I O N S W I T C H E D  P O S I T I O N
Figure 4.2. Rheodyne 6-port switching valve.
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or RESET position and in the SWITCHED position parts 2 and 3, 4 and 5 and 6  and 
1 are connected. Depending on the valve position, different external connections to 
the valve are selected. Valve switching finds application in areas such as sample 
clean-up, trace enrichment, method development, sample identification, boxcar 
chromatography, multi-column chromatography, and incremental gradient elution^. 
Of these, sample clean-up and trace enrichment are major areas of interest.
Valve switching may be used to carry out column switching, column selection, 
solvent switching, solvent selection, zone cutting, auxiliary pump on/off, trap solute 
in detector, recycle, fraction collection, sample injection, and detector selection
4. 1 .3 . Applications of Column Switching
Analytical samples are often so complex that one or several of the target component 
must be determined within a matrix of a very large number of other components that 
are present at higher or lower concentrations. Multi-setup methods are necessary 
with several purification steps before the chromatographic determination. Column 
switching systems should permit the multi-step to be transformed into single-step 
procedures by on-line purification. Since off-line techniques require further handling 
of the sample between the trace enrichement and the separation step, they are not 
highly suitable for fully automated techniques. In addition, they suffer from the 
disadvantages of possible sample loss and/or decomposition and are often complex 
and time- consuming.
The goal of all sample preparation system therefore must be to cope with these 
problems. The following points have to be considered if the method is to be used for 
routine determinations.
(i) The total analysis time should be short.
(ii) To facilitate the operation, the sample preparation should on-line to the HPLC 
separation system.
(iii) The sample preparation should be suitable for automation.
(iv) The sample preparation should be mild so that sensitive compounds can be 
handled.
(v) To minimize the problem of interferences, no loss of the separation power of the 
chromatographic systems is acceptable; on the contrary, an improvement in 
selectivity is desirable.
(vi) To reduce the time for development and optimisation of a given analytical 
problem the sample preparation should be generally applied in such a way that the 
experimental parameters can be changed on a rational basis with high flexibility.
4. 1. 3. 1. Trace Enrichment
Trace enrichment or preconcentration by on-line chromatographic techniques are 
based on the fact that the components will be retained in a narrow zone on the top of 
the column when a large volume of sample is pumped through the co lum n^,14 
Overloading can be overcome by diluting the sample before injection. If trace 
enrichment has to be effected for less strongly adsorbed components, the sample 
volumes must be smaller or the column volume must be increased to prevent 
"breakthrough".
Trace enrichment allows on-line concentration of samples and can be of particular 
use when dealing with samples from environmental media such as sea water or 
mineral w a te r  . A large volume of the sample is passed through a concentration 
column ( 1 0 -100  ml) under chromatographic conditions where the sample does not 
elute and is adsorbed onto the column. A reversed-phase column and water are 
typically used. After concentration, the precolumn is switched in line with a 
different solvent, so that it is rapidly eluted onto another column where separation 
can take place. Unfortunatly trace enrichment also concentrates other materials in 
the sample and this may cause interference and lack of sensitivity. One way to 
overcome this problem is to combine trace enrichment with automatic sample clean­
up.
4. 1. 3. 2. Pharmaceutical Formulations
Many pharmaceutical formulations such as creams, ointments, injectables, syrups, 
suppositories, and transdermal patches contain complex matrices. Analysis of the 
active components in these formulations, in many cases, requires substantial sample 
preparation such as liquid-liquid partition, dissolution, filtration, open column 
chromatography, minicolumn and cartidges, evaporation and reconstitution of 
sample r e s i d u e s ^ .  These manual sample preparations are time-consuming and limit 
sample throughput. Obviously, it is highly desirable to automate the sample 
preparation. Column switching offers a great opportunity to automate these manual 
procedures. Kenely et al. reported on the use of a microprocessor controlled, tandem 
reversed-phase HPLC method for analysing both cream and ointment
formulations 17 - 19
4. 1 3. 3. Sample Clean-up in Biological Fluids
The use of column switching has been applied to the determination of drugs in 
biological matrices with much success. A survey of literature showed that more than
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80% of column switching were in the area of analysing drugs in biological fluids. In 
many cases the biological fluid is directly injected onto the precolumn with no 
sample preparation whatsoever^ - 34 if  this is the case care should be taken that 
there are no particles present which might clog up the column. This offers obvious 
advantages in terms of speed of analysis and sample throughput. Some workers 
favour centrifugation of plasma prior to injection^ - 38^  followed by injection of 
the supernatant onto the precolumn.
Sample clean-up of biological samples is critical for the following r e a s o n s ^ ;
(i) complicated sample clean-up is time consuming and expensive;
(ii) there is a risk of loss of interesting compounds;
(iii) sensitive compounds may decompose during the sample treatment.
In order to prevent clogging of the precolumn and reduce the viscosity of samples, 
plasma may be diluted with water 40 0r aqueous buffer^l prior to injection. This 
procedure will increase the limit of detection and may not be possible in the case of 
drugs which are present in the very low nanogram range. Plasma may be 
deproteinized prior to i n j e c t i o n 4 2  - 44 with an organic solvent such as acetonitrile 
which causes precipitation of plasma proteins which are then separated by 
centrifugation and the supernatant injected. This procedure usually results in low  
recoveries for the drugs since acetonitrile acts as a strong eluent and the drugs do not 
become trapped on the precolumn.
Of growing importance therefore in clinical applications is the principle of 
adsorption of the aqueous plasma matrix on a special precolumn followed by:
(i). water wash to remove proteins;
(ii). Solvent change and backflush of drugs onto the analytical column;
(iii). Isolation of the precolumn for clean-up and re-equilibration. The need here is 
to remove strongly adsorbed species such as lipids and fats45.
4. 1 .4 . Considerations in Setting up a Column Switching System fo r  
Biopharmaceutical analysis
In order to optimise the recovery and selectivity of an assay major consideration 
must be given to (i) size and design of the precolumn; (ii) precolumn packing 
material; (iii) eluent for the wash phase; (iv) frits and tubing; (v) backflush vs 
forward flush mode (vi). sample pretreatment; (vii) lifetime of the precolumn; (viii)
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protein binding, and (viii) memory effects.
4. 1 .4 . 1. Size and Design of the Precolumn
Of major importance is the construction and geometry of the precolumn into which 
the adsorbent will be loaded. The design of the precolumn can be quite diverse, 
ranging in length from 2 mm to 3 cm and an inner diameter anywhere from 1 mm to 
4.6 mm. It is best to use as short a precolumn as possible to save on expensive 
adsorbent, enable easy and manual packing and to reduce b a c k p r e s s u r e ^ .
In a study by Werkhoven-Goewie et al47, different size precolumns were examined 
for their effects on band broadening ranging from (1.45 mm x 4.6 mm) to (41 mm x 
1.1 mm) to (30 mm x 4.6 mm). Under the conditions of the study the on-line 
coupling of the precolumn to the analytical column has a negligible effect on band 
broadening and the system performance was barely dependent on the precolumn 
design used. For more polar compounds the design of the precolumn may be more 
critical, with shorter columns being preferred. Other w orkers^O  when comparing a 
precolumn of dimensions 40 x 4.6 mm with cartidges 5, 10 and 20 mm long 
obtained full recovery of the analyte with all four types but found the number and 
amount of interfering peaks was reduced considerably with shortercolumns, the 5 
mm cartidge giving the best result.
For determination of clobazam and its active metabolite desmethyl clobazam, a 
micro precolumn was d e s ig n e d ^ .  A hole 4.5 x 1 mm i.d. is drilled within the axis 
of a valve and filled with suitable packing material. This, when used in conjunction 
with a narrow bore column, allowed a limit of detection of 2.5 ngm H for each drug 
in plasma after direct injection of the biological fluid, with little contribution to band 
broadening.
So in general best results are obtained with a small precolumn leading to fewer 
contribution to band broadening.
4. 1 .4 . 2. Precolumn Packing Material
The precolumn packing material chosen should display a high affinity for the 
analyte during the sampling step, a low affinity during the desorption stage and have 
high loadability. The most widely used packings are commercially available alkyl 
modified silica (Cjg, Cg and C2 ), ion-exchange resins.
Particle size exerts a profound effect on precolumn performance. Although it is 
known that larger size particles cause greater band d isp e rs io n ,49 most workers
favour particles with size 25-50 ¿im as precolumn packing in order to prevent 
clogging of the precolumn with particles from plasma. Employing a direct injection 
of plasma using particles in the range 25-50 pm with Corasil C ig  has been chosen 
by a number of workers^,50 - 54 ancj equivalent results obtained using these and 
three step method have been d e m o n s t r a te d ^ ,  in studies where a smaller particle size 
packing is used in the precolumn some form of sample pretreatment of plasma prior 
to injection was generally required.
4. 1 .4 .  3. Choice o f Eluents
The eluent must be chosen in such a way that the drug and its metabolites are 
retained while the bulk of unwanted constituents from plasma are flushed through. 
The mobile phase for flushing must be pure otherwise impurities will be 
concentrated and later eluted onto the analytical column where they will cause 
interferences. Care must also be taken that breakthrough does not occur. This is a 
function of the sample capacity of the concentration column which depends on the 
composition of the sample and the eluting strength of the solvent.
4. 1 .4 .  4. Frits and Tubing
It is r e c o m m e n d e d ^  that the steel capillaries from the injector to the precolumn 
should be of wider bore than those from the precolumn to the analytical column. 
This is especially important for viscous plasma samples. Zech and Huber has 
discussed to the importance of using sieves (although with an adequate filter 
function) instead of frits in order to avoid column b l o c k i n g ^ .  Sieves of the 
precolumn should not be too fine, sieves of at least 18 um pore size are 
r e c o m m e n d e d ^ . Also to guarantee a homogenous distribution of the adminstered 
plasma to the top of the guard column, crossed grooves should be fitted onto the 
surface of the end fitting which crosses the top of the p r e c o l u m n 2 5 .  Other workers 
have also found screens to be better than f r its5 6 . We found in our laboratory that if 
frits are used they need to be changed frequently.
4 . 1 . 4 .  5. Back flush! Forward flush
Backflush mode for the desorbtion of the drugs from the precolumn to the analytical 
column is by far the favoured m o d e^ 0 ,3 5 ,4 4 ,4 5  Backflushing prevents 
contamination of the precolumn and minimizes band broadening. It can be shown by 
the use of a strong fluorescent substance that the analytes are concentrated in a small 
region at the top of the precolumn so that their removal by backflushing minimizes 
their d i s p e r s io n ^ .  in the "elute through" mode these drugs initially in a narrow band
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at the top of the precolumn must pass through say the full 2 cm of packing, 
experiencing all the band dispersion effects of the c o l u m n 2 3 .  i n  the case of the few 
s t u d i e s ^ , 36,42,22 where forward flushing has been employed, it was advocated 
noted that the precolumns should be very small, less than 1 cm in length, so that the 
overall efficiency does not deteriorate as one might expect in the straight flush 
mode. Forward flushing does prevent the build up of contaminants at the head of the 
analytical column. However, in general, backflushing is to be favoured.
4. 1 .4 . 6 . Precolumn Lifetime
Although the lifetime of the precolumn will depend on a number of factors such as 
the particle size and type of the packing, the porosity of the frits, sample 
pretreatment and the plasma in general, each precolumn will be able to handle 
between 10-20 ml of plasma with the average being 15ml. The lifetime of the 
column depends on the total amount of plasma injected rather than the size of each 
injection. A precolumn therefore that can handle 400 x 50 pi injections will only 
handle 80 x 250 jul injections. With larger injection volumes, the reconditioning of 
the precolumn between injections is particularly important. Eventually the surface of 
the adsorbent in the precolumn will become modified with matrix elements from 
plasma resulting in a loss of effeciency and a decrease in recovery.
4. 1. 1 4. 7. Memory Effects
Memory effects from the precolumn ("substance bleeding") may be checked by 
injecting blank solutions between approximately every 10 injections. No memory 
effects should be observed. The switching procedures for clean-up of biological 
fluids in our laboratory will be described in Section 4. 2. 2. 2.
In this chapter, an analytical method for the determination of terbutaline in plasma is 
described and, validated. The method allows direct injection of plasma using a 
column switching technique. The method is based on the enrichment of the drug on 
a reversed-phase concentration column packed with Corasil RP C jg. The enriched 
drug was then separated, using the backflush mode on a Spherisorb ODS column 
using an isocratic phosphate buffer-methanol-sodium dodecyl sulphate-diethylamine 
in a ratio of 45:55:0.5:0.02 (v/v). Hitherto, only methods based on gas 
chromatography- mass spectrometry ( G C - M S ) 5 8  - 60 an{ j electrochemical 
detection^ using a thin layer amperometric detection employing a macro glassy 
carbon electrode, have proved suitable for the determination of low levels of 
terbutaline in human plasma. The method was found to compare favourably with a 
glassy carbon electrode when applied to the same conditions of analysis and
separation and providing a limit of detection of at least 0.8 ngml‘ 1. In addition, the 
on-line method of sample preparation is less laborious and time consuming than 
methods employing liquid-liquid extraction, thus providing an assay which is 
sensitive, cost-effective and expedient in its execution.
4 .2 .  Experim ental
4. 2. 1. Materials and Reagents
Terbutaline was obtained from Sigma (Poole, Dorset, England), and analytical grade 
sodium dihydrogen phosphate from Merck (Darmstatd, Germany). Orthophosphoric 
acid and diethylamine (Analar grade) were supplied by BDH (BDH Ltd., Poole, 
Dorset, UK) and HPLC-grade methanol was supplied by Labscan Analytical 
Sciences, Dublin, Ireland. Human plasma, obtained from Beaumont Hospital 
(Dublin, Ireland) was frozen until required, and thawed at room temperature. Water 
was distilled and then further purified using a Milli-Q water purification system ( 
Millipore, Milford, MA, USA). The preconcentration column was packed with 
Corasil (Waters, Milford, MA, USA) Cjg material (37 pm).
Carbon fibres, 14 pm in diameter, were obtained from Avco, Lowell, MA, USA. The 
surface of these fibres has no external coating. Silver epoxy was purchased from RS 
components, Corby, Northants, UK, and the glassy carbon used in the comparison 
studies was obtained from Princeton Applied Research (Princeton, NJ, USA).
4. 2. 2. Instrumentation and Operating Conditons
4. 2. 2. 1. Chromatography
Chromatographic separation was based on the work of Jarvie et al.61 following a 
slight modification to the ratio of methanol to aqueous component in order to obtain 
a sutitable retention time for terbutaline. The drug was separated on a Spherisorb 
ODS (10 pm) column (25 cmx4.6 mm i.d.) which was protected by a guard column 
packed with Cjg packing material. The mobile phase consisted of a mixture of 0.067 
M phosphate buffer, pH5, methanol, 40 g/1 sodium dodecyl sulphate (SDS) and 
diethylamine (DEA) in a ratio of [45:55:0.5:0.02]. Prior to the addition of SDS and 
DEA the mobile phase was filtered and degassed by sonication. The prepared eluent 
was delivered by a Waters (Milford,MA,USA) Model 501 HPLC pump at a flow  
rate of 1 ml/min. Before use, the column was conditioned by passing 100 ml mobile 
phase adjusted to contain 10 times the standard eluent concentration of SDS and 2.5 
times the standard eluent concentration of DEA. Sample introduction was via a 
Rheodyne (Cotati, CA, USA) Model 7010 injection valve, fitted with a 20 ul loop
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for direct injection.
For the purposes of extraction by column switching, the injector was fitted with a 1 
ml loop and a second pump (pump A) and the concentration column were connected 
to the analytical assembly via a Rheodyne Model 7000 six-port switching valve. The 
loading/washing eluent delivered by pump A was filtered degassed deionised water. 
The spiked plasma sample was injected through the injector port and washed by the 
water in pump A onto the concentration column (position 1, Figure. 4. 3). The drug 
was held on the concentration column while the other components in plasma are 
eluted to the drain. Meanwhile the eluent from pump B is passing through the 
analytical column and out to waste. On switching the valve after a pre-determined 
wash time (position 2, Figure. 4. 3), the eluent from pump B elutes the drug in 
backflush mode, which have been held on the concentration column, onto the 
analytical column where it was separated. In using the column switching valve the 
following variations in sample handling were studied: (i) sample pretreatment, (ii) 
concentration column packing, (iii) wash time and flow rate and (iv) analytical 
column.
4. 2. 2. 3. Amperometric Measurements
Oxidative amperometric measurements were performed using an EG&G Princeton 
Applied Research (Princeton, NJ, USA) Model 400 EC potentiostat connected to the 
flow cell described in Section 3. 2. 2 by crocodile pins. The drug was detected 
amperometrically by employing potential of +1.3 V at the working electrode. The 
resultant signals were recorded on a Philips Model PM8261 x-T recorder 
(Eindhoven, the Netherlands) at a chart speed of 300 mmhr’ ^ . The peak currents as 
a function of concentration were then measured for quantitative analysis.
4. 2. 2. 4. Standard Solutions and Calibration Curves
Stock solutions equivalent to 0.2 mg/ml of the drug in water were freshly prepared. 
These were diluted and added to drug-free plasma aliquots to generate spiked 
plasma standards in the concentration range 1-35 ngml"^. Each calibration point was 
run in triplicate over three consecutive days.
4. 2. 2. 2. Column Switching Extraction Procedure
1S3>
AFigure 4. 3. Column switching assembly, used for retaining terbutaline in the pre­
concentration column (a) and eluting the drug from the pre-concentration 
column (b). Reproduced from Kelly, M. and Smyth, M., J. Pharm, Biomed. 
Anal., 7 (1989) 1757.
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4. 3. R e s u l t s  a n d  d i s c u s s i o n
4. 3. 1. Hydrodynamic Voltammetry
The hydrodynamic voltammogram for terbutaline was obtained by injecting 35
ngml" of the drug into the chromatograph with the detector set at different working 
electrode potentials vs. Ag/Ag3PC>4 . The hydrodynamic voltammogram shown in
Figure 4. 4 indicates that a working potential of +1.4 V was required for maximum
response. When the potential was greater than +1.3 V, both background current and
the noise level increased rapidly. Accordingly, a potential o f +1.3 V was used in
subsequent experiments.
4. 3. 2. Optimisation o f Extraction Procedure
4. 3. 2. 1. Pre-column Selection
Terbutaline can be extracted into organic solvents, either as a zw itterion^  or as an 
i o n - p a i r ^ 2 , 6 3  guch off-line methods are time consuming, and may cause loss of the 
analyte through the formation of emulsions or artefacts, adsorption onto glassware 
or volatilisation at the evaporation stage. Solid-phase extraction was chosen to 
circumvent some of these problems and the column switching technique described in 
this chapter provided the requisite extraction selectivity in a reasonable time frame.
The first step in the set-up of the switching system involved selection of a suitable 
pre- (or concentration) column which would retain terbutaline completely, and 
which would allow the interfering substances in plasma to be completely removed 
during the wash step. The diameter of the precolumn should be similar to or smaller 
than that of the analytical column, and the precolumn should be as short as possible. 
The retention of terbutaline on the precolumn should ideally be similar to, or lower 
than, that on the analytical column in order to prevent band-broadening problems 
during the desorption and actual separation step. As regards the small size of the 
precolumn, this aspect is of importance because of supression of band broadening 
due to the precolumn, a low pressure drop and ,thus, a high flow rate during the 
separation step, ease of packing and replacement, and material saving. A short 
stainless-steel pre-column (10 mm x 1.5 mm i.d.) was chosen for this purpose. The 
precolumn served as a preconcentration and clean-up column and as a guard column 
to prevent contamination of the analytical column. The use of a precolumn on which 
the sample compound is preconcentrated before elution onto the analytical column 
provides a precise means of sample introduction and leads to high precision in 
quantitative determinations^,64 it is essential that terbutaline has a greater affinity
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Figure 4. 4. Hydrodynamic voltammogram of terbutaline obtained by injections of 35ng 
into the chromatograph with detection at carbon fibre electrode at different 
potentials (vs.Ag/Ag3P04).
for the sites on the surface o f the packing than for protein in plasma. Otherwise 
recovery of the drug from the precolumn will be low due to plasma protein binding. 
In order to asses the extent o f binding, the peak current obtained for a series of 
recovered authentic standards were compared with the peak currents obtained for a 
series of recovered plasma standards from the precolumn. Pellicular C jg material 
showed the most favourable retention characteristics for terbutaline when compared 
to Cg or cyano packing materials and proved to be the best among the packings tried 
in terms of recovery and cleanliness of chromatogram, and was therefore chosen as 
the precolumn packing.
The next stage was to find two compatible eluents of different elutropic s t r e n g th s ^ ;  
one weakly eluting solvent to concentrate terbutaline on the pre-column and a 
second strongly eluting solvent to elute terbutaline off the pre-column and onto the 
analytical column. The choice o f solvents is also important in terms of their mutual 
miscibility, as even slight incompatibility could result in a slug of solvent travelling 
down the analytical column partially carrying sample components which may cause 
band spreading. The washing/loading eluent (designated mobile phase A) ideally 
would have poor elution capability on the pre-column in order to ensure maximum 
concentration of the sample with minimum band broadening. Degassed deionised 
water was found to provide adequate concentration and was compatible with the 
aqueous based analytical mobile phase (mobile phase B) which effected full elution 
of the drug from the concentration column, and any possible band broadening was 
minimised by eluting in a backflush direction. Some workers may add a small 
amount of some organic modifier e. g. 4% acetonitrile to the wash phase but this 
may result in lower recovery for a drug6 6 .
Wash times were varied from 1 minute up to 10 minutes, and flow rates from 0.5 to
1.5 mlmin'l. Variation in these factors did not affect the chromatograms obtained to 
a large extent, but the sharpest peaks and cleanest chromatograms were obtained for 
a wash time 90 seconds and a flow rate of 1 mlmin- !. Shorter wash times result in 
very large plasma peaks while longer wash times gave rise to band broadening. 
Typical chromatograms of drug-free plasma and a plasma extract spiked with 
terbutaline at the 30 ngml' * level are shown in Figure 4. 5a and 4. 5b respectively.
4. 3. 2. 2. Boundary conditions
Consequently, after preconcentration of the samples, a wash step is absolutely 
necessary to remove a major part of interesting compounds. To determine the 
optimum wash time for the samples on the concentration column, plasma aliquots 
containing 10 ngml"* of the drug were injected onto the concentration column. The
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Figure 4. 5. HPLC chromatogram obtained by analysis of drug-free plasma extract (a), and 
an extract of plasma spiked with 30ngml'l of terbutaline (b).
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wash time (defined as the length of time between injection and switching of the 
valve) was varied between 1 minute and 3 minutes, and it was found that a 
maximum response was obtained at 1.7 minutes, in that it provided good clean up of 
the plasma components without causing the drug to elute. Seven replicate injections 
of plasma samples containing 10 ngm l'l terbutaline yielded a RSD of 5%.
4. 3. 3. Electrode pretreatm ent
The reason electrode pretreatment is required is that the surface of the changes with 
time due either to the adsorption of species from solution or chemical changes on the 
electrode surface itself. These changes often result in variations in sensitivity, 
reproducibility and selectivity.
The electrochemical pretreatment regeim which improved the peak current and 
reduced the noise to its orginal level, involved the anodisation of the microelectrode 
at +1.4V for 10 sec, then cathodisation at -1.4V for 10 sec vs. Ag/Ag3 P0 4  followed 
by equilibration for 5 minutes and the effect o f the procedure described above is 
shown in Figure 4. 6 b. The effect of pre-treating the electrode is to increase its 
current response, which is probably due to activation of the surface leading to the 
production of quinoidal functionalities. It also seemed to stabilise the noise 
contribution due to the charging current.
4. 3. 4. Assay Performance
The linearity of the method was determined by constructing a calibration curve in 
the concentration range 0-35 ngml'l terbutaline in plasma, and as shown from the 
data in Table 4. 1, the method is linear over this range with correlation coefficients 
of greater than 0.999 on each of three successive days.
Table 4. 1. Calibration Data For Terbutaline
Day Equation of the regression 
line
Correlation 
coefficient,r
1 y= 0.0390 + 0.0067x 0.9997
2 y= 0.0384 +0.004 lx 0.9998
3 y= 0.0370 + 0.0027X 0.9999
The precision of the assay was assessed by carrying out seven replicate runs over the
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Figure 4. 6 . HPLC chromatograms of 20ng terbutaline obtained by the analysing the drug 
before (a) and after (b) electrochemical pretreatment of the working electrode 
surface.
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concentration range 3, 5, 10, 20 ngml'l on each of three consecutive days. Between 
batch or intra-assay variability was assessed by constructing a calibration curve 
based on the mean (of seven) detector response values at each concentration level in 
the range 3, 5, 10 and 20 ngm H . Individual peak current values then interpolated on 
the regression line to yield 7 new values of x (i.e. "amount found") at each 
concentration. The mean, SD and CV for each amount found were then calculated 
with the intra-assay being expressed as the mean CV over the entire concentration 
range. Between-batch variability was calculated by constructing a calibration curve 
on each of 3 consecutive days in the same concentration range as above. Peak 
current values were interpolated on the individual regression lines to yield three new 
values of amount found at each concentration level. Between-batch variability was 
then calculated by obtaining the mean CV over the calibration range. Results from 
this experiment are presented in Tables 4. 2(a) and (b) and they show that the 
within-day CVs were 7.2, 5.3, 3.0 and 2.25% for the 3 ,5 , 10 and 20 ngmH  
cocnetrations, respectively with a mean coefficient of variation of 4.4%. The 
corresponding CV values for intra- (between-day) assays were 8.1, 7.0, 4.3 and 
3.0% respectively with a mean coefficient of variation of 5.6%. Recovery of 
terbutaline from plasma was assesed by comparing the peak current of extracted 
plasma samples containing 3, 8 , 15, 30 ngml'* terbutaline with the peak current of 
authentic (unextracted) standards, which were directly injected (i.e. without column- 
switching) onto the analytical column and at the concentration levels. The results in 
Table 4. 3 show that drug recovery was greater than 8 6 %, and usually greater than 
91%. The minimum detectable concentration was found to be 0.8 ng of terbutaline 
per 1 ml of plasma, at which the signal to noise ratio was 3:1. This limit of detection 
compares favourably with previous methods for determination of terbutaline in 
biological fluids and the method is capable of monitoring the therapeutic range of 
the drug.
TABLE 4. 2(a). Intra-Assay (Within-batch variation)
A m ount added 
(n g m l'1)
Mean amount found(ng)±SD 
n=7, ngm l'l
Coefficient of 
variation(CV),%
3 2.9+0.20 7.2
5 4.7±0.24 5.3
10 9.6±0.32 3.0
20 19.9±0.40 2.3
Mean 4.4
U 1
Table 4. 2(b). (Between-batch Variation)
Amount added 
(ngml'l)
Mean amount found(ng)±SD 
n=3, ngml'l
Coefficient of 
variation(C.V), %
3 2.96+0.21 8.1
5 5.20+0.33 7.0
10 10.10+0.42 4.3
20 20.20+0.50 3.0
Mean 5.6
Table 4. 3. Recovery Studies
Terbutaline concentration 
(ngml'l)
Detector response(nA) 
Extract Authentic
Recovery (%) CV (%)
3 0.12 0.14 86 9.2
5 0.59 0.63 93 7.4
8 0.31 0.34 91 6.0
30 1.21 1.26 96 3.5
4. 3. 5. Comparison with Conventional Glassy Carbon B ased D etector
The performance of the microelectrochemical flow cell was compared to a 
conventional macro-glassy carbon electrode flow cell, the electrode of which was 
polished successively with small particle size silicon carbide, alumina, diamond 
paste and then subjected to ultrasonic c l e a n i n g 6 7 .
As shown in Figure 4. 7, the detection limit of the carbon fibre electrode was shown 
to be approximately half that obtained using the macro glassy carbon electrode. 
Similar findings have been reported by Luscombe et al. in the determination of 
copper in urine using platinum disc microelectrodes instead of a conventional carbon
disc macroelectrode^S.
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Figure 4. 7. Chromatograms obtained by analysis of lngml'l terbutaline using (a) the
carbon fibre microelectroe at +1.3V vs Ag/Ag3PC>4 ; and (b) 2ng terbutaline 
using a macro-glassy carbonelectrode at +1.3V vs Ag/Ag3P0 4 .
4. 4. CONCLUSIONS
An HPLC method for the determination of terbutaline in human plasma based on 
pre-column switching and electrochemical detection using a carbon fibre flow cell 
has been described. The column switching technique permitted selective retention of 
terbutaline on the pre-column and provided satisfactory clean-up to avoid any 
interferences due to endogenous plasma components. The limit of detection of the 
method was found to be 0.8  ngm l'l, the mean overall coefficient of variation was 
5.60%, and drug recovery was in excess of 8 6 % over the concentration levels 
investigated.
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Simultaneous Determination of Salbutamol 
and Terbutaline at Overdose Levels in Human 
Plasma by HPLC with Electrochemical Detection
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5. l .  I n t r o d u c t io n
The monitoring of drugs in cases of overdose is one of the oldest areas of drug 
measurement in clinical medicine. In cases of overdosage with drugs the prime 
reason for an analysis is to establish which drug has been overdosed in order to 
apply the appropriate remedial action. The need will arise if the patient is comatose 
and cannot tell the physician himself and there is no evidence (medicine bottles, 
known history) to suggest the immediate cause.
Salbutamol and terbutaline are directly acting sympathomimetic amines, their main 
action being on the adrenergic receptors in the bronchi and respiratory tract. Both 
drugs induce bronchodilation and inhibit bronchospasm in doses which do not 
produce marked cardiac acceleration. They are extensively used in the treatment of 
asthma, chronic bronchitis, emphysema, and other bronchopulmonary disorders 
involving bronchospasm*. Overdoses of these drugs can cause palpitations and 
tachycardia, and excessive use of sprays containing these drugs can be so severe, 
that a relationship between intensity of action and drug dose is usually evident. That 
is as the dose is increased, the intensity of the undesirable side-effects also 
increases, sometimes resulting in fatal consequences^. It was suggested that 
parenteral ^-adrenergic simulants, including salbutamol, should be used with 
caution in severe bronchial asthma since high plasma-concentration o f free fatty 
acids had been associated with the development of ventricular arrythmias and other 
cardiotoxic effects^.
In clinical toxicology, the first goal of the analyst must be to identify the drug or 
toxic agent. In clinical situations, when rapid and accurate analyses are available, 
they have proven very helpful to the healthcare team. These results have helped 
guide therapy for acutely poisoned patients, have facilitated adjustments in drug 
therapy, and have provided reliable evidential information for rehabilitation, 
probation, and medicolegal programmes^. In most cases, analysis o f plasma 
concentrations is usually taken since this can normally be related to the 
concentration of the drug at the site o f action^. LC-ED has the ability to measure 
several compounds simultaneously^ and the potential recovery of 90% of the 
analytes.
For salbutamol and terbutaline, simultaneous methods based on gas 
chromatography-mass spectrometry7 ,8 ancj HPLC with fluorescence detection^ 
have been described in the literature, but the instrumentation is complex and sample 
preparation can be lengthy. A previous method based on high-performance liquid
U9
chromatography with electrochemical detection (LC-ED) using a glassy carbon 
electrode following a solvent extraction procedures has been described in the 
literature*®. Simultaneous isolation, separation and determination of salbutamol and 
terbutaline in human plasma at overdose levels is described in this chapter.
The method described below circumvents the "classical" sample purification 
approach involving extraction, by direct purification and enrichment of the sample 
on the pre-column. The good recovery, low cost, speed and simplicity of 
distinguishing the two drugs based on differing retention times, without changing 
the chromatographic conditions between samples, is particularly important for a 
proper study of the features of poisoning in relation to plasma concentrations of 
poisoned patients and the choice of the appropriate levels of antidote necessary for 
treatment of such cases.
5. 2. Experim ental
5 2. 1. Materials and Reagents
Epinepherine, diazepam, methyl dopa, nor-epinepherine, paracetamol, 
phenylepherine and terbutaline were obtained from Sigma (Poole, Dorset, England). 
Salbutamol was kindly supplied by Dr. J. Bloomfield (Trinity College Dublin). 
Human plasma, obtained from Beaumont Hospital (Dublin, Ireland) was frozen 
until required, and thawed at room temperature. Water was distilled and then 
further purified by passing through a Milli-Q water purification system (Millipore, 
Milford, MA, USA).
5. 2. 2. Instrumentation and Operating Conditions
5. 2. 2. 1. Construction o f  Carbon Fibre Flow Cell
The preparation of the carbon fibre microelectrode flow cell was carried out using a 
procedure described previously in Section 3. 2. 2. Oxidative amperometric 
measurements were performed using an EG&G Princeton Applied Research 
(Princeton, NJ, USA) Model 400 EC potentiostat connected to the flow cell by 
crocodile clips. The resultant signals were recorded on a Philips Model PM8261 X-t 
recorder (Eindhoven, The Netherlands) at a chart speed of 300 mm/hr. The 
experimental techniques employed in flow measurements are discussed in section 4.
2 . 2 . 2  and specialized data on the design and operation of the detector are also 
given in chapter 3.
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5. 2. 2. 2. Standard solutions and calibration curves
Stock solutions equivalent to 0.2 mg/ml of these drugs were freshly prepared in 
deionised water. These were diluted and added to drug-free plasma aliquots to 
generate spiked plasma standards in the concentration range 20-100 ng/ml. Each 
calibration point was run in triplicate over three consecutive days.
5. 2. 2. 3. O ptim isation o f  Detection Poten tia l
In order to determine the optimum applied potentials for salbutamol and terbutaline, 
hydrodynamic voltammograms were obtained by repeated injections of salbutamol 
and terbutaline standard solution containing 60 ng/ml of each drug into the 
chromatography system and recording the peak current, at fixed applied potentials.
5. 2. 2. 4. Examination o f Interferences
The effect of interference of caffeine, diazepam, epinepherine, isoprenaline, 
metadrenaline, methyldopa, nor-epinepherine, nor-metadrenaline, orciprenaline, 
paracetamol, phenobarbiton, phenytoin phenylepherine, propranolol, salicylate and 
theophylline in the proposed method was studied by the addition of such drugs to 
the plasma samples already spiked with salbutamol and terbutaline at a 
concentration levels similar to those of both drugs (70 ng/ml plasma).
5. 3. R e su l t s  and  d isc u ssio n
5. 3 . 1. Optimisation o f Chromatography/Detection Conditions
Figure 5. 1 shows the hydrodynamic voltammograms of salbutamol and terbutaline 
in the chromatographic system with 0.067 M phosphate buffer, pH5, methanol, SDS 
and DEA 45:55:0.5:0.02 (v/v) as mobile phase, The plots show a distinct sigmoidal 
dependence upon applied potential. A working potential of +1.30 V was thus 
chosen for the quantitation of both drugs. The required sensitivity, selectivity and 
reproducibility for this analysis were achieved by pre-anodisation of the 
microelectrode at +1.40 V for 10 s, then cathodisation at -1.40 V for 10 s vs. 
Ag/Ag3 PC>4 followed by equilibration for 5 min. Figure 5. 2 shows the effect of 
this electrochemical pretreatment.
Pretreatment of plasma was not required before injection into the chromatographic 
system, due to the column switching operation (Figure 4. 3). It was necessary that 
the mobile phase and the precolumn packing be chosen in such a way that the drugs 
were completely retained on the precolumn while the interfering components of
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Figure 5.
POTENTIAL, mV
1. Hydrodynamic voltammograms of salbutamol (o) and terbutaline (p) obtained 
by injections of 60ng dm g substance into the chromatograph with detection at 
carbon fibre working electrode at different potentials (vs. Ag/Ag3P04)
■172-
B0 5
TIME, min
0 5 10
TIME, min
F ig u r e  5.2. HPLC chromatograms of 40ng/ml terbutaline (a) salbutamol (b) obtained by 
analysis before (A) and after (B) electrochemical pre-treatment of the working 
electrode surface.
blood plasma eluted to waste. Pellicular Cjg material exhibited the most favourable 
retention characteristics for both drugs when compared to Cg or cyano packing 
materials and was therefore chosen as the pre-column packing. The loading/washing 
eluent delivered by pump A was filtered degassed deionised water. Degassed 
deionised water showed good compatibility with the aqueous-based analytical 
mobile phase. It also provided adequate washing in 1.7 min of gross plasma 
interferents. Seven replicate injections of plasma samples containing 30 ng/ml 
plasma salbutamol and terbutaline yielded a RSD within 5% for both drugs.
5 3.2. Study of Analytical parameters
The drugs were detected amperometrically by employing a potential of +1.3 V at 
the working electrode. The peak currents (measured as peak heights on the 
recorder) as a function of concentration were then measured for quantitative 
analysis. The peak current of both drugs were plotted separately versus 
concentrations in the range 20-100 ng/ml plasma, Regression analysis of the data 
was used to establish the calibration curve. As shown from the data in Table 5. 1, 
the method is linear over this range with correlation coefficients of greater than
0.992 over three days during which this experiment was carried out. The intra-assay 
precision (Table 5. 2) was within 7.8% for salbutamol and 5.6% for terbutaline, and 
the inter-assay precision (Table 5. 3) was within 6.7% for salbutamol and 5.5% for 
terbutaline. The accuracy, which was defined as the percentage difference between 
the mean concentration, was 6.8 and 5.5% or better for salbutamol and terbutaline 
respectively.
Table 5 .1 . Linear regreession data (y -  mx + b) and correlation
coefficients (r) fo r  plots of salbutamol and terbutaline.
(a) Salbutamol
Equation of the regression 
line
correlation 
coefficient, r
Day 1 y= 0.027 + 0.022x 0.9998
Day 2 y= 0.016+ 0.024x 0.9980
Day 3 y= 0.040 + 0.02 lx 0.9990
(b) Terbutaline
Equation of the regression 
line
Correlation
coefficients
Day 1 y= 0.033 + 0.034x 0.9990
Day 2 y= 0.032 + 0.036x 0.9998
Day 3 y= 0.084 + 0.032x 0.9920
Table 5. 2. Intra-assay precision
(a) Intra-assay precision for salbutamol
Amount added 
ngml'l
Mean amount found ±SD 
n=6 , ngml'l
Coefficient of 
variation(CV),%
Accuracy
%
2 0 18.4+0.7 4.3 7.8
50 47.5±1.7 3.9 5.0
70 66.4±3.0 5.1 5.1
80 75.8+2.0 3.1 5.2
10 0 97.2+4.5 5.1 2.8
(b) Intra-assay precision fo r  terbutaline
Amount added 
ngml‘l
Mean amount foundtSD 
n=6 , ngmH
Coefficient of 
Variation(CV)%
Accuracy
%
2 0 19.2+0.7 3.8 3.9
50 47.5±1.1 2.6 5.0
70 67.4+2.5 4.0 4.0
80 76.2+2.6 3.8 4.7
10 0 94.4±2.8 3.2 5.6
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(a) Inter-assay precision for salbutamo!
Table 5 .3 . Inter-assay precision
Amount added 
(ngml*1)
Mean amount found±SD 
n=3, ngml'*
Coefficient of 
Variation(CV),%
Accuracy
%
20 18.4±0.8 5.2 6.8
50 47.7*1.5 3.9 4.7
70 67.0±4.3 6.0 4.3
80 75.4±4.0 7.0 5.8
10 0 95.7+3.4 4.4 4.3
(b) Inter-assay precision for terbutaline
Amount added 
(ngml"1)
Mean amount found±SD 
n=3, ngml'l
Coefficient of 
Variation(CV), %
Accuracy
%
2 0 19.0±0.7 4.5 4.8
50 47.6±1.2 3.4 4.9
70 66.9+2.7 5.0 4.4
80 76.0+2.5 4.0 5.3
10 0 94.5±3.0 3.7 5.5
Interference studies on plasma samples co-spiked with caffeine, diazepam, 
paracetamol, phenobarbiton, phenytoin, propranolol, salicylate and theophylline 
gave chromatograms free from any interference. Epinepherine, isoprenaline, 
metadrenaline, methyldopa, norepinephrine, nor-metadrenaline, orciprenaline and 
phenylepherine were detected with retention times different from those of 
salbutamol and terbutaline. A typical chromatogram for a mixture of 
norepinephrine, salbutamol and terbutaline in plasma at the 80ngml~l level is 
shown in Figure 5. 3. The retention times of epinephrine, methyldopa and 
phenylephrine were 5.0, 1.0 and 6.5min respectively.
The total absolute recovery of the method was tested on spiked plasma samples, by 
comparison with directly injected aqueous samples, The recovery of both drugs 
from human plasma at 30, 60, and 90 ngmHwas always more than 94%. The limit 
of detection for the assay was set at 1 ng and 0.8  ng/ml plasma for salbutamol and 
terbutaline respectively (signal-to-noise ratio of 3:1)
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F ig u r e  5. 3. Chromatograms obtained by analysis of plasma containing 80ng/ml of 
norepinephrine (a), terbutaline (b) and salbutamol (c).
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F ig u re  5. 4. Plots of the mean values found with carbon fibre microelectrode flow cell 
(FC) against the mean values found using glassy carbon macroelectrode 
flow cell (GC) for salbutamol (A) and terbutaline (B).
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The proposed method was compared with detection involving the use of macro- 
glassy carbon electrode. A convenient way to compare the two methods is to plot 
the mean values found using the carbon fibre flow cell against the mean values 
obtained using the conventional glassy carbon electrode. Plots for both salbutamol 
and terbutaline are shown in Figure 5. 4, and the data are presented in Table 5. 4. 
Linear regression gave the following equations; y =0.013 + 1 x, r = 0.9996 for 
salbutamol and, y = 0.051 + l x , r =  0.9999 for terbutaline. The results clearly show 
that although slightly higher values are obtained with the microelectrode flow cell at 
low concentrations, a good agreement between the methods was obtained. When the 
results were compared by calculating the respective limits of detection, the use of 
the microelectrode flow cell allowed salbutamol and terbutaline to be detected at 
lower levels than with the conventional flow cell.
Considering the laborious preparation time required for polishing the glassy carbon 
electrode, the detection with the microelectrode flow cell is labour saving and less 
time consuming. These parameters are highly considered in hospital routine work 
for studying of the features of poisoning in relation to plasma concentrations of 
poisoned patients. In conclusion, the necessary assay sensitivity and selectivity 
were achieved with amperometric detection using a microelectrode flow cell. 
Optimisation of the extraction procedure using the column-switching technique 
maximised the recovery and resolution of the drugs, and provided a chromatogram 
free from interference by endogenous substances and other commonly ingested 
drugs. The resulting method proved simple without using extensive sample 
purification, and was fast and reliable in the measurement of the drugs in plasma at 
overdose levels.
Table 5. 4. Comparison of the carbon fibre microelectrode flow  cell 
(CF) with conventional glassy carbon detector (GC)
(a) Salbutamol
Amount added (ngmH) Mean amount found (ngmH) 
CF GC
20 18.4 17.9
30 28.2 27.0
40 37.7 37.2
60 56.8 56.0
80 75.8 75.6
10 0 94.4 94.0
1 1 0 103.6 103.1
(b) Terbutaline
Amount added (ngml'l) Mean amount found (ngmH)
CF GC
20 19.2 18.8
30 28.5 27.9
40 37.3 37.0
60 57.7 56.9
80 76.2 76.5
10 0 94.4 93.9
1 1 0 103.4 103.0
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Determination of Gentian Violet in 
Human Urine and Chicken Feed
Chapter 6
H 7 .
6. 1 .  Introduction
Gentian violet (GV; hexamethyl pararosaniline), also known as crystal violet, is 
classified as a triphenyl methane dye, and has been marketed since 1951 for a 
variety of uses. Crystal violet has anthelmintic properties and has been used in the 
treatment of strongyloid infestation *. The compound has also been used in humans, 
as an antimicrobial agent in the treatment of bum victims, to treat umbilical cords of 
infants, as a vaginal cream, for various purposes in veterinary medicine, and as a pH 
indicator substance. At present, the U.S. Food and Drug Administration (FDA) 
permits the use of GV (8 ppm) in poultry feeds as a mould inhibitor. Crystal violet 
was determined to be mutagenic to Bacillus Subtilis, Escherichia Coli, and 
Salmonella Typhimurium and cytotoxic to mammalian cells 3. Au et al. 4,5 
demonstrated its genetic cytotoxicity to Chinese hamsterovary (CHO) cells. Concern 
about the health risks and carcinogenicity associated with the use of GV requires 
that a routine laboratory method be developed to monitor the drug and its 
metabolite.
Typical approaches for determining GV have involved the use of potentiometry 6 t 
spectrophotometry 7 ancj mass spectrometry8 , and lately by HPLC with 
amperometric detection using a glassy carbon electrode 9. Microelectrodes, 
however, have a lower dependency on flow rate and thus lower noise associated 
with flow rate fluctuations*®" *3,
The method described in this chapter was used to determine GV in human urine and 
chicken feed. The method could also determine GV in the presence of the 
metabolite leuco gentian violet.
6 . 2. E x pe r im e n t a l
6 . 2. 1. R eagents a n d  M aterials
Carbon fibres, 14 pm in diameter, were obtained from Avco, Lowell, MA, USA.. 
Chemicals were used without further purification. All chemicals were of analytical- 
reagent grade, unless otherwise indicated. Gentian violet ( U S P * 4 ) crystal violet 96 
%) was obtained from Sigma and was used to prepare reference standards.
Chicken basal diet containing GV at 0 ppm and fortified feed containing GV at 2.5, 
5.0, and 10.0 ppm were kindly supplied by the National Food Centre (Dublin, 
Ireland). Human urine for control and recovery analyses were provided by healthy 
volunteers. The urine specimens were collected in polycarbonate bottles and were
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stored at - 4°C until analysis. Stock standard solutions equivalent to 0.20 mg ml"* 
GV were freshly prepared in LC grade methanol, mixed and then stored in a cool 
place (ca 4°C) and protected from light. These were diluted and added to GV-free 
urine aliquots to generate spiked urine standards in the concentration range 1 - 3 0  
ppb. The "spiked" samples were left for at least 1 hr before they were analysed to 
permit any possible interactions between the drug and urine constituents.
6 . 2. 2. C yclic Vollammetry
Cyclic voltammetric experiments were initially recorded on blank solutions of 0.05 
M acetate buffer, followed by solutions containing 1 x 10'3 M GV dissolved in
0.05 acetate buffer solution (pH 5.5) at a glassy carbon electrode. These 
experiments were performed with a three electrode system consisting of a glassy 
carbon electrode (EG&G Princeton Applied Research) as working electrode, a 
saturated calomel electrode (SCE) and a platinum wire counter electrode connected 
to an EG&G Princeton Applied Research (PAR) Model 264A potentiostat, and an 
Omnigraph 2000 X-Y recorder. Before any electrochemical measurement, the glass 
cell and the counter electrode were soaked in HNO3 solution, and then rinsed 
throughly with triplydistilled water. Voltammetric conditions were as follows: 
initial potential 0 V; final potential 1.6 V and scan rate 50 mVs-*. Prior to scanning, 
the electrode was cleaned by washing with distilled water, polishing the surface 
with aluminium oxide powder (0.3 jum), rinsing again with distilled water followed 
by acetone and finally drying with a tissue-paper. The presence of any adsorption 
process was investigated by multiple CV scanning without pretreatment of the 
glassy carbon electrode.
6 . 2. 3. Extraction and Clean-up Procedures
6 . 2. 3. 1. Poultry Feed
The sample preparation and clean-up procedures were reported previously by 
Roybal et al 9. Blank feed and sample feed were ground to pass through a 1 mm 
sieve (Pascal Eng. Co. Ltd., Crawley, U.K). Ground chicken feed was mixed, stored 
in a quart glass jar, and kept in a cool, dry place. 2 0  g ground feed was then 
accurately weighed into a 500 ml centrifuge bottle. 200 ml methanol/1 M HC1 
(99+1) was added and the mixture was shaken vigorously for 1 h on a mechanical 
shaker, then left to stand overnight. An appropriate aliquot of the supernatant was 
then pipetted into a 15 ml centrifuge tube according to the following schedule: GV 
(ppm), aliquot (ml)): 10 ppm, 1 ml; 5 ppm, 2 ml; and 2.5 ppm, 4 ml. The aliquot 
was then diluted to 10 ml with mobile phase and mixed. The solution was then
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filtered through a disposable, 5 um polytetrafluoroethylene (PTFE) membrane 
(Millipore Corp., Bedford, MA) into a 25 ml Erlenmeyer flask. 20 pi of filtered 
solution was then injected into the liquid chromatograph. The concentration of GV 
(ppm) in feed was calculated as follows:
ppm = (P/S) x (C/W) x (D) (7)
where P = peak height (mm) obtained from injection of filtered solution, S = 
average peak height (mm) obtained from injection of standard, C = concentration 
(ppm) of injected standard, D = final volume (ml) of filtered solution, and W = 
initial weight of feed sample taken for analysis.
6 . 2. 3. 2. H um an Urine
The procedures for extracting GV from urine speciemens were based on the work of 
Rushing and Bowman *5 a  10 0  mi portion of spiked human urine in a 165 ml 
culture tube was adjusted to pH 7.0 with 6 M NaOH. After the addition of 50 ml of 
dichloromethane the tube was gently shaken by hand for 3 min with care taken to 
prevent emulsification of the contents. The tube was then centrifuged for 5 min at 
500 rpm and the dichloromethane layer removed by syringe, percolated through 20 
g of sodium sulfate in a glass funnel (3.0 cm diameter), and collected in a 250 ml 
round-bottom flask. The extraction process was repeated with two additional 20 ml 
portions of dichloromethane, the sodium sulfate washed with 5 ml of 
dichloromethane, and the combined extracts evaporated to dryness on a 30 °C 
water bath using water pump vacuum. The dry residue was transferred to a 50 ml 
round-bottom flask by using 4 successive 1 ml rinses of the dichloromethane which 
were then evaporated to dryness as described. The residue was finally dissolved in
1.0 ml of methanol and 100 pi (lOg equivalents of urine) were injected for analysis.
6 . 2. 4. H PLC
The HPLC separation used in this study for the chromatographic separation of the 
triphenylmethane dye is similar to those reported by Roybal et al 9. The system 
consisted of a stainless steel column (250 x 4.6 mm i.d.) packed with cyano packing 
material (particle size 5 pm) (Hichrom Ltd, Reading, Berkshire, RG7 4PE, U.K.). 
The mobile phase was acetonitrile-acetate buffer (60 + 40); the acetate buffer was 
prepared by adjusting 0.1 M sodium acetate solution (8.2 g sodium acetate/1000 ml 
deionised water) to pH 4.5 with glacial acetic acid (ca 8 ml). The resulting solution 
had a pH of 6.0. Sample injections to the column were effected via a syringe- 
loading Rheodyne valve (Cotai, CA, U. S. A.). The analytical column was protected
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by a 20 mm direct-connect guard column, (LC-18-DB, Supelco, Inc., Bellefonte, 
PA 16823) packed with CN packing material (Lichrosorb 10 CN, HPLC 
Technology, Macclesfield, Cheshire, U.K.). All solvents used in the HPLC system 
were filtered through a disposable 0.5 pm fluoropore filter (No. FHLP 04700, 
Millipore, Bedford, MA, U. S. A.). Oxidative amperometric measurements were 
performed using an EG&G Princeton Applied Research Model 400 EC potentiostat 
connected to the flow cell by crocodile pins. GV was detected amperometrically by 
employing a potential of + 1.3 V at the working electrode. The resultant signals 
were recorded on a Philips Model PM8261 X-t recorder (Eindhoven, The 
Netherlands) at a chart speed of 300 mm h r" *.
The peak currents as a function of concentration were then measured for quantitaive 
analysis. Operating conditions : LC mobile phase at room temperature; the mobile 
phase flow rate was maintained at 1 .0  ml min'l through the analytical column; 
column temperature, ambient; column pressure, ca. 2500 psi; the normal operating 
current range was set at 20 nA and 2 nA for full-scale deflection for the analysis of 
GV in human urine and polutry feed respectively.
6 . 3. R e su l ts  and  D isc u ssio n
6.3. 1. Cyclic Voltammetrie B eh aviour
A typical cyclic voltammogram for a 1 x 10~3 M solution of GV obtained using a 
glassy carbon working electrode in 0.05 M acetate buffer (pH 5.5) supporting 
electrolyte is shown in Figure 6 . 1. The voltammogram showed one peak on anodic 
scanning between 0 to +1.4 V, with no peak on the reverse scan. The appearance of 
a single anodic peak in the first cycle only, with no cathodic peak on the reverse 
scan, is indicative of the irreversible nature of the oxidation process. Further cycling 
without reactivation of the electrode (scan B) showed complete suppression of the 
anodic peak indicating that the reaction product is strongly adsorbed on the 
electrode surface.
6 . 3. 2. Optim isation o f  H PLC -E D  C onditions
In order to determine the optimum applied potential for amperometric detection 
following liquid chromatography, a hydrodynamic voltammogram was constructed 
for GV (Figure. 6 . 2) by injecting 100 jul of 30 ppb GV standard solutions of the 
compound and recording the detector response at intervals of 0.10 V over a range of 
+ 0.40 V to 1.40 V. The voltammogram verifies that GV undergoes a single 
oxidation within this potential range. The maximum currents were achieved at a
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F ig u r e  6 .1 .  Cyclic voltammogram of 1 x 10 '^ M GV in o.o5 M acetate buffer (pH6) at a 
stationary glassy carbon electrode (A). The inset in (B) shows the cyclic 
voltammo grams obtained after recycling without intervening activation of the 
electrode.
Potential (Volts)
F ig u r e  6 . 2. Hydrodynamic voltammogram obtained for 30 ngml'l GV standard solution.
Mobile phase: acetonitrile-acetate buffer (60 + 40), pH 5.5; working 
electrode: 14 pm carbon fibre.
potential of + 1.40 V; however, the magnitude of the background current was about
0.004 nA at this applied voltage. It was found that reducing the potential to + 1.30 
V afford a significant reduction in background current, which resulted in better 
signal-to-noise ratios; therefore, an applied potential of + 1.30 V was selected for 
the remainder of the LC-ED studies. This was in accord with the observations 
performed with cyclic voltammetry. Using cyclic voltammetric data, existing HPLC 
information and the hydrodynamic voltammogram, the chromatographic system was 
developed to meet the requirement of both separation and detection of GV in 
poultry feed and in human urine.
6 . 3. 3. P retrea tm en t o f  the Carbon F ibre W orking Electrode
The electrode response is usually affected by the features of the sample matrix. 
Urine is a complex medium that contains many complex biological materials that 
can interfere with the performance of the analysis. In the proposed procedure, the 
occurrence of matrix effects (defined as the relative sensitivity in the presence of a 
matrix to that in the absence of of a matrix) during urine analysis was significant. It 
was necessary to counteract the matrix effect when the carbon-fibre electrode 
surface became contaminated. Electrochemical pretreatment was used to solve this 
problem. The working electrode was treated by applying - 1.40 V for 40 s and then 
+ 1.40 V for 40 s (vs. Ag/Ag3 P0 4 ) followed by equilibration for 3 min. When the 
upper potential limit was extended to + 1.5 V, many fibres were either broken or 
provided noisy and erratic oxidation peaks. When this pretreatment procedure was 
applied in the analysis of the urine specimens obtained from healthy volunteers, the 
interferences from other urinary constituents were effectively eliminated (Figure 6 . 
3).
Chemical pretreatment of the carbon fiber electrode were also tried. The working 
electrode was immersed for 20 min in HNO3 , H2 SO4 , H2 O2  and concentrated acid 
dichromate solution. In all these cases the resulting test voltammograms showed 
poor defined peak shapes. The flow system used provides short contact between the 
sample and the active surface allows minimal contamination of the electrode 
surface.
Table 6 . l"a" shows a comparison of precision determined with and without using 
the pretreatment procedure. From this it can be seen that, the absolute and the 
relative standard deviation were significantly lower using the pretreatment 
procedure. The pretreatment regime also improved the correlation coefficient for 
the calibration graph and the sensitivity of the method. Table 6.1 "b" shows that the
Time(mm)
Figure 6 . 3. Influence of electrochemical pretreatment on the current response of the
electrode: (a) Blank urine extract; (b) current response for 5 ngml'l spiked 
urine speciemen after electrochemical pretreatment and (c) current response 
before electrochemical pretreatment. See experimental for additional details.
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Table 6 .1  (a). Comparison o f performance using the electrochemically
modified and unmodified electrode fo r determination o f 4  
ppb GV in human urine.
GV concentration/ppb 
With pretreatment Without pretreatreatment
Absolute error*/ppb 0.35 1.30
R. S. D.(%) 3.49 9.82
* The absolute error is defined as the difference between the measured and the 
certified value of GV.
Table 6 .1  (b). Urine concentrations ofG V  (ppb) before and after 
pretreatment procedures from  urine samples
Concentration of GV found / ppb 
No pretreatment After pretreatment
Urine sample concentration
4.0 ppb 2.81 3.65
7.5 ppb 5.06 7.08
12.5 ppb 8.91 11.88
25.0 ppb 16.74 23.25
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measured concentration of GV in urine is reduced significantly before using the 
pretreatment procedures, making the pretreatment of the electrode an essential step 
for the determination of GV using the microelectrode flow cell. A similar 
improvement was observed when the pretreatment procedure was applied during the 
analysis of the animal feed. One explanation of this behaviour is the increase of the 
effective rates of electron transfer by generating electrocatalytic functional groups 
at the surface of the electrode due to the pretreatment.
6 . 3. 4. Determ ination o f G entian V iolet in H um an Urine and Poultry Feed.
The analytical procedure was then applied to control human urine and poultry feed 
samples to establish the limit of detection and recovery of the method.
6 . 3. 4. 1. Linear Range
A series of external GV standards were prepared in a mixture consisted of 
methanol: water (95:5), and a calibration graph constructed by injecting between 1 
and 30 ppb of GV for standard solutions for urine samples analysis and between 1 
and 20 ppm for polutry feed analysis. Typical chromatograms of the blank and of a 
1 ppm solution of GV are shown in Figure 6 . 4. Peak currents were measured and 
graphs of peak current versus amount injected were constructed. The linear 
calibration curves indicated that the oxidation of GV at the carbon fibre working 
electrode is reproducible over these ranges using the microelectrode flow cell and 
the chromatographic conditions, with correlation coefficients of greater than 0.996 
for both studies. The characteristics of these curves were slope: 1.2 x 10'3 nA/ppb, 
and 9.1 x 10‘2 nA/ppm and intercept 1 x 10~3 nA, 2 x 10 " 3 nA for human urine and 
poultry feed analysis respectively. These calibration ranges were considered 
suitable for the applications being undertaken in this study.
6 . 3. 4. 2. Precision
The method described has been applied to a number of samples of human urine and 
poultry feed. The LC-ED chromatograms obtained for GV extracted from human 
urine and chicken feed as described earlier, showed a well defined peak for GV 
with a retention time of 11 min (Figure 6 . 5 and 6 . 6). The precision was measured 
as the relative standard deviation of a repeated injection of the same quantity of a 
sample at 4, 7.5, and 10 ppb urine samples and at 2.5, 5, and 10 ppm feed samples. 
The results summarized in Table 6 . 2"a" and "b" display an acceptable level of 
accuracy and precision, with RSD ranging between 2.33 to 5.07 %. Using a second 
detector (glassy carbon detector), whose precision was more accurately known, in
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F ig u re  6. 4. Typical chromatogram of peak separation of a calibration standard containing 
GV 1 pgml'l (b) and chromatogram for balnk standard solution.
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F ig u r e  6. 5. HPLC of GV-free human urine (a) and (b) the same urine spiked with 
5 ngml'l. Chromatographic conditions (see text).
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F ig u r e  6. 6. Sample chromatograms of (a) GV-free chiken feed, (b) chicken feed 
containing 2 pgml" 1 G V See text for conditions.
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Table 6. 2 (a). Precision o f the assay in urine
Concentration
spiked/ppb
Mean concentration 
found*/ppb
SD RSD(%)
4.0 3.65 0 . 1 1 3.49
7.5 7.08 0.14 2.33
10 .0 9.45 0.30 5.07
Table 6. 2 (b). Precision of the assay in chicken feed
Concentration Mean concentration SD RSD(%)
spiked/ppb found*/ppb
2.5 2.38 0 .10 5.27
5.0 4.73 0 .1 2 3.22
10 .0 9.60 0.16 2.63
*n = 5
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series with the carbon fibre detector gave 2.0 % RSD for 5 ppb urine injections of 
GV compared with 2.7 % RSD for the microflow cell. Although the figure for the 
microflow cell is slightly worse than for the conventional glassy carbon 
electrochemical flow detector for the majority of trace level determinations this 
precision will be perfectly adequate. Using an automated sample injector it should 
be possible to improve the precision figures for both detection systems. These 
results are in good agreement with those published with other authors.
6 . 3. 4. 3. Recovery Studies
The extraction procedures produced a "clean" extract and consequently good 
recoveries of GV. Table 6 . 3 shows the overall recovery of GV, which was assessed 
by comparing the representative peak currents for spiked urine specimens and 
poultry feed sample taken through the study with the peak current for corresponding 
standards. The recoveries of GV from spiked urine blanks and from chiken feed 
ranged from 91.69 to 94.09 % at ppb levels and from 94.85 to 95.70 % at ppm 
levels and averaged 94.06 %. These recovery levels are satisfactory, and the 
concentration of the "spiked samples" did not appear to influence the recovery of 
GV residues in urine specimens. Data represented in Table 6 . 3 indicates that the 
developed method has good precision.
6 . 3. 4. 4. Interference Study
In many cases quantitation of metabolites in addition to the parent dmg will be 
required if these metabolites are pharmacologically active. Intestinal microflora, 
under anaerobic conditions, are capable of metabolizing GV by reduction to its 
leuco (colorless) f o r m  * 6 .  According to the USA National Center for Toxicological 
Research 17, this leuco derivative (LGV) is then "structurally similar to the 
classical aromatic carcinogens". The possible potential interference of the leuco 
derivative in the detemination of GV was tested using the proposed method.
Figure 6 . 7 shows the chromatogram observed for simultaneous determination of 
GV and LGV. It can be seen from this figure that both forms are well resolved and 
there were no significant effects due to the added interferent. This metabolic 
product would not be expected to interfere in real samples as the level of spiking 
was considerably higher than that normally found in human urine.
Table 6 .3  (a). Recovery o f  spiked GV from  urine specimens.
Sample
GV concentration / ppb
Present Mean amount found* Mean recovery (%)
A 2.0 l .83 91.69
B 5.0 4.63 92.66
C 15.0 14.11 94.09
n — j.
Table 6. 3 (b). Recovery ofG V  from  chicken feed
G V concentration / ppb
Sample Present Mean amount found* Mean recovery (% )
A 2.5 2.39 95.7
B 5.0 4.74 94.85
C 10.0 9.63 95.38
*n = 5.
19%
Time (min)
14 12 10 8 6 4 2 0
Time (min)
F ig u r e  6 . 7. Typical chromatogram of the separation of the leucogentian violet from
gentian violet at + 1.3 V. A: blank urine extract; b: 30ngml_1 spiked human sample.
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6. 3. 4. 5. Sensitivity Comparison
The sensitivity of the proposed method was compared with detection involving the 
use of macro-glassy carbon electrode. In principle, the smaller the working 
electrode the better, because smaller electrodes reach steady states more quickly *8 
The limit of detection was taken to be the concentration at which the signal was 
three times greater than the noise of the base line. A comparison of the limits of 
detection obtained using the microflow cell for determination of GV in human urine 
with that obtained with the conventional cell is illustrated in Table 6 . 4. It was 
anticipated that decreasing the size of the electrode would lead to lower limits of 
detection (more favorable signal-to-noise "S/N" ratios) using the microflow cell, 
compared to the conventional flow cell. The minimum detection limit for the 
method was estimated to be 0.5 ppb; this limit of detection compares favourably 
with previous methods. A secondary source of noise ,other than the interferents 
found in the matrix could be the electronic noise of the potentiostat/current 
amplifier *9 an(j a lower noise level would be expected with a potentiostat more 
suitable for the lower currents encountered with carbon fibre electrodes. The 
carbon-fiber working electrode has a much smaller surface area, so that the currents 
flow through it is much smaller than that through the glassy carbon electrode.
6 . 3. 4. 6 . Flow-rate D ependencies
From the analytical point of view, flow rate independent amperometric detection 
may help to reduce the background noise level, particularly in the case of FI and 
HPLC detection where electroactive impurities lead to baseline fluctuation 
depending on flow rate pulsations. Practically, most HPLC pumps cause 
unavoidable pulsations of the mobile phase2 0 ,2 1
The flow-rate dependency of the carbon fiber microelectrode and 50 um carbon 
disk electrode has been examined by injecting 5 ppb GV in methanol through the 
flow cell. Data illustrating the dependency of peak currents upon the flow rate of 
the running solvent for the electrodes are presented in Figure 6 . 8 for oxidation of 
GV in mobile phase. Each plotted data point is the average of five or more 
replications. From this data the 14 jum carbon fiber electrode is clearly superior to 
the 50 um glassy carbon electrode, which has a larger flow rate dependency of peak 
current. Previous studies demonstrated that an improved signal-to-noise ratio was 
obtained using carbon fiber microelectrodes (compared a conventional glassy 
carbon electrode) at positive potentials^. At these potentials, the oxidation of 
buffer impurities gave rise to noisy baselines at glassy carbon electrode because of
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Table 6. 4. Detection limits0 fo r  the determination of GV using the
microelectrode and macroelectrode methods coupled with 
HPLC analysis
Limit of detection / ppb
Conventional flow cell 0.80 ppb
Carbon fiber flow cell 0.50 ppb
a Detection limits (S/N ratio of 3:1) calculated in units of concentration of 
GV added to human urine specimens
b Conditions: mobile phase, acetonitrile-acetate buffer pH 6 ; (60+40); 
applied potential, + 1.3 V vs Ag/Ag3 PC>4 reference electrode; flow rate,
1 .0  ml min'l.
2 o f
Cu
rr
en
t 
(n
A
)
Flow rate (ml/min)
F ig u r e  6. 8. Flow rate dependency of peak current for oxidation of GV in mobile phase: 
E = +1.3 V vs. Ag3 PC>4 ; (o) carbon fiber microelectrode; (a) conventional
glassy carbon macroelectrode.
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F ig u re  6. 9. Peak currents obtained from the first five and the last five urine samples of 20 
consecutive injections over a period of lOh. GV was spiked into human urine 
at 5 ngml'l.
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the strokes of the liquid chromatography pump; the microelectrode flow cell was 
much less susceptible to this noise.
6 . 3. 4. 7. Stability Studies
The stability of the urine samples and the carbon fibre electrode was examined. The 
stability of the samples at room temperature was tested by making 2 0  consecutive 
injections of the same urine over a period of approximately 10 h. As demonstrated 
in Figure. 6 . 9 , there were no significant changes in the peak current between the 
first five and the last five. In fact, there was no significant changes in the 
chromatograms after the consecutive injections. This indicated that the urine 
samples containing the drug were stable at room temperature during the test period. 
In addition, urine samples spiked with the test compound were stable for more than 
20 days at -4®C.
The stability study results also indicated the carbon fiber was performing extremely 
well even after a large number of injections. In fact, the same carbon fiber had been 
used for 10  different urine samples before the first sample of the stability study was 
injected. These results suggest that the carbon fiber electrode could endure more 
than 30 injections of urine samples before replacement was needed.
6.4. C onclusion
This research describes a sensitive LC-ED method for quantitative analysis of GV 
in human urine and chicken feed using an electrochemical microelectrode flow cell. 
The detector has been found to exhibit a considerable improvement in the limit of 
detection and in some instances decreased dependence on flow rate over that found 
with the conventional method under these experimental conditions. It is considered 
that the method will be useful for both clinical and pharmacokinetic studies.
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Determination of Malachite Green in 
Environmental Samples
Chapter 7
2 ù é >
7. 1. IN T R O D U C T IO N
Malachite green, like most dyes, is known by a number of synonyms; most of these 
are trade names and the dye may be sold under synonyms such as Victoria Green B 
or WB, New Victoria Green Extra O 1 or II, Diamond Green B, BX or P extra, 
Solid green O, Light Green N and Astramalachite Green. Despite the active use of 
malachite green in fisheries practice for 50 years, the history of its use has been 
punctured by continuing series of misunderstandings and confusion. A detailed 
history of the development and manufacture of malachite green was described by 
Karri. There is considerable scope for further research, particularly into areas such 
as possible tetragenic effects, effect on host and pathogen, and environmental 
persistence. The use of malachite green will undoubtedly continue^, since no 
alternative effective compound has so far been discovered. Provided that due care is 
excercised in its use, no significant problems should be anticipated. Treatment side 
effects were first reported by Mazuranich and Nielson^, who noticed that the 
incidence of "white spot" disease in silver salmon increased when eggs were treated 
with 5 mg/L (1:200,000) malachite green for one hour every other day. Malachite 
green reacts with oxygen in the water, thereby lowering dissolved oxygen. High 
initial oxygen levels will help prevent anoxia during treatment^. The bacteriostatic 
action of malachite green is due to its three six-membered (phenyl) rings and the 
two substituted amino groups, each with two ethyl radicals^. The triaminotriphenyl 
methane dyes (crystal violet, parafuschin and new magenta) have increased activity 
because of the alkylated amino groups on the three phenyl rings, allowing 
resonance among all three rings instead of only two6 . Enzyme studies indicated that 
the dye causes irreversible inhibition of thiol enzymes, and irreversible inhibition of 
non-thiol enzymes?. In the case of trypsin, malachite green combines mainly with 
the imidazole groups of histidine residues.
The leuco (colourless) form of malachite green is non-toxic , possibly because of its 
non-polar structure^. Leucomalachite green tends to reduce the toxic effects of the 
latter. Evidently, MG is detoxified by reduction to LMG^. Malachite green injected 
intravenously into male rats (3.0 to 3.5 mg/100 gm body weight) was acutely toxic, 
producing clinical signs of asphixiation^. Histological examination revealed excess 
fluid in the lungs and electrocardiograms indicated a slower heart rate. Cytochrome 
C injections (2mg per mg malachite green) abolish intoxication symptoms. In vitro, 
malachite green did not affect oxygen saturation of haemoglobin or intact human 
erythrocytes. There was no marked reduction in blood oxygen in samples taken
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after poisoning, indicating that the hypoxic effect of the dye is probably of 
endogenous origin.
The lethal oral dose of malachite green for rabbits is 75 mgkg'* daily; death occurs 
within six to ten days*®. Ingestion causes diarrhea and abdominal pain. 
Intraperitoneal injections of 0.1875 mg malachite green in physiological saline are 
lethal to mice; similar injections of 1.5 mg malachite green are lethal to rats.
Because of the staining properties of MG, careful handling is necessary; preparation 
of stock solution helps to minimize handling difficulties. Users should wear 
protective clothing and avoid contact with the chemical since it is carcinogenic* *.
Today's environmental sample may be either aqueous, organic liquid, organic or 
organic solids, sludge or slurry, or a combination thereof. The one thing they have 
in common is that each sample represents a small part of the whole and may vary 
from a one-second grab to a several-day composite sample. The laboratory should 
be familiar with the sample type, source, and sampling procedure as well as with 
any safety information required for handling. This knowledge will prevent the 
analysis of a sample of questionable validity and assist the laboratory in taking a 
subsample for analysis. The laboratory should have written procedures for proper 
praparation of equipment and containers for sampling, and description of sampling 
procedures for use by field sampling personnel.
Besides the original acquisition of the sample, the taking of the subsample for use in 
the laboratory is most critical and often overlooked or treated lightly, e.g. shaking a 
sludge sample for 2 min and pouring or pipeting off 25 ml will not yield a 
representative sample. A representative sample normally requires the use of a high 
speed blender from which the sample is withdrawn at different liquid levels while 
being blended. Therefore, procedures to assure that possible errors in sampling and 
subsampling should be addressed and minimized.
The Environmental Protection Agency (EPA) in the USA have produced a 
m a n u a l * 2 0f standard methods for analysis of polluants in waters. These include 
methods for multiclass analysis, for example, analysis of about 40 chlorinated, 40 
organophosphorous and seven carbamate polluant species. A problem in the 
analysis of residues in water is whether the residue is actually in the water or in 
suspended particles of silt, soil, plant material, or even aquatic animal life. Water 
samples may vary from the crystal-clear water of a mountain stream to the deep 
green water of a stagnant lake or the brown of flood water saturated with suspended 
solids. If only the residue in the water is of interest, other material must be
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removed. Filtration is adequate for most water samples, but where there is a 
suspension of colloidal material, the addition of a small amount of a divalent salt 
such as calcium chloride to flocculate the clays is recommended. In some cases 
centrifugation will also be necessary. Residues in water are usually very low. This 
means that a considerable concentration is required before the residue can be 
detected by HPLC. This may take the form of a partition into a water-immiscible 
solvent or removal of the residue on to a column either by adsorption or ion- 
exchange and subsequent elution in a smaller volume. Problems may arise with 
each of these systems. If a solvent that is lighter than water is used, then the 
emulsion can sometimes be dispersed by adding sodium chloride, which increases 
the difference in density and also affects the surface tension of the water. It is 
usually necessary to partition more than once for complete recovery of the residue. 
The use of a solvent that is heavier than water makes the process easier since it can 
be run out of the bottom of the separating funnel.
Slow flow rates are the main problem associated with traditional adsorption 
columns although a pump can be used. Waters Sep-Pak columns are reproducible, 
disposable, and easy to use.
Enviromental analysis for trace phenols are among the most important applications 
of HPLC with electrochemical detection, especially of waters, as the samples can be 
injected into aqueous mobile phases without any pretreatment, provided that the 
analyte concentration is not less than ca. 20 ngml"*. At lower concentrations, off­
line or on-line enrichement is necessary, e.g. by adsorption on silica gel, liquid- 
liquid extraction, ion-exchange or trapping in cartidges containing a reversed phase 
packing. For example, traces of phenols (0.1-10 ngml"*) have been determined in 
potable water*3,14 Microarray working electrode*^ was used for determination of 
carbamate pesticides (e.g. amino carb, carbendazine, chlorporpham, desmediphan) 
in river water, these compounds can be oxidised at about +1.1 V*6 . The detection 
limits varied from 40 to 150 pg (2-7 ngml"*) and the response was linear over three 
concentration decades*?. The sample pretreatment was minimal and the detection 
limit was lower by a factor of 60 than that with glassy carbon electrode. Most 
phenols are electroactive and either oxidised at solid electrodes within the potential 
range from + 0.7 to +1.1 V (Figure 7. 1), or reduced at mercury electrodes (e.g. 
nitrophenols).
In Europe, malachite green is regularly used for the control of Saprolegnia 
parasitica and also in the treatment of proliferative kidney disease (PKD). Its use is 
controlled within the EEC by guidelines laid down in each of the individual
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Fig. 7. 1. P otential regions o f th e  ox idation  o f  som e phenols o f  environm ental 
in te re s t. E m pty  boxes —  irreversib le  oxidation ; shaded  boxes — a reducible produci 
is fo rm ed , which is not the p rincipal oxidation  p ro d u c i; solid boxes —  reversible 
o x id a tio n . C arbon  pas te  e lec tro d e , m edium  o f 90%  v/v 0 . \ M  c itra te . pH  4.0, and 
10%  e th an o l. P o ten tia l scan ra te , 200 m V /sec. 1 —  Phenol; 2 —  catechol; 3 —  
hy d ro q u in o n e ; 4 —  2 -m ethy lpheno l; 5 —  4 -m e ih y lp h e n o l;6 — 3.5-dim ethylphenol; 
7 —  2.4-d im ethy lphenol; 8 —  2 ,3 .6 -trim eth y lp h en o l; 9 —  2,3,5-trim ethylphenol; 10 
—  2-ch lorophenol; 11 — 3-ch lo ropheno l; 12 —  4-chlorophenol; 13 —  2.4-dichloro- 
p h e n o l; 14 —  2 .5 -d ich lorophenol; 15 —  2,4 .6 -irich lo ropheno l; 16 — 2.4.5-trichloro- 
p h e n o l; 17— 2 ,3 ,4 .6 -te trach lo ro p h en o l; 18— P cn tach lo ropheno l; 19—  l-naphtho l; 
20  —  carbo fu ran  p h en o l; 21 —  4*m ethylth iophenol.
Reproduced from Stulik, K. and Pacakova, V., EJectroanalytical 
Measurements in Flowing Liquids, Wiiey, New York, 1987, p. 239.
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member states. In Ireland, these state that the concentrations of malachite green in 
fish farm water effluent and water extracted for drinking water purposes should not 
exceed 100 jig/1 and 1.0 jig/1 respectively Under the fisheries and agriculture 
research programme (FAR), an EEC project into the the environmental fate of 
malachite green is presently being carried out in Trinity College Dublin.
In response to concerns regarding the health risks associated with the use of 
malachite green, an increasing number of methods have been developed in the past 
decade for its determination in environmental samples and food fish tissue.
A thin-layer chromatographic (TLC) method was first used for the analysis of 
malachite green residues in edible f i s h  18. A methanolic solution of material 
extracted from fish was analysed by TLC on silica gel followed by densitometric 
detection and quantitation at 610 nm. An extension of this w ork^ made use of a 
high performance liquid chromatographic (HPLC) separation on a LiChrosorb RP-8 
or Spherisorb Octyl column with subsequent spectrophotometric detection and 
quantitation at 600 nm.
The simultaneous determination of malachite green and methylene blue in rainbow 
trout and amago muscle using high performance liquid chromatography with 
subsequent spectrophotometric d e t e c t i o n ^  has recently been reported. Residues of 
malachite green were determined, using a colorimetric method, in muscle, eggs, and 
fry of Atlantic salmon (Salmo salar) and chinook salmon (Oncorhynchus 
tshawytscha) which had been treated with the chemical at fish hatcheries^l. Allen 
and M e i n e r t z 2 2  reported on a post-column reaction for the simultaneous analysis of 
chromatic and leuco forms of malachite green and crystal violet by high- 
performance liquid chromatography with spectrophotometric detection at 588 nm. 
This system made use of a post-column reaction chamber containing Pb02 situated 
between the HPLC column and the spectrophotometric detector. Separation of the 
leuco and chromatic forms of the dye was effected on the HPLC column, after 
which they passed through the post-column reaction chamber and subsequently into 
the spectrophotometric detector. This method has recently been applied to the 
analysis of the chromatic and leuco forms of malachite green in w a t e r 2 3 .  The 
method proved successful for the determination of the chromatic form of malachite 
green in river and drinking water samples. In addition, it was also possible to carry 
out the simultaneous analysis of the chromatic and leuco forms without the need for 
post-column modification.
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7. 2. EX PER IM ENTA L
7.2.1.  C hem icals and R eagents
Malachite green oxalate and leuco malachite green were obtained from Aldrich 
(Gillingham, Dorset, UK) and from BDH (Poole, UK) respectively. Acetic acid 
(Analar grade) was supplied by BDH and HPLC grade methanol was supplied by 
Labscan Analytical Sciences (Dublin, Ireland). Analytical grade sodium dihydrogen 
orthophosphate was obtained from BDH. This compound and the supporting 
electrolyte were used without purification.
Deionised water was used throughout this work and was obtained by passing 
distilled water through a Milli-Q water purification system (Millipore, Milford, 
MA, USA).
7. 2. 2. Apparatus
Voltammetric studies were performed using an EDT potentiostat (EDT Research, 
London, UK) in conjunction with a JJ X-Y Model PL4 recorder (JJ Lloyd 
Instruments Ltd, Southampton, UK). A three electrode cell system was employed, 
incorporating a 0.28 cm^ area glassy carbon electrode (EG&G Princeton Applied 
Research), a saturated calomel reference electrode and a platinum counter electrode-
Amperometric measurements were performed using an EG & G Model 400 EC 
potentiostat (EG&G Princeton Applied Research) connected to the flow cell by 
crocodile pins.
Malachite green was detected amperometrically by employing a potential of +1.2 V 
at the working electrode. The resultant signals were recorded on a WPA Model CQ 
95 X-t recorder (WPA, Linton, Cambridge, UK). The peak currents (measured as 
peak heights on the recorder) as a function of concentration were then measured for 
quantitative analysis.
Malachite green was separated on a 250 x 4.6 mm i.d. cyano (CN) stainless steel 
column, particle size 5 pm, (Hichrom Ltd, Reading, Berkshire, UK) using a 70/30 
methanol/0.1 M sodium acetate, pH 4.5. A Waters Model 501 HPLC pump was 
used for mobile phase delivery and sample introduction was via a Rheodyne 
(Cotati, CA, USA) Model 7010 injection valve, fitted with a 20 pi loop for direct 
injection. For extraction purposes, Techelut 100 mg/1.0 ml cyano solid phase 
extraction cartridges (HPLC Technology, Cheshire, UK) were used in conjunction 
with a Techelut 12 position manifold.
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7. 2. 3. Voltammetric Procedures
The supporting electrolytes used for pH and cyclic voltammetric studies were 
prepared from a 0.1 M stock solution of sodium dihydrogen orthophosphate. All 
solutions were prepared in deionised water and were adjusted to the required pH 
with 0.2 M orthophosphoric acid or sodium hydroxide.
Cyclic voltammetry was performed on solutions containing lx l0 '3  M malachite 
green dissolved in the supporting electrolyte. Voltammetric conditions were as 
follows: initial potential 0.0V; final potential +1.3 V; scan rate 50 mV/s; current 
range 20 p A .
Hydrodynamic voltammetric studies were carried out by injecting 5 mg/1 of 
malachite green, dissolved in 95 % methanol containing 0.05 M sodium acetate, pH 
4.5, into the chromatograph with the detector set at different working potentials vs 
Ag/Ag3P04.
Cleaning potentials of +1.3 V and -1.3 V were applied for 60 seconds respectively 
between each injection. Hydrodynamic voltammograms were constructed by 
plotting the peak current against the applied potential. The optimum potential for 
malachite green determination was found from the position of the plateau on the 
hydrodynamic wave.
1 . 2 .  A. E xtraction Procedure
Drinking water samples were collected from the Dublin city water supply and river 
water samples were collected from Arklow, Co. Wicklow. The samples were stored 
in plastic containers at 4°C on return to the laboratory prior to analysis on the same 
day.
Drinking water and river water samples were adjusted to pH 5.0 with acetic acid 
and spiked with 1 ug/1 malachite green prior to extraction and preconcentration on 
the solid phase extraction cartridges. These cartridges were preconditioned with 2 
ml of methanol followed by 5 ml of deionised water. 250 mis of the spiked water 
sample was eluted through the column at a flow rate of 7 ml/min after which the 
retained malachite green was eluted with two 0.5 ml volumes of mobile phase. 
These 0.5 ml aliquots were combined and used for chromatographic analysis.
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The liquid chromatographic analysis of the chromatic form of malachite green was 
based upon the method of Roybal et al^4. The chromatography of malachite green 
was investigated by varying the methanol content and the pH of the mobile phase.
The chromatographic separation of the chromatic and leuco forms of malachite 
green was carried out on a cyano column using 70/30 methanol/0.1 M sodium 
acetate, pH 4.5 with amperometric detection at +1.2 V vs Ag/Ag3 PC>4 .
7. 2. 6 . C alibration, R ecovery an d  R eproducibility
Calibration graphs were constructed by plotting peak current against concentration 
for a series of chromatic malachite green standards, prepared in mobile phase, at a 
potential of +1.2 V vs Ag/Ag3 P0 4  and a mobile phase flow rate of 0.9 ml/min.
Aliquots of malachite green standards, made up in 0.1 M sodium acetate, pH 4.5, 
were added to drinking water and river water samples to give final concentrations of
1.0 pg/L. Replicate spiked samples and the corresponding blanks were extracted 
according to the extraction procedure previously described. Recoveries of chromatic 
malachite green from drinking water and river water samples were assessed by 
comparing the peak currents obtained for the extracts with those of standard 
solutions.
The reproducibility of the method was ascertained by determining the relative 
standard deviation of five successive measurements of extracts of water samples.
7. 3. RESULTS AND DISCUSSION
7. 3. 1. Voltam m etric B eh aviour o f  M alachite G reen
The voltammetric behaviour of the chromatic form of malachite green was studied 
over the pH range 4 - 12 in 0.05 M phosphate buffer using differential pulse 
voltammetry (DPV) at a glassy carbon electrode. The single anodic peak obtained 
in the range studied was found to be pH dependent.
The equation relating peak potential to pH for those pH values up to 6.5 was 
calculated to be:
7. 2. 5. Chromatographic Separation o f  Chromatic M alachite Green
Ep = 1.03 - 4.36 x IQ'2 pH (V) (8)
2 1H-
The equation describing the relationship between peak potential and pH for those 
pH values over 6.5 was found to be;
Ep = 0.87-1.81 x 10*2 pH (V) (9)
A plot of pH against peak current indicated a pKa value of 6.5. This value is in 
close agreement with the value of 6.9 previously reported25.
In the cyclic voltammogram of malachite green, no cathodic peaks were present in 
the reverse scan, thus indicating that the oxidation process was irreversible in 
nature.
7. 3. 2. C hrom atographic A nalysis o f  C hrom atic M alachite G reen
In the initial chromatographic studies, variations were made in the mobile phase 
composition to optimise the analysis time and peak width. A mobile phase 
composed of 70/30 methanol/sodium acetate buffer, pH 4.5 yielded the optimum 
results.
In order to determine the working potential used for the amperometric detection of 
malachite green, hydrodynamic voltammograms were constructed.
The hydrodynamic voltammogram shown in Figure 7. 2 exhibited one wave, a 
finding which was in accordance with the results obtained from the pH and cyclic 
voltammetric studies. The hydrodynamic voltammogram indicates that a working 
potential of +1.3 V was required for maximum response. However, at potentials 
greater than +1.2 V, both the background current and noise levels increased rapidly. 
Consequently, a potential of +1.2 V was used throughout the study, as this gave the 
optimum signal to noise ratio.
A pretreatment protocol which improved the peak current involved the pre- 
anodisation of the microelectrode at +1.3 V for 60 seconds followed by 
cathodisation at -1.3 V for 60 seconds vs Ag/Ag3P04, followed by equilibration at 
+1.2 V for 3 min.
7. 3. 3. Precision o f  M eth o d
Calibration curves prepared on each of three successive days were linear over the 
range 0-15 mg/1 with correlation coefficients of greater than 0.999 as shown in 
Table 7. 1.
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Figure 7. 2 . Hydrodynamic voltammogram of malachite green obtained by injecting 5mg/l 
malachite green into the chromatogram with subsequent detection at the 
carbon, fibre working electrode at different potentials (vs Ag/Ag3PC>4).
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The reproducibility of the method was determined from five replicate injections of 
5 mg/1 and 0.25 mg/1 standard solutions. Typical reproducibilities, determined from 
the coefficient of variation of the peak currents, of 3.6% and 5.4% were achieved at 
the 5 mgL'l and 0.25 m gl'l levels respectively.
The detection limit, defined as three times the signal to noise ratio, was 0.1 mgH. 
However, as previously mentioned, a lower detection limit should be possible with 
the use of a potentiostat designed to specifically measure the low currents at carbon 
fibre microelectrodes.
Table 20. Regression equations and correlation coefficients fo r  calibration
curves in the range 0 - 1 5  mg/L prepared on each o f three successive 
days
Day Regression
equation
Correlation
Coefficient
1 y= 0.01068 +0.20155x 0.9997
2 y= 0.02328 +0.21557x 0.9998
3 y= 0.01821 +0.21392x 0.9998
7. 3. 4. Analytical Application
The chromatographic method was applied to the analysis of drinking water and 
river water samples spiked with 1.0 ¿ig/L chromatic malachite green. In Figure 7. 3, 
chromatograms are shown for a blank drinking water extract and a spiked drinking 
water extract.
The chromatograms show well defined peaks for the chromatic form of malachite 
green with a retention time of 5.9 minutes. There were no late eluting peaks in the 
analysis, thus enabling successive injections to be made without the need for a wash 
period.
The mean recoveries for malachite green were found to be 82% and 41% in 
drinking water and river water samples respectively. The reproducibility of the 
determination was measured by carrying out successive injections for drinking
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Figure 7. 3. HPLC chromatograms of drinking water extracts,(A) blank drinking water 
sample (B) drinking water sample spiked with 1 ¿ig/1 malachite green.
2 i t
i
water extracts. The reproducibility, as determined by the relative standard 
deviation, was 6.5%.
In Ireland, the current directives on malachite green in water state that the 
maximum permissible levels in fish farm effluent water and water extracted for 
drinking purposes should not exceed 100 pgl'* and 1.0 jigl'* respectively. The 
chromatographic method described here is capable of determining malachite green 
at the 1 .0  pgl'l level.
The sample analyses were carried out in the nanoampere (nA) current range. The 
use of lower current ranges was prohibited by the presence of early eluting 
electroactive species which in the low current ranges produced large 
chromatographic peaks that obscured the analyte peak of interest. As part of 
continuing research in Trinity College Dublin, the incorporation of an extraction 
procedure into the analytical methodology is being investigated. It is hoped that this 
will eliminate these electroactive species thus allowing sample analyses to be 
carried out in the lower current range, and as a consequence improve the detection 
limits.
The low recoveries of malachite green from river water samples was thought to be 
due to its sorption on organic material in the water column. The fraction of 
dissolved or colloidally dispersed organic macromolecules, such as humic 
substances or non-filterable particles in natural waters, have been shown to exert 
significant sorptive properties towards organic compounds. Harrison et al. indicated 
that organic compounds of low solubility exist in the water column primarily sorbed 
on suspended solids^^. The accumulation of such organic compounds in sediments 
has been attributed to their sorption on suspended solids and subsequent settling^?. 
Similar findings were reported by Rushing and Bowman^S for the analysis of 
gentian violet in wastewater. The low recoveries encountered during this analysis 
were attributed to the adsorption of gentian violet onto particulate matter present in 
the wastewater.
Further chromatographic work is in progress to determine the extent to which 
malachite green is sorbed onto organic matter. This speciation work is of 
considerable importance in elucidating the distribution of malachite green in a water 
system.
2/<?
7. 3. 5. Electrode Stability
The stability of the electrode is of importance in order to define the period of time 
over which the electrode can be used without a significant decrease in the 
sensitivity. The response of the electrode to a 5 mg/L malachite green standard 
solution was measured over a nine day period. As shown in Figure 7. 4, a 
significant decrease in the response was observed after the fourth day.
The carbon fibre flow detector yielded peaks whose currents had relative standard 
deviations of 5.4 %, 4.8 %, 6.1 % and 5.6 % on each of the first four days 
respectively. After 6 and 9 days of continuous use, the electrode response was 61% 
and 38% respectively of its initial value, with relative standard deviations of 9% 
and 11%. There was no leakage from the electrode during its operating lifetime and 
the nature of its construction made it very stable in the mobile phase.
As the carbon fibre working electrode can be easily and cost effectively replaced, 
this decrease in sensitivity is not of major consequence. The use of a glassy carbon 
macroelectrode would otherwise require extensive physical cleaning and polishing 
steps to renew the electrode surface and consequently regain a sensitive response.
7. 3. 6 . A nalysis o f  Chrom atic and Leuco M alach ite  Green
The chromatographic separation and detection of the chromatic and leuco forms of 
malachite green, shown in Figure 7. 5, was achieved on a cyano column using a 
mobile phase composed of 70/30 methanol/0.1 M sodium acetate, pH 4.5 and 
amperometric detection at +1.2 V. Under these conditions the leuco and chromatic 
forms of malachite green separated into two well resolved peaks with retention 
times of 5.0 and 5.9 minutes for the leuco and chromatic forms respectively.
This ability to simultaneously analyse the chromatic and leuco forms is of great 
importance in studying the biotransformation of malachite green into its leuco form. 
Werth et al.29, have shown that the organs of rats, injected with malachite green, 
contain a considerable proportion of leuco malachite green two hours after 
injection. Although never tested, the leuco form of malachite green is structurally 
similar to classical aromatic amine carcinogens. In their study on the detoxication of 
malachite green in rats by the formation of the leuco form of malachite green, the 
authors determined the distribution of leuco malachite green in tissues by carrying 
out the photometric titration of leucomalachite green with potassium permanganate 
in a weak acid solution. However, extreme care had to be exercised in order to 
ensure that there was quantitative oxidation whilst at the same time avoiding excess
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Figure 7. 4. Current response of carbon fibre working electrode to a 5 mg/1 malachite 
green .solution over a nine day period.
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Figure 7. 5. Typical chromatograms for (A) 5 mg/1 leuco malachite green and (B) a
mixture .containing 5 mg/1 of chromatic and leuco forms of malachite green.
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titration of potassium permanganate which would otherwise cause oxidative 
destruction of the molecule. In addition, the background presence of the chromatic 
form of malachite green in the sample extract meant that its concentration had to be 
determined prior to the titration.
Allen et al.22,23 have previously reported on the use of a post column oxidation 
step to allow the determination of the chromatic and leuco forms by 
spectrophotometric detection. This involved the packing and incorporation of a lead 
dioxide column into the chromatographic apparatus.
The use of the chromatographic method described here should allow direct analysis 
of a sample extract for chromatic and leuco forms of malachite green without the 
need for any post column modification procedure, as the use of the carbon fibre 
flow cell represents a small volume, easily incorporated system which can be 
simply maintained and replaced when the sensitivity of the response decreases.
At the present time, work is being carried out as part of ongoing research in Trinity 
College Dublin to adapt this methodology to the simultaneous analysis of the 
chromatic and leuco forms of malachite green in tissue samples.
As the leuco form is one of the final intermediates in the production of chromatic 
malachite green, it is therefore a potential contaminant in commercial supplies. The 
use of the HPLC method described is ideally suited for rapid quality control of the 
final product to determine possible contamination from leuco malachite green.
7 .4 .  C o n c l u sio n s
A high performance liquid chromatographic method has been developed for the 
analysis of chromatic malachite green in drinking water and river water, based on 
solid phase extraction, reversed phase chromatographic separation on a cyano 
column and amperometric detection using a carbon fibre flow cell. The method 
compares favourably with that reported by Allen et a l ^ .  The use of 
electrochemical detection in conjunction with high performance liquid 
chromatography permits the sensitive and reproducible determination of the 
chromatic form of malachite green in drinking water samples at those levels 
required under current legislation. In terms of detection limit, a lower value should 
be obtainable with the use of a potentiostat specifically designed for the 
measurement of the small currents associated with microelectrodes.
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The use of electrochemical detection for the analysis of malachite green shows
potential for the simultaneous determination of its chromatic and leuco forms. Both
the parent drug and the metabolite can be measured in a single chromatogram using
LC-ED.
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